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Abstract  XI 
Abstract 
 
This thesis encompasses the first molecular characterisation of SH3 protein expressed in 
lymphocytes 2 (SLy2), a novel member of the recently described SLy family of adapter 
proteins. SLy2 was previously identified as hematopoietic adapter containing SH3 and SAM 
domains 1 (HACS1) on the basis of its deregulated expression in different hematopoietic 
cancer cell lines (Claudio et al., 2001). Database analysis defined an identical modular 
organisation of SLy and SLy2, with an N-terminal NLS-, a central SH3- and a C-terminal SAM 
domain.  
SLy2 is expressed throughout the hematopoietic tissues, but also in muscle, heart, brain 
and colon. In vivo overexpression in B cells of a transgenic mouse line established a role for 
SLy2 in the initial spreading and contraction of B cells in response to contact with antigen 
containing surfaces. In vitro overexpression of wildtype SLy2 protein in HeLa cells resulted 
in the prominent and robust induction of branched F-actin structures like lamellipodia and 
peripheral ruffles, to which SLy2 also specifically localised. This primary effect was 
accompanied by markedly enhanced spreading and correlated with diminished 
proliferation, most probably due to defective cytokinesis in SLy2 overexpressing cells. A 
detailed analysis of HeLa cells overexpressing different SLy2 deletion mutants could define 
the impact of the various domains on the function of SLy2 and especially demonstrated 
the importance of the SH3 domain. Furthermore, the conserved serine residue 23 could be 
identified as a potential switch for regulating SLy2 activity.   
Overexpression studies with different point mutants of Rac1 suggested a direct role for this 
small GTPase in the SLy2 induced F-actin structures, as dominant negative Rac1N17 
abrogated the F-actin inducing effects of SLy2, whereas constitutively active Rac1V12 even 
enhanced this phenotype.   
Ultimately, the members of the cortactin family of nucleation promoting factors (NPFs), 
cortactin and its lymphocyte homologue HS1 could be identified as interaction partners of 
SLy2. As their role in the induction of lamellipodia and immunological synapses (IS) has 
been clearly established before, they are highly likely to represent the downstream 
effectors of SLy2 activity.  
 
With the generation of gene targeted SLy2 deficient mice, an in-depth analysis of this 
novel regulator of branched F-actin structures in vivo is now possible.  
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1. Introduction 
1.1. Adapter proteins in cell signalling 
Signal transduction is enabled by the concerted actions of modifying enzymes, such as 
kinases, phosphatases, proteases, ubiquitinases etc., their target proteins and a distinctive 
set of adapter proteins that serve as molecular scaffolds for the former to assemble and 
interact. Given the abundance of many signalling proteins and the high degree of 
redundancy between different signalling pathways, the spatial organisation of interactions 
is of pivotal importance to ensure the specificity of the transduced signal. This specificity is 
frequently brought up by the action of adapter proteins that consist of multiple protein-
protein interaction domains, bringing the target proteins into close vicinity. In addition, 
many adapter proteins contain domains that mediate binding to lipid motifs, thereby 
locating the signalling complexes to the plasma membrane.  
Src homology 2 (SH2) and Src homology 3 (SH3) domains belong to the most highly 
abundant and best known protein-protein interaction domains. Both were first described 
in the non receptor tyrosine kinase (non-RTK) Src (Hidaka et al., 1991; Koch et al., 1991). 
SH2 domains bind highly specific to phosphorylated tyrosine residues and thus imply the 
capacity to integrate the activational status into a binding decision. Well established is the 
binding of two SH2 domains to the two phosphorylated tyrosine residues in 
immunoreceptor tyrosine based activation motifs (ITAM), that are present in many 
intracellular domains of different immune receptors, such as Igα and Igβ (Underhill and 
Goodridge, 2007). Also SH3 domains are widely distributed across the proteom and 
mediate binding to evolutionary conserved proline rich sequences that display the 
consensus sequence pxxp, where p stands for proline and x for any amino acid (Feng et al., 
1994). Worth mentioning, also an interaction with ubiquitin-containing structures has 
been reported recently (He et al., 2007). In contrast to the phospho-tyrosine binding SH2 
domains, the binding of SH3 domains to their target sequences is not intrinsically 
regulated but rather controlled by the accessibility of the binding regions. The issue of 
specificity is obvious in adapter protein – target protein binding and indeed, SH3 domains 
show a high degree of promiscuity when analysed in in vitro binding assays. Apparently, 
the amino acid composition of the close vicinity of the proline rich sequence or the SH3 
domain is of major importance here.  
Sterile-alpha-motif (SAM) domains were first described in the yeast Saccharomyces 
cerevesiae and the fruit fly Drosophila melanogaster and named according to their 
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abundance in sex determining proteins and high content of α-helices. They are abundant 
throughout the whole mammalian genome, yet their function is still not completely 
elucidated, and even high sequence identity between two SAM domains can not 
necessarily predict similar functions. SAM domains are involved in protein-protein 
interactions through their ability to homodimerise. However, also differing protein 
domains can be bound in a heterologous fashion. Additionally, they have been described 
to bind RNA molecules, e.g. in the case of the protein Smaug from D. melanogaster (Qiao 
and Bowie, 2005). 
1.1.1. The SLy protein family 
In 2001, two reports described the identification of novel and homologous proteins, 
characterised by the presence of two protein-protein binding domains (an SH3 and a SAM 
domain) and a nuclear localisation signal (NLS) (Claudio et al., 2001; Beer et al., 2001). Beer 
and coworkers termed the protein SH3 protein expressed in lymphocytes (SLy), whereas 
Claudio et al. emphasized the less restricted expression pattern of a homologous protein 
with the name hematopoietic adapter containing SH3 and SAM domains (HACS1). As HACS1 
is also called SLy2, the identification of these proteins marked the discovery of an as yet 
unknown protein family of putative adapter proteins. A third report, published later that 
same year, described the (re-)identification of SLy2 as a nuclear protein, containing a SH3 
and a SAM domain, being preferentially expressed in mast cells and thus termed Nuclear 
protein containing SAM and SH3 domains (NASH) (Uchida et al., 2001).  
Both SLy-proteins show a strikingly similar molecular organisation. Aligning the amino acid 
sequences of both proteins reveals a sequence identity of close to 43% (Figure 1). Yet, the 
identical regions are not evenly distributed across the proteins, but seem to cluster. The 
two sections with the highest degree of sequence identity comprise the amino acids 170-
231 (72%) and 251-315 (63%). An additional region of high identity is located at the N-
terminus from amino acid 1-28 (62%).  
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Figure 1: Amino acid sequence alignment of murine SLy and SLy2. Identical amino acids in both 
sequences are indicated in black. The N-terminus, the SH3 and the SAM domains are indicated with a green, 
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Astoul et al. demonstrated that SLy is phosphorylated on the serine residue 27 upon T cell 
receptor (TCR) signalling (Astoul et al., 2003). In agreement with this and the exclusively 
lymphoid occurrence of SLy, gene-targeted mice expressing only a truncated protein 
lacking the NLS and Ser27 (SLyΔ/Δ), display defects in various lymphocyte functions. The 
proliferative responses of SLyΔ/Δ T and B cells upon activation are diminished and the 
marked reduction in the marginal zone B cell compartment is in agreement with lowered 
Ig serum levels (Beer et al., 2005; Scheikl et al., 2008). Interestingly, the phenotype of mice 
with a complete deletion of SLy (SLy-/-) shows no difference to those expressing the 
truncated form. In addition to the defects in peripheral lymphocyte function, also the 
thymic development of SLyΔ/Δ and SLy-/- cells is defective (Reis et al., submitted). All 
mentioned defects accumulate in the finding of impaired rejection of semi-allograft 
transplants in SLyΔ/Δ mice (Beer et al., 2005). Although there is evidence for elevated 
apoptosis induction in SLy deficient thymocytes, until now, the molecular mechanism of 
the effects of the SLy truncation remains ill-explained, which is partially due to the still 
unresolved issue of interaction partners of this adapter protein. With respect to a 
molecular mechanism it is of high interest, that one apparent defect of the truncated SLy 
protein from the SLyΔ/Δ mice is the inability to translocate to the nucleus what the wildtype 
protein readily does (Beer et al., 2005).  
The genomic region around the sly2-locus (21q11.2) is frequently targeted by translocation 
events in hematopoietic malignancies (Mitelman et al., 1997). This is interesting since 
SLy2/HACS1 was initially discovered in a transcriptional study on multiple myelomas, in 
which this novel protein was shown to be overexpressed (Claudio et al., 2001). Both 
findings led to a first hypothesis of SLy2 being a novel signalling component in potentially 
cancer related pathways. Some time later, intriguing evidence on the role of SLy2 in B 
lymphocyte differentiation was reported (Zhu et al., 2004). As also shown in this report, 
Zhu et al. found that the expression of SLy2 in B cells is elevated upon activation of the 
cells by differentiation inducing stimuli. Consistently, they could show that the 
overexpression of SLy2 in splenic B cells leads to the differentiation towards a plasma cell 
fate. Despite these interesting data it has to be noted that until now, the experimental 
evidence explaining SLy2 function from a mechanistical point of view remains 
fragmentary. 
The third member of the SLy family, SAM and SH3 domain containing 1 (SASH1) shares the 
high structural similarity of the other SLy proteins. SASH1 was first described by Zeller et al., 
who identified it in a comparative screen for genes downregulated in breast cancer cells, 
1. Introduction  5 
which stands in marked contrast to the above mentioned SLy2 overexpression. This led to 
the classification of SASH1 as a potential tumour suppressor (Zeller et al., 2003). Klaus-Peter 
Janssen and his group could demonstrate that SASH1 is also significantly downregulated 
in other malignant tissues, such as liver and colon. Decreased SASH1 expression levels 
correlated with the formation of metastases and statistical analyses have established the 
lowered protein levels as an independent negative prognostic parameter for patient 
survival (Rimkus et al., 2006). The pronounced discrepancies to the potentially oncogenic 
role of SLy2 clearly await further analysis.  
SASH1 has twice the size of SLy or SLy2 and thus contains additional domains. A coiled-coil 
domain is located in the N-terminus, whereas a second SAM domain resides within the C-
terminus of the protein. The middle part of the protein shows the highest sequence 
identity with SLy and SLy2. Deduced from its occurrence in arthropods, SASH1 probably 
represents the founding member of the family, as the other ones are only found in the 
vertebrate phylum. Accordingly, the additional domains in the N- and the C-terminus must 
have been deleted during the gene duplications that led to the generation of SLy and 
SLy2. 
1.2. Cytoskeletal structures in eukaryotic cells 
Three pillars make up for the cellular skeleton, intermediate filaments, microtubule and 
actin filaments. Their combined activity provides the essential forces to regulate cell shape, 
adhesion and migration, vesicle transport, secretion, phagocytosis and mitosis to name 
but a few functions. Its important role in cell function is impressively illustrated by the fact 
that proteins involved in assembly and regulation of the cytoskeleton represent almost 3% 
of all human genes (Venter et al., 2001).  
The least is known about the intermediate filaments that are assembled from different 
families of proteins depending on the cell type. Among the many participating families are 
various keratins, vimentins, nexins and also the lamins of the nuclear envelope. Their name 
is based on the finding that their diameter (10-12 nm) is located between that of 
microtubules (25 nm) and actin-filaments (5-8 nm). They form a dense network crossing 
the cell and thus serve different functions, from offering a signalling scaffold to the 
mechanical transduction of forces generated by movements at the cell membrane. Also, 
they have been implicated in the maintenance of cellular integrity, for example during the 
extravasation of lymphocytes, as they are endowed with a surprising flexibility towards 
externally applied forces. It has been shown that they assemble from monomeric subunits 
into the extended filaments crossing the cytosol; however, the molecular mechanisms 
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remain elusive. In contrast to microtubules and actin filaments, intermediate filaments do 
not elongate by treadmilling, which is the hallmark of the former two (reviewed in (Helfand 
et al., 2004; Goldman et al., 2008)).  
Microtubules represent the largest cytoskeletal compound and are assembled from 
heterodimers of α and β tubulin. Their formation is controlled by the activity of the 
microtubule organising centre (MTOC) and other accessory proteins (Luders and Stearns, 
2007). They elongate by addition of new monomers to the ends of existing filaments, 
whereas new tubulin monomers are provided by depolymerisation from the other end of 
the filament, a process known as treadmilling. Motorproteins such as kinesins associate 
with the microtubular network and mediate transport of e.g. vesicles along these filaments 
(Lakamper and Meyhofer, 2006). Geiger and coworkers already established more than 20 
years ago that the MTOC of cytotoxic T cells reorients towards the contact site of T cell and 
target cell (Geiger et al., 1982). Accordingly, they carry out a crucial role in secretion and 
thus lymphocyte effector functions (reviewed in (Huse et al., 2008)). In addition, 
microtubules have been described to support actin cytoskeletal structures, e.g. in the 
maintenance of an immunological synapse (IS) (Bunnell et al., 2001). Of note, small 
GTPases from the Rho family are involved in the regulation of the microtubular network. 
Thus, there is intensive cross talk between the actin and the tubulin cytoskeleton, which is 
essential e.g. in cell migration (Watanabe et al., 2005). Yet, the most prominent function of 
the microtubular network is clearly its role in cell division, where the MTOC turns into the 
spindle body, which organises the retraction of the chromosome connected microtubules 
and thus mediates the distribution of the sister chromatids to the newly forming daughter 
cells (reviewed in (Cuschieri et al., 2007)).  
The third, and best described, component of the cytoskeletal structures is the actin 
filament network. It is assembled from monomeric β-actin molecules, each with a 
molecular weight of 42kDa. Polymerisation of these monomers into the filamentous 
polymers is mediated by a plethora of different nucleation and elongation factors, which 
are assisted by capping proteins whose activity restricts filament growth. Depolymerising 
factors such as cofilin mediate the degradation of filaments and thus replenish the pool of 
monomeric actin (Ono, 2007). Actin filaments are not symmetrical but display two diverse 
ends, a slow growing so called pointed end and a fast growing barbed end. Like 
microtubules, also actin filaments grow by treadmilling. Compared with the other two 
cytoskeletal systems, the actin network shows the highest degree of complexity, due to its 
ability to form linear as well as branched filaments, depending on the accessory factors. 
Given its inherent flexibility and evolutionary conservation it is not surprising that the actin 
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network is involved in almost all aspects of cellular life (for review see (Welch and Mullins, 
2002). 
1.2.1. From G- to F-actin 
The formation of mulitmeric actin filaments from monomeric subunits has been a matter 
of intensive research for decades (reviewed in (Pollard et al., 2000). The molecular 
concentration of globular (G-) actin inside a cell is approximately 100 μM and most 
molecules of this pool are present in an ATP bound form. This is remarkable, as the critical 
concentration needed for filamentous (F-) actin polymerisation in in vitro systems 
represents approximately 0.1 μM and a 100 μM pool of ATP bound actin polymerises to F-
actin in a matter of seconds, leaving only 0.1 μM G-actin behind (Pollard, 1983; Pollard, 
1986). Thus, the question is apparent how the cell maintains such a high concentration of 
monomeric actin avoiding immediate and constant polymerisation. This issue is tackled 
from two sides: First, G-actin is constantly bound by either one of two small proteins, 
thymosin-β4 (43 amino acids) or profilin (125-139 amino acids) and binding of the former 
to ATP bound G-actin completely inhibits polymerisation (Pantaloni and Carlier, 1993; 
Perelroizen et al., 1994). Given the finding that the cellular concentration of thymosin-β4 is 
even higher than that of G-actin, it accounts for the bulk amount of unpolymerised actin 
(Cassimeris et al., 1992). Profilin competes with thymosin-β4 for actin binding and the 
exchange of actin between these two proteins is rapid. Profilin binding interferes with 
actin filament nucleation but allows the elongation of existing filaments (Goldschmidt-
Clermont et al., 1992). However, its affinity for F-actin is low, as the profilin target binding 
motif in actin is masked in assembled filaments. Profilin adds a further level of regulation 
to actin polymerisation, as it binds to nucleation factors, such as Arp2/3 complex, WASP 
and formins and thus leads to the controlled delivery of new monomers to the growing 
barbed end of the filament. Furthermore, it mediates the exchange of ADP to ATP on the 
actin monomer, which leads to the re-activation of the previously disassembled monomers 
(Perelroizen et al., 1996). The second mechanism employed to prevent uncontrolled actin 
polymerisation is the blocking of barbed ends by accessory proteins, such as gelsolin or 
capping protein. These molecules display a nanomolar affinity for barbed ends. Given their 
micromolar concentration in the cytoplasm, most barbed ends will be present in a capped 
conformation and are thus not prone to further elongation. Capping proteins bind 
polyphosphoinositides, which reduces their affinity to barbed ends, thus connecting an 
enhanced activational status of the cell with F-actin elongation (Schafer et al., 1996).  
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1.2.2. Assembly factors promote de novo actin polymerisation 
The de-novo nucleation of G-actin monomers into oligomeric complexes is an 
energetically unfavorable process (Chhabra and Higgs, 2007). Thus, to facilitate efficient 
and regulated polymerisation, different assembly factors are employed. 
1.2.2.1. The Arp2/3 complex 
The Arp2/3 complex represents a seven subunit multimeric assembly of ARPC1-5, Arp2 and 
Arp3. Both latter proteins resemble actin (actin related proteins) and cooperatively mimic 
the barbed end of a preformed actin dimer (Pollard, 2007). Due to the strong elongatory 
capacity of the barbed end (10-fold stronger than that of the pointed end) this structure 
favours the attachment of further G-actin molecules, and thus nucleates new filaments. 
Since the Arp2/3 complex shows a high affinity for the pointed end of actin filaments it 
remains bound to this end of the filament, serving as capping protein at the same time. 
Most importantly, the Arp2/3 complex contains the ability to bind to the sides of existing 
filaments, where it nucleates polymerisation of new filaments with the exact angle of 70° 
and thus induces the generation of the branched actin networks (Figure 2). Being the only 
assembly factor with the ability to induce branching of actin filaments, Arp2/3 was shown 
to be essential for the formation of lamellipodia and other broad F-actin structures and is 
thus indispensable for the generation of a leading edge in moving cells (Mullins et al., 
1998; Bailly et al., 2001). As the intrinsic nucleation activity of the Arp2/3 complex is 
relatively low, this complex needs to be activated and assisted by nucleation promoting 
factors (NPFs) to exert its full nucleation capacity (see below).  
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Figure 2: The first steps of actin nucleation are mediated by assembly factors. (A) The first 
oligomerisation steps from actin monomers to trimers are energetically unfavored, and are therefore unlikely 
to occur without external assistance (B=barbed end; P=pointed end). (B) Different assembly factors provide a 
molecular scaffold, which facilitates the nucleation of oligomeric actin complexes. Arp2/3 binds to existing 
filaments and therefore induces the generation of branched, dendritic F-actin networks. Assembly factors 
from the formin family and the spire proteins both mediate the formation of linear F-actin filaments, which 
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1.2.2.2. Formin proteins 
As opposed to the already mentioned Arp2/3 complex, formins occur and function as 
homodimeric protein complexes that are bound to the barbed end of actin filaments 
(reviewed in (Goode and Eck, 2007)). They mediate elongation by preventing the binding 
of capping proteins to the barbed end and move together with the growing filament, a 
process called “processive capping”. As a second mechanism of action, they recruit profilin 
(bound to actin-ATP) to the barbed end of the filament. As deduced from this mode of 
action it is obvious, that formins only mediate the formation of linear actin filaments. But at 
least some of the 15 members of the mammalian formin family mediate the bundling of 
parallel actin polymers, thus facilitating the formation of higher ordered F-actin complexes 
(Figure 2). Their function is facilitated by two essential domains, the formin homology 1 
(FH1) and the formin homology 2 (FH2) domain (Pruyne et al., 2002). While the FH2 domain 
mediates the homodimerisation of the protein and the binding to F-actin, the FH1 domain 
is responsible for the recruitment of the profilin-actin dimers (Watanabe et al., 1997; Higgs, 
2005). Being activated by small GTPases from the Rho family, the formins reside rather 
upstream in the signalling cascades leading to F-actin assembly. The importance of the 
formin mDIA1 in T cell function was recently shown in mdia1 deficient mice, whose 
thymocytes and T cells displayed severe problems in egression from the thymus and 
trafficking to secondary lymphoid organs, respectively (Sakata et al., 2007). 
1.2.2.3. Spire 
A third and completely different mechanism of nucleation is employed by the protein spire 
as initially discovered in D. melanogaster (Quinlan et al., 2005). This protein is highly 
conserved up to the vertrebrate phylum and contains an array of four consecutive Wasp 
homology 2 (WH2) domains (Figure 2). As these domains mediate binding of monomeric 
actin this molecular structure results in the formation of an actin tetramer, which serves as 
nucleation platform for further assembly, whereas the first WH2 domain at the same time 
carries out capping functions to prevent disassembly of the newly forming actin filament 
(Baum and Kunda, 2005).  
1.2.3.Two classes of NPFs facilitate network formation 
In order for a cell to reorganise its actin cytoskeleton in response to external stimuli or 
changed environmental conditions, these diverse signals have to be integrated and 
transmitted towards the assembly factors, to promote their activation and subsequent F-
actin formation. This function is carried out by different NPFs, which roughly cluster into 
two different groups. The first group comprises the well described Wiskott-Aldrich-
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Syndrome proteins (WASP and neural-(N-)WASP) and the related WASP family-verprolin 
homologous proteins (WAVE 1-3). The second group represents the novel, non-canonical 
factors cortactin and its homologous protein HS1, which is restricted to lymphocytes (for 
reviews, see (Weed and Parsons, 2001; Takenawa and Miki, 2001)).  
1.2.3.1. NPF I: WASP, N-WASP and WAVE proteins 
WASP is the founding member of this family of proteins (Derry et al., 1994). Its mutated 
form is responsible for the human immune disorder it is named after (see 1.2.3.), which is 
marked by defective actin cytoskeletal organisation in leukocytes and platelets. The 
proteins from the WASP and WAVE families are large multidomain scaffold proteins that 
integrate various signals towards F-actin formation at the membrane. WASP and N-WASP 
show a very similar structure, but display different expression patterns. While WASP is 
expressed only in the hematopoietic system (thus explaining the syndrome it was named 
after), N-WASP was identified initially in neural tissues, but is expressed also in a wide 
variety of other organs. Of the WAVE family, WAVE2 is expressed ubiquitously whereas 
WAVE 1 and 3 are enriched in the brain, but are also found in other tissues. All proteins in 
these two families share common domains. As they mediate their effects on F-actin 
formation by activation of the Arp2/3 complex, all WASP and WAVE proteins contain an 
Arp2/3 interaction motif, the CA (central acidic) domain in the C-terminus, which is 
essential for their function. The other indispensable motif is the V domain (verprolin 
homology), which lies N-terminally adjacent and is responsible for the binding of G-actin 
(Takenawa and Miki, 2001). The N-terminus of the WASP proteins is formed by the WASP-
homology 1 domain (WH1), which does not occur in WAVE proteins. It mediates the 
constitutive binding to the adapter protein WASP-interacting protein (WIP), which has 
been, amongst other functions, implicated in maintaining the stability of WASP to such an 
extent, that WIP deficient cells show also severely diminished WASP levels (de la Fuente et 
al., 2007). Indeed, the WH1 domain is a hot-spot, which is targeted by approximately 50% 
of WASP mutations found in WAS patients (Rong and Vihinen, 2000). 
To conclude, this suggests a mechanism of F-actin nucleation through the WASP mediated 
recruitment of G-actin monomers to the Arp2/3 complex. This leads to the complex 
formation between one G-actin molecule and the two structurally related Arp domains, 
which mimics the trimeric actin complex needed to nucleate polymerisation (Blanchoin et 
al., 2000), and thus increases the nucleation capacity of Arp2/3. 
WASP family proteins are activated by different means and therefore facilitate the 
integration of multiple signalling pathways to F-actin formation (Takenawa and Suetsugu, 
12  1. Introduction 
2007). As the proteins are present in an auto-inhibited state in unstimulated cells, the main 
mechanism of activation is the release of the intramolecular binding of the VCA domain to 
the central region. Phosphorylation of a central tyrosine residue by Src family kinases 
inhibits this intramolecular complex, assisted by the binding of phosphatidyl-inositol (4,5) 
biphosphate (PIP2) (Rohatgi et al., 1999; Cory et al., 2002). Accordingly, this leads to the 
activation of WASP downstream of antigen and growth factor receptors. The third 
mechanism mediating activation of WASP proteins is the binding of active (=GTP bound) 
Cdc42 to the central GTPase binding domain (GBD) (Rohatgi et al., 1999). The sequential 
action of Cdc42 and WASP mediated Arp2/3 activation finally leads to the generation of 
filopodia and the induction of cell movement. 
Also the WAVE proteins 1-3 are activated through Rho family GTPases, namely Rac1. Yet, 
WAVE proteins do not contain a GBD and consistently no direct binding of Rac1 to WAVE 
could be shown. Instead, proteins of the WAVE family employ adapter proteins that 
mediate an indirect interaction with Rac1. The protein IRSp53, initially identified as an 
insulin receptor substrate, was shown to bind to the proline rich stretch in WAVE2 by virtue 
of its C-terminal SH3 domain, and proved to be essential for Rac induced membrane 
ruffling. As IRSp53 binds active Rac1 with its N-terminus this leads to the formation of a 
trimeric complex that finally yields the activation of WAVE2 (Miki et al., 2000). In addition to 
IRSp53 a cluster of proteins assembled around WAVE is essential for its function. This 
tetrameric complex comprises the proteins Sra-1, Abi1, Nap and HSPC300 and is 
constitutively bound to WAVE, which essentially mediates binding to activated Rac (Steffen 
et al., 2004; Innocenti et al., 2004). WAVE is responsible for the bulk of branched actin 
formation in lamellipodial structures and accordingly it has also been shown to be of 
pivotal importance in the formation of an IS and the subsequent activation of the T cell 
(Suetsugu et al., 2003; Nolz et al., 2006). This explains at least partially the inhibitory effect 
of dominant negative Rac1 on T cell activation and the dispensability of WASP for T cell-
APC synapse formation and initial T cell activation (Cantrell, 2003; Cannon and Burkhardt, 
2004).  
1.2.3.2. NPF II: Cortactin and HS1    
The second class of nucleation promoting factors comprises only two proteins, cortactin 
and its lymphocyte homologue HS1. The former was identified in a screen for 
phosphorylated targets of Src kinases, where it represented the most prominently 
phosphorylated protein (Kanner et al., 1990). Cortactin has been implicated in various 
processes which are all governed by dynamic branched F-actin cytoskeletal structures 
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associated with membranes. Amongst others are the formation and movement of the 
leading edge in migration, the growth of axons, invadopodia formation during metastasis 
of cancer cells and endocytosis (Kinnunen et al., 1998; Bowden et al., 1999; Cao et al., 2003; 
Bryce et al., 2005). Consistent with the participation in invadopodia formation, 
upregulation of cortactin expression is reported for many malignant tissues and correlates 
with poor prognosis (Weaver, 2008).  
HS1 was identified by Kitamura and colleagues as a potential transcription factor (what 
later proved wrong) and raised interest due to its expression pattern, which was 
completely restricted to all cells of hematopoietic origin (Kitamura et al., 1989). Common 
knowledge on cortactin is much broader than on HS1, yet given the high degree of 
sequence identity, structural homology and the mutual exclusive expression, similar 
functions for both proteins are proposed. They represent cytoplasmic multi-domain 
adapter proteins that contain several repeats of a 37 amino acid motif (6.5 x in cortactin 
and 3.5 x in HS1) (Figure 3). This cortactin repeat mediates the binding of F-actin (Wu et al., 
1991; Weed and Parsons, 2001). In addition to the unique repeats, both proteins contain an 
N-terminal acidic domain (NTA), which mediates binding of the Arp2/3 complex (Uruno et 
al., 2001) and both, the cortactin repeats and the NTA domain are essential for localisation 
of cortactin to lamellopodia (Weed et al., 2000). With the NTA domain and the adjacent 
cortactin repeats, the N-terminal half clearly serves the binding of the effector molecules. 
Further C-terminally resides a proline, serine, threonine and tyrosine rich stretch, which is 
targeted by different kinases and SH3 domain containing proteins and is thus probably 
involved in regulatory mechanisms. Ultimately, the C-terminal SH3 domain of cortactin is 
responsible for the interaction with various proteins, the most prominent being WASP, N-
WASP and WIP, which further increases the integratory capacity (Mizutani et al., 2002; 
Kinley et al., 2003; Martinez-Quiles et al., 2004).  
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Figure 3: Domain structure and functions of NPFs II cortactin and HS1. Depicted are both proteins of the 
cortactin family. The Arp2/3 and F-actin binding domains are displayed in green. The regulatory domain is 
painted in blue. The respective interaction partners of each domain are shown below the depicted 
molecules. Adapted from (Cosen-Binker and Kapus, 2006) and (Weed and Parsons, 2001). 
 
Ser/Thr-phosphorylation of cortactin by the active-rac binding kinase p21 activated kinase 
(PAK) and ERK increases the F-actin binding and inducing activity, while Tyr-
phosphorylation through Src and Fyn downregulates both effects (Martinez-Quiles et al., 
2004). This suggests an equilibrium model, where Ser/Thr phosphorylation leads to the 
activation of cortactin and the subsequent induction of branched F-actin structures, while 
Tyr-phosphorylation frees cortactin from old filaments and thus replenishes the pool (Fan 
et al., 2004). Such sophisticated regulatory mechanisms identify cortactin as a central 
switch in Arp2/3 activation that has the ability to integrate signals from a wide variety of 
internal and external stimuli.  
Cortactin binds to the Arp3 subunit and this binding leads to the activation of the Arp2/3 
complex. The cortactin repeats mediate simultaneous binding to F-actin, which together 
with the Arp3 binding stabilises and thus extends the life span of the branch points in the 
dendritic F-actin meshwork, which ultimately increases the net amount of cellular 
branched F-actin (Weaver et al., 2001; Uruno et al., 2003). As cortactin and WASP bind to 
different domains of Arp2/3, a ternary complex is possible and even supported through 
the binding of the cortactin SH3 domain to N-WASP or WIP. Consistently, this complex 
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results in the synergistically increased induction of Arp2/3 mediated F-actin formation 
(Uruno et al., 2001). To conclude, cortactin positively influences the formation of branched 
F-actin networks first via assisting in WASP mediated activation of Arp2/3 and second via 
the stabilisation of already formed complexes.  
Like cortactin, also HS1 binds the Arp2/3 complex and F-actin, suggesting a similar mode 
of action. However, in marked contrast to cortactin and the WASP proteins, HS1 is not 
activated through Rho family GTPases but was shown to be Tyr-phosphorylated 
cooperatively by Syk and Lyn kinases upon antigen receptor crosslinking (Yamanashi et al., 
1997). The mutation of two conserved Tyr-residues, Tyr378 and Tyr397 to alanine, 
interfered with lymphocyte activation by disruption of IS formation. This was due to 
impaired binding and thus diminished localisation of the SH2 domain containing Rac 
activator Vav1 at the IS (Gomez et al., 2006). Given the prominent role of Rac2 in 
lymphocyte function, this might be the main mechanism of HS1 to drive actin 
polymerisation (see below). A very refined analysis is presented by Butler and colleagues, 
which proposes a switch capacity for HS1, at least in NK cells (Butler et al., 2008). 
Depending on the differential phosphorylation of the tyrosine residues 378 and 397, HS1 
activity in NK cells is either inducing ICAM dependent adhesion and subsequent killing of 
target cells or chemotactic migration.  
With respect to cortactin function, it is as yet unclear if HS1 also binds to WASP and WAVE 
proteins to increase branched F-actin network formation. Albeit it was recently shown that 
HS1 is bound and phosphorylated by c-Abl and that this kinase additionally interacts with 
WAVE2 in T cells (Huang et al., 2008).  
The implication of HS1 in actin dynamics in various lymphocyte species is consistent with 
its restricted expression pattern. Analysis of RNAi mediated knock down of HS1 in T cells 
determined its role in antigen induced formation of an IS and the resulting T cell activation 
and proliferation (Gomez et al., 2006). Along the same lines, HS1 deficient mice display 
severely impaired B cell function, resulting in defective clonal expansion and a reduced 
induction of T-independent immune responses (Taniuchi et al., 1995).  
In conclusion, cortactin and HS1 both bind to Arp2/3 and F-actin and thus stabilise 
branched F-actin meshworks. The additional mechanisms of action and the regulatory 
circuits are partially different for these non-canonical NPFs, yet they show parallels in that 
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1.2.4.Small GTPases of the Rho family in F-actin regulation 
The first and name giving member of the Ras homology (Rho) family was identified in 1985 
by virtue of its homology to the then recently found Ras oncogenes. Although being 
initially discovered in the genome of the sea slug aplysia, three orthologues in the human 
system were found soon and named RhoA, RhoB and RhoC (Madaule and Axel, 1985). In 
the following years, the other members of the family, the Rac proteins and Cdc42 were 
described, and the group was established as a Ras independent signalling entity (Didsbury 
et al., 1989; Bender and Pringle, 1989). Like Ras, all Rho family proteins represent small 
GTPases of approximately 21kDa. As all other GTPases, they occur in two different states, 
GTP-bound or GDP-bound and accordingly they can function as molecular switches. It is 
common knowledge that the GTP binding activates Rho proteins. The activity of these 
proteins is thus positively regulated by cofactors which mediate the exchange of GDP to 
GTP, so called guanine nucleotide exchange factors (GEFs). Being activated downstream of 
many cell surface receptors, they mediate the signal transduction of external stimuli to Rho 
family GTPases. Since the intrinsic GTPase activity of the Rho proteins is low, they need the 
assistance of GTPase activating proteins (GAPs). Hydrolysation of GTP to GDP renders the 
GTPase inactive. For all members of the Rho family, a plethora of different GEFs and GAPs 
has been described (reviewed in (Moon and Zheng, 2003; Rossman et al., 2005)). 
Concluding, the Rho GTPases are crucial for the signal transduction from a multitude of cell 
surface receptors to the cytoskeleton. 
1.2.4.1. Rho 
Due to its homology to Ras, Rho was initially believed to also be endowed with an 
oncogenic capacity. Only some time later it turned out, that this small GTPase had a strong 
effect on the induction of F-actin structures (and none on oncogenic processes) (Figure 4 C 
and (Ridley and Hall, 1992)). Microinjection of the Rho-protein into Swiss-3T3 murine 
fibroblasts rapidly induced the formation of stress fibres, intracellular cables composed of 
bundled linear F-actin complexed with myosin. In a mechanism similar to that of the 
muscle-cell actin-myosin network, stress fibres control cell contractility. To transduce the 
contractile forces to the membrane, the fibres are connected to membrane associated 
focal adhesions (FA) at their distal poles. FAs consist of densely clustered integrin 
molecules, which are connected to the actin cytoskeleton via intracellular adapter 
proteins. Accordingly they are crucial for cell adhesion to the substratum and thus carry 
out essential functions in spreading and migration as they provide the necessary traction 
and anchor points to focus the contractile forces (reviewed in (Campbell, 2008)). 
1. Introduction  17 
Consistently, also the formation of FA was shown to be drastically increased upon Rho 
signalling (Figure 4 D and (Ridley and Hall, 1992)). GTP-bound Rho activates two 
downstream effectors that are crucially involved in stress fibre formation. Rho-GTP binds 
and activates the formin mDIA1. As described above, formins represent actin assembly 
factors, the activity of which leads to the formation of linear F-actin filaments (Figure 2) 
(Kovar, 2006). Interestingly, mDIA1 localises to FAs and subsequently leads to actin 
polymerisation and stress fibre growth (Butler et al., 2006). As formins remain at the fast 
growing barbed end of the actin filament, the stress fibre will grow as long as mDIA1 is 
attached. The second important Rho target in stress fibre formation is Rho kinase (ROK) 
which is activated upon binding Rho-GTP. This Ser/Thr kinase phosphorylates important 
downstream targets, among which is the myosin light chain 2 (MLC2) and several myosin 
regulatory factors. Their ROK mediated phosphorylation increases the contractility of the 
cells. In addition, ROK activity leads to pronounced stress fibre formation (Leung et al., 
1996). However it has to be mentioned that only the activity of both, mDIA1 as well as ROK 
is sufficient to mimic Rho activity with respect to functional stress fibre assembly 
(Hotulainen and Lappalainen, 2006). 
1.2.4.2. Rac 
As Rac and Rho proteins share a highly identical sequence it is surprising how different 
their impact on the cytoskeleton is. As established in Alan Hall’s laboratory at the 
beginning of the 1990s, Rac microinjection into murine fibroblasts resulted in the 
prominent induction of lamellipodia (Figure 4 E and (Ridley et al., 1992)). As opposed to 
stress fibres, lamellipodia are composed of branched F-actin filaments, without the 
addition of myosin. Accordingly, they are not involved in cell contractility but rather 
provide the scaffold and the protruding force needed in forward movement at the leading 
edge of a migrating cell. As such, the lamellipodium makes up for the most distal 1-5 μm of 
the cellular rim with a thickness of approximately 200 nm (Small and Resch, 2005). As the 
lamellipodium is composed of diagonally arranged F-actin filaments and the leading edge 
is pushed forward by laterally moving filaments, prominent branching of F-actin has to 
occur. The necessity of this Rac dependent formation of branched F-actin structures is 
impressively illustrated by the fatal phenotype of Rac-deficient mice. The Rac-/- embryos die 
already during gestation (E9.5) due to failures in germ layer arrangement caused by 
defective migration of the embryonic cells (Sugihara et al., 1998). The Arp2/3 complex is of 
essential importance in this respect, as no other assembly factor can induce branched 
filaments. This hypothesis is supported by RNAi studies proving the essential role of this 
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assembly complex in lamellipodia formation. In the same publication, Steffen and 
coworkers also determined the indispensability of the WAVE complex in this respect 
(Steffen et al., 2006). However, WAVE is not the only target of activated Rac protein, as 
shown by the later time point of embryonic lethality in WAVE2 deficient mice (E12.5) (Yan 
et al., 2003). A second mechanism to induce the formation of branched F-actin structures is 
initiated by the Rac-GTP dependent activation of PAK. As mentioned before, this 
serine/threonine kinase phosphorylates the NPF II cortactin at a crucial serine residue, 
resulting in its activation (Vidal et al., 2002; Martinez-Quiles et al., 2004).  
As will be discussed later, lamellipodial structures in lymphocytes are of great importance 
e.g. in the establishment of an IS. Accordingly, Rac1 and Rac2 carry out important roles in 
different aspects of lymphocyte function (Gomez et al., 2001; Arana et al., 2008). 
Finally it has to be mentioned that there is also intensive cross talk between Rho and Rac 
mediated pathways. For example, to induce cell migration it is crucial not only to push 
forward the leading edge, but also to disrupt FAs, whose foci of clustered integrins 
mediate strong adhesion to the substrate. Also, the Rho mediated increase in contractility 
would rather have inhibitory effects on the migration of cells. Consistently, active PAK 
counteracts the formation of FAs and stress fibres (Manser et al., 1997). The minimal 
adhesion needed to provide traction for migration is brought about by focal complexes 
that also contain clusters of integrin and whose formation is induced by Rac dependent 
activation of PAK (Figure 4 F and (Sells et al., 1997)). Yet, the regulatory circuits are 
probably more complex as sequential activation of Cdc42 and Rac has also been shown to 
lead to the subsequent activation of Rho (Nobes and Hall, 1995), a process that could be 
important in migration due to the Rho dependent retraction of the rear end of a cell, which 
marks the last step of the migration process. 
Many of the functional analyses of Rac mediated processes have been facilitated by two 
point mutants (Ridley et al., 1992). Rac1V12, carrying a valin at amino acid position 12 is 
constantly bound to GTP and thus permanently activated. In contrast, Rac1N17, containing 
an asparagin residue in position 17, displays a high affinity towards GDP and accordingly 
remains inactive. Both mutants have been generated analogous to previously 
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1.2.4.3. Cdc42 
The third prominent member of the Rho family is the GTPase Cdc42, which was initially 
discovered in yeast (Johnson and Pringle, 1990). The implication of Cdc42 in F-actin 
regulation in mammalian cells was characterised in Alan Hall’s laboratory. The 
microinjection of Cdc42 in murine fibroblasts resulted in the marked induction of filopodia 
all around the cells (Figure 4 G). Filopodia are thin, finger like protrusions emanating from 
the peripheral branched F-actin network in the lamellipodium at the leading edge. In 
contrast to the latter, they are composed of linear F-actin filaments, organised into higher 
order complexes by the F-actin bundling protein fascin (reviewed in (Chhabra and Higgs, 
2007)). Interestingly, to visualise optimal filopodia formation, the cells had to be coinjected 
with dominant negative Rac1N17. Otherwise, the initial filopodia quickly reorganised into 
lamellipodia due to the activating effect of Cdc42 on Rac (Nobes and Hall, 1995). Along the 
same lines, as apparent in Figure 4 G, Cdc42 induced filopodia originate in the 
lamellipodium surrounding the whole cell. This reveals a first hint towards filopodia 
function: to probe the surrounding environment before migration is initiated; accordingly, 
filopodia are important for chemotaxis. 
With respect to the factors involved in filopodia regulation, much remains elusive until 
now. The binding and activation of N-WASP through Cdc42 suggests filopodia induction 
via the Arp2/3 complex (Miki et al., 1998). However, N-WASP deficiency or RNAi mediated 
knock down of Arp2/3 does not abrogate filopodia induction by Cdc42 (Lommel et al., 
2001; Steffen et al., 2006). In contrast, Cdc42 was found to interact with and activate the 
formin mDIA2 (Peng et al., 2003). For several reasons formins are likely to be the Cdc42 
effectors in filopodia formation: first they are known to induce linear F-actin formation, and 
localise specifically to the tips of growing filopodia. Second and most strikingly, the knock 
down of mDIA2 results in the abrogation of filopodia formation and the opposite is caused 
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Figure 4: Rho family GTPases exert distinct effects on the F-actin cytoskeleton. Murine Swiss 3T3 
fibroblasts were treated to activate Rho, Rac or Cdc42. Cells were either stained for F-actin with phalloidine 
(A, C, E and G) or with α-vinculin to mark FAs (B, D, F and H). The following stimuli were applied: A+B, 
untreated; C+D, LPA to activate Rho; E+F, microinjection of constitutively active Rac1V12; G+H microinjection 
of the Cdc42-GEF FGD1 resulting in activation of Cdc42. The induction of stress fibres and FAs (C+D), 
lamellipodia (E+F) and filopodia (G+H) is obvious (Picture taken from (Hall, 1998)).  
1.2.5. The actin cytoskeleton in lymphocyte activation 
The life threatening severity of the Wiskott-Aldrich-Syndrome impressively illustrates the 
importance of F-actin cytoskeletal reorganisations for hematopoietic cell function 
(Notarangelo et al., 2008). The analysis of T cells from WAS patients proved defective 
proliferative responses upon stimulation with α-CD3 (Molina et al., 1993). A more detailed 
analysis, facilitated by WASP deficient mice argues against a role of WASP in TCR proximal 
signalling but rather in the subsequent actin polymerisation dependent sustained 
activation of the T cells (Zhang et al., 1999). Consistently, WASP deficient T cells show 
impaired exo- and endocytosis, resulting in diminished levels of IL-2. Surprisingly, it was 
shown recently that WASP deficient T cells can form and maintain an intact IS, suggesting 
that the IL2 defect is caused by an IS-independent function of WASP (Cannon and 
Burkhardt, 2004). In contrast, RNAi mediated knock down of WAVE2 in T cells completely 
abrogates the formation of the F-actin rich platform between T cells and APC, which serves 
as a scaffold for the IS. Accordingly, the WAVE2 depleted cells show a diminished Ca2+ 
release in response to TCR ligation and display markedly lowered transcription from the il2-
locus (Nolz et al., 2006). 
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The IS was initially described by Kupfer and coworkers, when they analysed the 
polarisation of T cells interacting with APCs or cytotoxic T cells with target cells (Kupfer and 
Dennert, 1984; Kupfer and Singer, 1988). The hallmark of the IS is the so called bull’s eye 
structure, formed by a ring of integrins clustered around a central focus of TCR molecules. 
These regions carry out different functions and are referred to as peripheral 
supramolecular activation cluster (pSMAC) and central supramolecular activation cluster 
(cSMAC), respectively. The integrin (mostly LFA-1) rich pSMAC mediates the adhesion to 
the APC, while the cluster of TCRs in the cSMAC accounts for sustained signalling. This 
assembly is mirrored on the APC side by a ring of ICAM1 organised around peptide loaded 
MHC molecules. A plethora of accessory signalling and structural proteins localise 
specifically to either one of the two structures and accordingly ensure correct T cell 
activation. In addition the secluded area between the two cells allows the spatially highly 
restricted release of cytokines or cytotoxic agents, minimising side effects or collateral 
damage (reviewed in (Huse et al., 2008; Dustin, 2008)). In the meantime, multiple different 
IS have been described, differing largely by the cells connected by them (e.g. regulatory 
synapses between regulatory T cells and target T cells or cytotoxic synapses between CTLs 
and target cells).  
Actin reorganisation plays an essential role in the formation of an IS, as treatment of the 
cells with inhibitors of actin polymerisation completely abrogates polarisation of the cell 
(Bunnell et al., 2001). Interestingly, also interference with the microtubular cytoskeleton 
affects the IS, however only at a later time point, rather suggesting a function in the 
maintenance of this complex structure. Being dependent on WAVE2, Rac and Arp2/3 
complex signalling, the IS is largely understood as a lamellipodial structure. In agreement 
with this hypothesis, also HS1 was shown to be of pivotal importance for intact F-actin 
polarisation at the IS. Knock down of HS1 resulted in impaired T cell-APC conjugate 
formation and ultimately led to diminished IL2 production. This effect was mainly 
mediated by the abrogated recruitment of the Rac-GEF Vav1 to the IS (Gomez et al., 2006).  
With respect to the amount of research being done on the T cell IS, surprisingly little is 
known about the IS formed by B cells. Batista and coworkers have shown that B cells form 
an IS with antigen containing membranes and that also in the B cell synapse a ring of LFA-
1 surrounds the antigen receptor enriched cSMAC (Carrasco et al., 2004). However, in 
marked contrast to T cells, B cells display a biphasic response to membrane bound antigen. 
The pronounced morphological changes are represented by an initial spreading phase, in 
which the B cell engages as many BCRs as possible with the cognate antigen. The 
subsequent retraction gathers the collected antigen and concentrates it into the cSMAC 
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(Figure 5 A+B). Of note, both actin polymerisation as well as cognate antigen binding are 
mandatory for these processes to occur (Fleire et al., 2006; Lin et al., 2008). This 
choreography was shown to be supported by the Rac2 dependent increase of integrin 
binding downstream of BCR signalling, subsequent adhesion to the antigen containing 
membrane and the concomitant reorganisation of F-actin (Arana et al., 2008), for an actual 




Figure 5: B cell spreading on antigen containing membranes. (A) Scanning electron microscope (SEM) 
pictures of a transgenic MD4-B cell interacting with COS-7 cells expressing a membrane bound form of HEL-
GFP as the cognate antigen. (B) Confocal laser microscopic pictures of a transgenic MD4-B cell interacting 
with a planar bilayer containing henn egg lysozyme (HEL) linked to fluorescently labelled Fab molecules as 
cognate antigen for the transgenic BCR. Pictures taken from (Fleire et al., 2006).  
 
In contrast to the well-defined function of HS1 in T cell IS formation, its implications in B 
cell spreading and contraction in response to antigen remain poorly understood. Only 
recently HS1 has been identified as a central player in the mediation of cytolytic synapse 
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1.3. Objective 
Adapter proteins play pivotal roles in the transduction of intracellular signals. They 
facilitate the formation of multi-protein complexes and thus organise the tempo-spatially 
regulated interaction of signalling proteins. The SLy family comprises three members, all of 
which are putative adapter proteins due to their decisive domain structure. The founding 
member of the family, SLy, was shown to be phosphorylated upon TCR ligation and was 
thus believed to be involved in the subsequent signalling cascades (Astoul et al., 2003; 
Beer et al., 2005).  
Due to the remarkable degree of structure and sequence-related identity between SLy and 
its closest relative SLy2, there was specific interest in the role of SLy2 in intracellular 
signalling processes. As the latter is expressed in a much broader range of tissues than its 
lymphocyte restricted homologue SLy, it was one objective of this thesis to unravel SLy2 
function and its impact in different cell types.  
In the beginning of the work on this thesis, the molecular knowledge about this putative 
adapter protein was extremely poor and accordingly the main task was to define the 
molecular properties of SLy2. Subsequent in vitro analyses in different cell lines should help 
to define pathways and conditions where SLy2 exerts its activity. Furthermore, due to the 
characteristic domain structure of SLy2, a comprehensive analysis on the participation of 
the individual domains in the different functions of SLy2 should be performed. Of special 
interest in this respect were the NLS and the serine residue 23 since the deletion of these 
features in the SLy protein had a deleterious effect on SLy function, as established in the 
SLy-mutant mouse strain (Beer et al., 2005). Finally, the intracellular localisation of SLy2 was 
also in the focus of attention, with respect to a potential recruitment to specific subcelluar 
structures. 
On the basis of the thus generated in vitro results, SLy2 function in different mouse models 
should be assessed. Therefore, gene-targeted SLy2 deficient and SLy2 overexpressing 
transgenic mice were to be generated concomitantly. Their phenotypic analysis would 
thus lead to an extensive elucidation of this novel adapter protein.  
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2.1. Materials 
2.1.1. Chemicals Supplier 
Aceton Merck, Darmstadt  
Agarose Biozym, Hamburg   
Ampicilin, sodium salt Sigma-Aldrich, Taufkirchen 
Ammoniumchloride Merck, Darmstadt 
Ammoniumperoxodisulfate (APS) Sigma Taufkirchen 
Bactoagar BD Biosciences, Heidelberg 
BES Roth, Karlsruhe 
β-mercaptoethanol Gibco, Karlsruhe 
BrdU Sigma-Aldrich, Taufkirchen 
Bromphenolblue Merck, Darmstadt 
BSA (Bovine Serum Albumine) Sigma-Aldrich, Taufkirchen 
Calcium Ionophore Sigma-Aldrich, Taufkirchen 
Calyculin Sigma-Aldrich, Taufkirchen 
Chloroform Roth, Karlsruhe 
Complete Mini Protease Inhibitor Cocktail, EDTA free Roche, Mannheim 
DAPI Invitrogen, Karlsruhe 
Desoxyribonucleids (dATP, dCTP, dGTP, dTTP) MBI Fermentas, St. Leon-Rot 
Dextransulfate Amersham Biosciences, 
 Braunschweig 
Diethylpyrocarbonate (DEPC) Roth, Karlsruhe 
Digitonin Calbiochem, USA 
N,N’-Dimethylformamide Merck, Darmstadt 
Dithiothreitol (DTT) Invitrogen, Karlsruhe 
Dimethylsulfoxide (DMSO) Sigma-Aldrich, Taufkirchen 
DMSO Sigma-Aldrich, Taufkirchen 
DNA standard Fermentas, St. Leon-Rot 
ECL GE Healthcare, Munich 
EDTA Sigma-Aldrich, Taufkirchen 
Ethanol Merck, Darmstadt 
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Ethidium bromide Merck, Darmstadt 
Fluoromount-G Northern Biotech, 
 Birmingham, USA 
Formaldehyde Roth, Karlsruhe 
FuGENE 6 Transfection reagent Roche, Mannheim 
Ganciclovir (Cymeven) Syntex, Aachen 
Gelatine Sigma-Aldrich, Taufkirchen 
Geneticin (G418) Gibco, Eggenstein 
Glacial acetic acid Merck, Darmstadt 
Glycerine Merck, Darmstadt 
HCG Intervet, Unterschleißheim 
HEPES buffer Invitrogen, Karlsruhe 
Hypochloric acid Roth, Karlsruhe 
IGEPAL (NP-40) Sigma-Aldrich, Taufkirchen 
Isopropanol Merck, Darmstadt 
L-glutamine Biochrom, Berlin 
Glycerine Sigma-Aldrich, Taufkirchen 
Kanamycine Sigma-Aldrich, Taufkirchen 
LB-Agar Roth, Karlsruhe 
LB-Medium Roth, Karlsruhe 
LPS Sigma-Aldrich, Taufkirchen 
Methanol Merck, Darmstadt 
mIL-2 R&D Systems GmbH, 
 Wiesbaden 
mIL-4 R&D Systems GmbH, 
 Wiesbaden 
Mineral oil Sigma-Aldrich, Taufkirchen 
Mitomycine C Sigma-Aldrich, Taufkirchen 
MOPS Sigma-Aldrich, Taufkirchen 
N-lauryl sarcosine Sigma-Aldrich, Taufkirchen 
Paraformaldehyde Merck, Darmstadt 
PBS Invitrogen, Karlsruhe 
PDBU (Phorbol 12,13-Dibutyrat) Sigma-Aldrich, Taufkirchen 
PDGF Sigma-Aldrich, Taufkirchen 
Penicilline/streptomycine Biochrom, Berlin 
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Phalloidin, TRITC Sigma-Aldrich, Taufkirchen 
Phalloidin, Alexa-633 Invitrogen, Karlsruhe 
Phenol Roth, Karlsruhe 
PMA (Phorbol 12-myristate 13-acetate) Sigma-Aldrich, Taufkirchen 
PMSG (pregnant mare serum gonadotropin) Intervet, Unterschleißheim 
PMSF (Phenylmethanolsulfonylfluoride) Sigma-Aldrich, Taufkirchen 
Protease inhibitor cocktail Sigma-Aldrich, Taufkirchen 
Saponine Sigma-Aldrich, Taufkirchen 
Skim milk powder Oxoid, Hampshire, Great 
 Britain 
Sodium azide Sigma, Taufkirchen 
Sodium chloride Roth, Karlsruhe 
Sodium citrate Roth, Karlsruhe 
SDS (sodium dodecyl sulfate) Schuchart, Hohenbrunn 
Sodium hydroxide Merck, Darmstadt 
TEMED (N,N,N’N’-Tetraethylmethylendiamine) Sigma-Aldrich,Taufkirchen 
Triton-X-100 Merck, Darmstadt 
Trypan blue solution in PBS Sigma-Aldrich, Taufkirchen 
Trypsin/EDTA Invitrogen, Karlsruhe 
Trypton Roth, Karlsruhe 
Tween 20 Merck, Darmstadt 
Yeast extract Roth, Karlsruhe 
2.1.2. Radiochemicals 
5’-[α-32P]-d-CTP redivue, specific activity ~3000 Ci/mmol  
[32P]-Orthophosphate, specific activity ~3000 Ci/mmol  
[Methyl-3H]-Thymidine, specific activity 5.0 Ci/mmol 
[35S]-Methionine, cysteine, specific activity ~1000 Ci/mmol 
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2.1.3. Antibodies 
All antibodies used in flow cytometry were purchased from Becton&Dickinson, Heidelberg, 
if not otherwise stated. All secondary antibodies used in western blot analyses originated 
from Dianova, Hamburg. A polyclonal α-SLy2 antibody was generated by Eurogentec, 
Belgium. It was purified and tested for specificity prior to usage in this study. The 
oligopeptide used for its generation was RELTNGSEEQSKTSS. 
Table 1: Additionally used antibodies 
Description Species/label Application Supplier 
Primary antibodies    
α-actin Mouse Western blot Sigma-Aldrich, 
Taufkirchen 
α-BrdU PE Flow cytometry Dianova, Hamburg 
α-cortactin Rabbit Western blot, 
immunofluorescence 
Cell signalling, USA 
α-GAPDH Mouse Western blot Hytest, Finnland 





α-lamin A/C Mouse Western blot Cell signalling, USA 
α-myc Mouse Western blot, IP Dianova, Hamburg 
α-rac1 Mouse Western blot Pierce, USA 
Secondary antibodies    
α-rabbit Alexa 633 Immunofluorescence Invitrogen, Karlsruhe 
α-mouse Alexa 633 Immunofluorescence Invitrogen, Karlsruhe 
α-rabbit Cy3 Immunofluorescence Jackson 
ImmunoResearch, 
Suffolk, UK 




2.1.4. Enzymes Supplier 
MMLV, reverse transcriptase Invitrogen, Karlsruhe 
Mung bean nuclease New England Biolabs, 
 Frankfurt 
PFU, Polymerase Stratagene, La Jolla, USA 
Polynucleotide kinase Roche, Mannheim 
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Pronase E Sigma-Aldrich, Taufkirchen 
Proteinase K Roche, Mannheim 
Restriction enzymes New England Biolabs, 
 Frankfurt 
 Roche, Mannheim 
 Fermentas, St. Leon-Rot 
RNase A Sigma-Aldrich, Taufkirchen 
SAP (Shrimp alkaline phosphatase) Biolabs, New England 
T4-DNA-ligase Fermentas, St. Leon-Rot 
Taq-polymerase Roche, Mannheim 
 
2.1.5. Reagents Supplier 
BCA Protein Assay Pierce, Rockford, USA 
CD90+/B220+ MACS beads Miltenyi, Bergisch Gladbach 
Cell strainers (50 μm, 70 μm, 100 μm) Falcon, New Jersey, USA 
Cover glasses Hecht KG, Sondheim 
DIG easy Hyb, Northern Blot kit Roche, Mannheim 
Dispenser tips  Brand GmbH, Wertheim 
ExpressHyb hybridisation solution  Clontech-Takara, France 
Films, hyperfilmTM-ECL GE Healthcare, Munich 
Films, autoradiography, Biochrom Kodak, Cologne 
Lympholyte M, blood cell isolation kit Cedarlanes, USA 
Microspin S-200 HR columns GE Healthcare, Munich 
Nylonmembrane, Gene Screen Plus NEN® Research products, 
 USA 
Nylonmembrane, Hybond N+ GE Healthcare, Munich 
Nylonmembrane, Protran BA 85, Cellulose nitrate Schleicher&Schuell 
 BioScience, Dassel 
Object slides Engelbrecht GmbH, 
 Edermünde 
Paper, Whatman 3MM VWR, Darmstadt 
Parafilm M American National CanTM, 
 Chicago, USA 
pGEM T easy, PCR cloning kit Promega 
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Pipette tips Starlab, Ahrensburg 
Plastics for cell culture Corning, New York, USA 
 Falcon, New Jersey, USA 
 Greiner, Solingen 
 Nunc, Wiesbaden 
Protein Standard for Western blotting GE Healthcare, Munich 
QIAGEN Plasmid Isolation kits QIAGEN, Hilden 
Quick & Easy BAC Modification kit Gene Bridges, Dresden 
QuickChange site directed mutagenesis kit Clontech-Takara, France 
Reagent tubes Eppendorf, Wesseling-
 Berzdorf 
RNA Isolation kit (Fluka) Sigma-Aldrich, Taufkirchen 
SMART™-RACE cDNA amplification kit Clontech-Takara, France 
Sterile filters Sartorius, Göttingen 
TA cloning kit Invitrogen, Karlsruhe 
Takara Ladderman labelling kit Takara, France 
Ultracentrifuge Tubes Beckman-Coulter, Krefeld  
    
2.1.6. Electronic devices Supplier 
β-Counter LKB Wallac Perkin Elmer, USA 
Centrifuges, table top 
 Biofuge fresco  Heraeus,  Hanau  
 Megafuge 1.0 R  Heraeus,  Hanau  
Centrifuges, cooling  
 Sorvall® RC 26 PLUS Heraeus,  Hanau 
 Megafuge 1.0, Heraeus,  Hanau 
 Rotor 2250 
 Omnifuge 2.0 RS  Heraeus,  Hanau 
Confocal microscope, LSM510 Zeiss, Jena 
Developer machine Curix 60 Agfa, Cologne 
DNA-crosslinker BIO-LINK BLX  Biometra, Göttingen 
Electrophoresis chambers for DNA and RNA Hoefer, Amstetten 
Electroporation device Gene Pulser II Biorad, Munich 
ELISA Reader Sunrise Tecan, Crailsheim 
30  2. Materials and methods 
FACSCanto Becton Dickinson GmbH, 
 Heidelberg 
Gel documentation system BioDoc Analyze, Biometra, 
 Göttingen  
Gel dryer Biorad, Munich 
Hybridisation oven OV3  Biometra, Göttingen 
Incubator BBD 6220  Heraeus, Hanau 
Microscope Axiovert 25 Zeiss, Jena 
PCR machines  
 T3 Thermoblock  Biometra, Göttingen 
 T1 Thermoblock  Biometra, Göttingen 
 TGradient  Biometra, Göttingen 
Photometer Gene Quant  Pharmacia Biotech 
Phosphoimager, Typhoon 8600 GE Healthcare, Munich 
Shaker for bacterial cultures, 3015  GFL, Burgwedel 
Sterile work bench, Hera Safe  Heraeus, Hanau 
Thermomixer  
 Termomixer Compact Eppendorf, Wesseling- 
  Berzdorf 
 DRI Block  Techne, Jahnsdorf 
Ultracentrifuge L60 Beckman Coulter, Krefeld 
Ultracentrifuge rotor SW55Ti and corresponding buckets Beckman Coulter, Krefeld 
Ultra-sonifier, Branson-Sonifier 450  G.Heinemann, Schwäbisch 
 Gmünd 
Ultra-Turrax, T25 basic IKA Werke GmbH, Staufen 
Waterbaths:  
 WNB22 Memmert, Schwabach 
 1092  GFL, Burgwedel 
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2.2. Buffers and media 




Actin-stabilisation buffer 100 mM PIPES, pH 6.9 
 30% glycerol 
 5% DMSO 
 1 mM MgSO4 
 
DEPC treated H2O for RNA treatment 1ml DEPC per 1l H2O 
 Stirred over night, then 
 autoclaved 
 
dNTP-Mix 1 mM dATP 
 1 mM dCTP 
 1 mM dTTP 
 1 mM dGTP 
 
FACS staining buffer PBS 
 2%FCS 
 0.02% Na-azide 
 
FACS staining buffer (thymocytes) DMEM 
 2%FCS 
 0.02% Na-azide 
  
Fixing solution for radiolabelled gels 40% methanol 
 10% glacial acetic acid 
 
Loading dye, DNA, (10x) 0.05% bromphenol blue 
 0.05% xylene Cyanol FF 
 50% glycerol 
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Loading dye, protein, (5x) 30 mM Tris, pH 6.8 
 10% SDS 
 45% glycerol 
 25% β-mercaptoethanol 
 0.05% bromphenol blue 
Lysis buffer (protein samples) 1% NP – 40 
 1% Laurylmaltosid 
 10 mM NaF 
 1 mM Na3VO4 
 1 mM PMSF  
 10 mM EDTA  
 170 mM NaCl  
 50 mM Tris, pH 7.5 
 1 Protease Inhibitor Cocktail 
 tablet per 10 ml 
 
Lysis buffer (whole organ lysates and IP) 140 mM NaCl 
 5 mM MgCl2 
 20 mM Tris, pH 7.6 
 2 mM NaF 
 1% Digitonin or NP-40 
 1 Protease Inhibitor Cocktail 
 tablet per 10 ml 
 
Lysis buffer (ES cells) 10 mM NaCl 
 10 mM Tris, pH 7.5 
 10 mM EDTA 
 0.5 % N-Lauryl-Sarcosine 
 400μg/ml Proteinase K 
 
Lysis buffer (Erythrocytes) 155 mM NH4Cl 
 10 mM KHCO3 
 100 mM EDTA 
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MACS-buffer PBS 
 0.5% BSA 
 2.5 mM EDTA 
 degassed and filtered 
 stored at 4°C 
 
Maleic acid buffer  100 mM maleic acid 
 150 mM NaCl 
 pH 7.5 
 
MEN buffer for northern blot (10x) 200 mM MOPS 
 50 mM Na-Acetate  
 10 mM EDTA 
 pH 7.0 
 DEPC treated H2O 
 stored in the dark 
 
PBS 13.7 mM NaCl 
 2.7 mM KCl  
 80.9 mM Na2HPO4 
 1.5 mM KH2PO4 
 pH 7.4 
 
PCR buffer (10x) 500 mM KCl 
 100 mM Tris-HCl, pH 8.3
 15-25 mM MgCl2 
 0.1% gelatine 
 
Pronase E 10 mg/ml   
 10 mM Tris, pH 8.0 
 10 mM NaCl  
 selfdigest 1h at 37°C 
 
Proteinase K 10 mg/ml in H2Obidest  
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Running buffer (Western Blot) (1x) 50 mM MOPS  
 50 mM Tris base   
 0.1% (w/v) SDS 
 1 mM EDTA, pH 7.7 
 
SSC 20x 3 M NaCl 
 0.3 M tri-sodium citrate 
 
Solution I (Alcalic lysis) 50 mM glucose  
 25 mM Tris  
 10 mM EDTA 
 
Solution II (Alcalic lysis) 0.2 M NaOH 
 1% (w/v) SDS 
 
Solution III (Alcalic lysis) 60.0% Potassium acetate  
 11.5% glacial acetic acid  
 28.5% H2Obidest 
 
TAE buffer for electrophoresis 40 mM Tris, pH 8.0 
 20 mM glacial acetic acid
 2 mM EDTA 
 
TBS-T (20 x) 200 mM Tris/HCL, pH 7,4 
 3M NaCl 
 0.01% Tween 
 
TE-Puffer  10 mM Tris, pH 8.0 
 1 mM EDTA, pH 8.0 
 
TNE buffer for mouse tail biopsies 10 mM Tris, pH 8.0 
 100 mM NaCl 
 1 mM EDTA, pH 8.0 
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Transfer buffer (Western Blot)(20 x)  25 mM Bicine  
 25 mM Bis Tris  
 1 mM EDTA 
 
Wash B (IP, low salt) 150 mM NaCl 
 10 mM Tris pH 7.6 
 0.2 % digitonin or NP-40 
 1 Protease inhibitor cocktail 
 tablet per 10ml 
 
Wash C (IP, high salt) 500 mM NaCl 
 10 mM Tris, pH 7.6 
 0.2 % digitonin/NP-40 
 1 Protease inhibitor cocktail 
 tablet per 10ml 
 
Wash buffer I (Southern Blot) 2x SSC   
 0.05% SDS 
 
Wash buffer II (Southern Blot) 1x SSC 
 0.1% SDS 
 
2.2.2. Bacteria culture media 
Bacteria were generally cultivated in autoclaved Luria-Bertani (LB) complete media 
Table 2: Composition of bacteria culture media 
Description Composition Amount per litre 
LB Tryptone 10g 
 Yeast extract 5g 
 NaCl 10g 
 H2Odest ad 1l 
 pH 7. 2   
 
Solid media were generated by addition of 15g agar/litre LB media. Liquid bacterial 
cultures were shaked at 37°C over night; dishes were incubated overnight at 37°C without 
shaking. 
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Bacterial dishes with colonies were sealed with parafilm and stored for a maximum of 4 
weeks at 4°C. For long term storage, the cultures were mixed with 50% sterile glycerine 
and kept at -80°C.  
2.2.3. Cell culture media 
All media used during this study were purchased from Invitrogen, Karlsruhe. Leukemia 
inhibiting factor (LIF) was generated as supernatant of the LIF producing clone CHO-LIF-D. 
Table 3: Media and additives for eucaryotic cell culture 
 ES EF EL-4 Jurkat 293 FT HeLa Primary 
lympho-
cytes 






RPMI RPMI DMEM DMEM RPMI 
Additives        
FCS 10% 5% 10% 10% 10% 10% 10% 
Penicilline 
(U/ml) 




100 100 100 100 100 100 100 
L-glutamine 2 mM 2 mM 2 mM 2 mM 2 mM 2 mM 2 mM 
β-ME ( mM) 0.05 0.05     0.05 
LIF 1%       
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2.2.4. Antibiotics 
To positively select for bacteria carrying plasmids, the culture media were supplemented 
with ampicilline, kanamycine, chloramphenicole or tetracycline. Transgenic ES cells after 
electroporation were selected with neomycine and ganciclovir. 
Table 4: Procaryotic and eucaryotic antibiotics 
Substance Stock solution 
Working 
concentration 
Ampicilline 100 mg/ml in H2Obidest, sterilised 100 μg/ml 
Kanamycine 100 mg/ml in H2Obidest, sterilised 100 μg/ml 
Substance Stock solution 
Working 
concentration 
Chloramphenicole 25 mg/ml in isopropanol 12.5 μg/ml 
Tetracycline 100mg/ml in H2Obidest, sterilised 20μg/ml 
Neomycine 




Stock solution 2 mg/ml in sterile H2Obidest; 
128 μl in 500 ml media 
2 μM 
2.3. Bacteria, cell lines and animals 
2.3.1. Bacteria 
Two different lines of bacteria were used to propagate plasmid vectors. 





Bacterial line Genotype Reference 
E. coli XL1-blue endA1, hsdR17, thi-1, supE44, recA1, relA1, gyrA96, 
Δ(lac), (F’proAB), lacIqZΔM15, Tn10 (TetR) 
Stratagene, USA 
E. coli DH5α supE44, ΔlacU169, (Φ80lacZΔM15), hsdR17, recA1, 
endA1, gyrA96, thi-1, relA1 
(Hanahan, 1983) 
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2.3.2.Cells and cell lines 
Table 6: Cells and cell lines used during this study 
Cell/Cell line Description Reference 
Jurkat human T-lymphoma cells ATCC 
Jurkat SLy2-wt-HA Jurkat cells, lentivirally transduced with pWPI-SLy2-
wt-HA  
generated during this 
study 
Jurkat SLy2-ΔNLS-HA Jurkat cells, lentivirally transduced with pWPI-SLy2-
ΔNLS-HA  
generated during this 
study 
Jurkat SLy2-S23A-HA Jurkat cells, lentivirally transduced with pWPI-SLy2-
S23A-HA  




Jurkat cells, lentivirally transduced with pWPI-SLy2-
ΔSH3-HA  




Jurkat cells, lentivirally transduced with pWPI-SLy2-
ΔSAM -HA  
generated during this 
study 
Jurkat GFP Jurkat cells, lentivirally transduced with pWPI  generated during this 
study 
HeLa human epithelial cell line ATCC 
HeLa SLy2-wt-HA HeLa cells, lentivirally transduced with pWPI-SLy2-wt-
HA  
generated during this 
study 
HeLa SLy2-ΔNLS-HA HeLa cells, lentivirally transduced with pWPI-SLy2-
ΔNLS-HA  
generated during this 
study 
HeLa SLy2-S23A-HA HeLa cells, lentivirally transduced with pWPI-SLy2-
S23A-HA  
generated during this 
study 
HeLA SLy2-ΔSH3-HA HeLa cells, lentivirally transduced with pWPI-SLy2-
ΔSH3-HA  
generated during this 
study 
HeLa SLy2-ΔSAM-HA HeLa cells, lentivirally transduced with pWPI-SLy2-
ΔSAM -HA  
generated during this 
study 
HeLa GFP HeLa cells, lentivirally transduced with pWPI generated during this 
study 
293FT Derived from 293T. Used to maximize the production 
of lentiviral particles 
(Naldini et al., 1996) 
ES cells E14.1 Murine embyonic stem cells generated from the 
mouse line 129/SvJ Ola 
(Kuhn et al., 1991) 
EF cells Embryonic fibroblasts, generated from d14.5 post 




Primary cells, cultivated after organ homogenation  Prepared continuously 
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2.3.3. Animals 
All animals used during this study were kept in the animal house of the Heinrich-Heine-
University, Düsseldorf. Blastocysts, needed for the generation of gene-targeted mice were 
prepared from C57BL/6 mice. Female CD1 mice served as foster mothers. The SLy2 locus 
was inactivated in 129/Ola SvJ stem cells and backcrossed to C57BL/6 to yield SLy2-/- mice 
of MHC haplotype H-2b. The transgenic SLy2 overexpressing mice were generated by 
Miltenyi Biotech, Bergisch Gladbach, on 129/Ola SvJ background. Also these mice were 
backcrossed continuously to C57BL/6 during this study. 
2.4. Primers 
All primers used during this study were purchased from Metabion (Martinsried). 
Table 7: Primers 
Name Sequence Application 
Type_SLy2-ko_for GGATCTCATTGTGATTCCGTGG 5’ primer for 
typing of SLy2 
gene-targeted 
mice 
Type_SLy2-ko_wt rev GACTTGGAGCTGTCAATGTAAC 3’ wt primer for 
typing of SLy2 
gene-targeted 
mice 
Screen_SLy2-ko_ko rev GAGAATAGGAACTTCGGAATAGG 3’ ko primer for 
typing of SLy2 
gene-targeted 
mice 
Screen_SLy2-tg_for CTGAAGGAGACTGTGGTTGAGTGGTGG 5’ primer for 
typing of SLy2 
transgenic mice 
Screen_SLy2-tg_rev CGTAATCTGGAACATCGTATG 3’ primer for 
typing of SLy2 
transgenic mice 
SLy2_LA_for TCCCCCGGGAGACAAGGAGAAACACCAAAAACC Amplification of 
the long arm of 
homology 
SLy2_LA_rev AAATATGCGGCCGCAAAGTATATVTCGTVGTGTATCTGG Amplification of 
the long arm of 
homology 
SLy2_SA_for_XhoI CCGCTCGAGGCCCTTGGCTACGTTTACAGC Amplification of 
the short arm of 
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homology 
SLy2_SA_rev_SalI ACGCGTCGACGAGGCATTGGATGGCTTCCT Amplification of 





the neo-gene for 






the neo-gene for 














for the fosmid 
based targeting 
construct 
SLy2_5’ probe_for GTTAACTGAGAACCACCCAG Amplification of 
the 5’ flanking 
probe 
SLy2_5’probe_rev ACCTACCTTTCAATTTCATTGC Amplification of 
the 5’ flanking 
probe 
SLy2_3’probe_for GCCTAAGACCAGAACTTCTAGC Amplification of 
the 3’ flanking 
probe 
SLy2_3’probe_rev CCAGGCTGGCTTCTTCATGC Amplification of 
the 3’ flanking 
probe 
SLy2_cDNA_for_SwaI ATTTAAATACCATGCTAAAGAGGAAGCCATCC Amplification of 




the SLy2 cDNA 
SLy2_dNLS_for ATCAAAGCTCTTTCTGAGGAAAAAG Generation of a 
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Name Sequence Application 
NLS deficient 
SLy2 species 
SLy2_dNLS_rev TAGACTTCCTCCACTGCTTGAAG Generation of a 
NLS deficient 
SLy2 species 
SLy2_S23A-mut_for CCGAAGCGCAGCGCTTTTGGGAATTTTGAC Mutates the 
serine 23 to 
alanine 
SLy2_S23A-mut_rev GTCAAAATTCCCAAAAGCGCTGCTGCGCTTCGG Mutates the 
serine 23 to 
alanine 
SLy2_dSH3_for TTAGAAGAGGAAGCAGCTCCT Generation of a 
SH3 deficient 
SLy2 species 
SLy2_dSH3_rev GCCACAGAATGGCCCTGAGT Generation of a 
SH3 deficient 
SLy2 species 
SLy2_dSAM_for GAAACCACTGTAGAACATGAAAAG Generation of a 
SAM deficient 
SLy2 species 












Cloning of the 
human SLy2 
cDNA 
Exon 5 rev GTAGGGGCTGTCATCATCCAGTCG Identification of 
upstream cDNA 
sequences in a 
RACE PCR (GSP-
1) 
Cortactin_cDNA-for AAAGCTAGCACCATGTGGAAAGCCTCTGCAGG Cloning 
Cortactin_cDNA-rev TTTCTCGAGCTGCCGCAGCTCCACATAG Cloning 
CD2-IC_cDNA-for AAAGCTAGCACCATGTGCAAGAGGAGAAAACGGAACAGG Cloning 
CD2-IC_cDNA-rev TTTCTCGAGATTAGGGGGCGGCAGTGAAACAC Cloning 
RhoA-GTPase_cDNA-for AAAGCTAGCACCATGGCTGCCATCAGGAAGAAAC Cloning 
RhoA-GTPase_cDNA-rev TTTCTCGAGCAAGATGAGGCACCCAGAC Cloning 
Cdc42-GTPase_cDNA-for AAAGCTAGCACCATGCAGACAATTAAGTGTGTTG Cloning 
42  2. Materials and methods 
Name Sequence Application 
Cdc42-GTPase_cDNA-rev TTTCTCGAGTAGCAGCACACACCTGCGG Cloning 
Rac1-GTPase_cDNA-for AAAGCTAGCACCATGCAGGCCATCAAGTGTGTG Cloning 
Rac1-GTPase_cDNA-rev TTTCTCGAGCAACAGCAGGCATTTTCTCTTC Cloning 
3BP2_cDNA-for AAAGCTAGCACCATGGCGGCTGAGGAGATGCAG Cloning 
3BP2_cDNA-rev TTTCTCGAGCCTGGGCCCAGCGTAGCCG Cloning 
Cbl-b_cDNA-for AAAGCTAGCACCATGGCCGGCAACGTGAAGAA Cloning 
Cbl-b_cDNA-rev AAACTCGAGGGTGGCTACGTGAGCAGGAG Cloning 
CD34-IC_cDNA-for AAAGCTAGCACCATGAACCGTCGCAGTTGAG Cloning 
CD34-IC_cDNA-rev AAAGTGGAGCAGTTCTGTGTCAGCCACCA Cloning 
C3G-cDNA-for AAAGCTAGCACCATGAGCAGCGGCCTCGGCCT Cloning 
C3G-cDNA-rev AAACTCGAGGGTCTTCTCTTCGCGGTCTG Cloning 
DAB2_cDNA-for AAAGCTAGCACCATGTCTAACGAAGTAGAAACAAGC Cloning 
DAB2_cDNA-rev AAATCTAGACTAGGCAAAAGGATTTCCGA Cloning 
SLP65_cDNA-for AAAGCTAGCACCATGGACAAGCTGAATAAGATAAC Cloning 
SLP65_cDNA-rev ACACTGGAGTGAAACCTTCACAGCATATTTC Cloning 
SLP76_cDNA-for AAAGCTAGCACCATGGCCTTGAAGAATGTCC Cloning 
SLP76_cDNA-rev ACACTCGAGCAGACAGCCTGCAGC Cloning 
Gab1_cDNA-for AAAGCTAGCACCATGAGCGGCGGCGAAGTGGTTTGCT Cloning 
Gab1_cDNA-rev ACACTCGAGCTTCACATTCTTGGT Cloning 
RN-tre_cDNA-for AAAGCTAGCACCATGATTCAAGTCTTGCAGCTTG Cloning 
RN-tre_cDNA-rev AAACTCGAGCAGCAACACTGATTCCTGCA Cloning 
2.5. Plasmid vectors 
2.5.1. Original vectors 
Different original vectors, some of them commercially available, were used in the 
generation of plasmid constructs. 
Table 8: Original vectors used to generate all constructs during this study 
Description Properties Reference 
pBluescript II KS + AmpR, KanR, f1 ori, Col E1 ori, lac-
Promotor, lacZ-Fragment, rop- 
Stratagene, USA 
pCR II-TOPO Allows the direct cloning of PCR 
products by T/A cloning. 
AmpR, KanR, f1 ori, Col E1 ori, lac-
Promoter, lacZ-Fragment 
Invitrogen, Karlsruhe 
pBS neo  pGK neoR poly A in pBluescript  K. Pfeffer, Düsseldorf 
pGEM7 TK Contains the thymidine kinase 
gene from Herplex Simplex Virus 
K. Pfeffer, Düsseldorf 
pWPI Lentiviral, bicistronic expression (Zufferey et al., 1998) und 
http://tronolab.epfl.ch 
2. Materials and methods  43 
 
Description Properties Reference 
construct, containing the pEF2α 
promoter and an IRES controlled 
GFP gene. 
Rac1V12 Contains a GFP-tagged 
constitutively active form of rac1 
(Ridley et al., 1992) 
Rac1N17 Contains a GFP-tagged dominant 
negative form of rac1 




ChloramphR, Basis for fosmid 
constructs 
www.bacpac.chori.org 
pBAD Bacterial expression plasmid 
coding for λ-recombinases Redα 
and Redβ 
Gene Bridges, Dresden 
pSEC Tag Expression of myc-tagged 
proteins 
Invitrogen, Karlsruhe 
p1026x Contains a bipartite promoter 
with the lck-proximal promoter 
and the IgH enhancer 
(Iritani et al., 1997) 
2.5.2. Constructs generated during this study 
Table 9 depicts all constructs which were cloned during this study, originating from the 
previously mentioned original vectors. 
Table 9: Vectors generated during this study 
Description Original vector Insert Properties 
Target vector 
(conventional cloning) 
pBluescript II KS + Short arm of homology, 
Long arm of homology, 
neoR and HSV-tk 
cassettes 
Targeting constructs for 
homologous 
recombination in ES cells 
Target vector 
(fosmid based cloning) 
pEPIfos+SLy2 genomic 
sequences 
neoR and HSV-tk 
cassettes 
Targeting construct for 
the homologous 
recombination in ES cells 
5’ flanking probe  pCR II-TOPO 5’flanking probe 
(1000bp) 
Contains the 5’flanking 
probe for the targeting of 
the SLy2 locus 
3’ flanking probe pCR II-TOPO 3’flanking probe 
(1000bp) 
Contains the 3’flanking 
probe for the targeting of 
the SLy2 locus 
pWPI-SLy2-wt-HA pWPI SLy2-cDNA fused to an 
HA tag 
Lentiviral SLy2 expression 
vector 
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pWPI-SLy2-ΔNLS-HA pWPI SLy2-ΔNLS-cDNA fused 
to an HA tag 
Lentiviral SLy2 expression 
vector 
pWPI-SLy2-S23A pWPI SLy2-S23A-cDNA fused 
to an HA tag 
Lentiviral SLy2 expression 
vector 
pWPI-SLy2-ΔSH3-HA pWPI SLy2-ΔSH3-cDNA fused 
to an HA tag 
Lentiviral SLy2 expression 
vector 
pWPI-SLy2-ΔSAM-HA pWPI SLy2-ΔSAMcDNA fused 
to an HA tag 
Lentiviral SLy2 expression 
vector 
Rac1V12+mCherry Rac1V12 mCherry, red fluorescent 
protein, derivative of DS 
red 
Eucaryontic expression 
vector for the 
simultaneous expression 
of Rac1V12 and Cherry 
Rac1N17+mCherry Rac1N17 mCherry, red fluorescent 
protein, derivative of DS 
red 
Eucaryontic expression 
vector for the 
simultaneous expression 
of Rac1N17 and Cherry 
pSEC Tag+cortactin pSEC Tag Cortactin cDNA  Expression of myc-tagged 
cortactin 
pSEC Tag+CD2_IC pSEC Tag CD2_intracellular 
domain cDNA  
Expression of myc-tagged 
CD2-intracellular domain 
pSEC Tag+RhoA pSEC Tag RhoA cDNA  Expression of myc-tagged 
RhoA 
pSEC Tag+Cdc42 pSEC Tag Cdc42 cDNA  Expression of myc-tagged 
Cdc42 
pSEC Tag+Rac1 pSEC Tag Rac1 cDNA  Expression of myc-tagged 
Rac1 
pSEC Tag+3BP2 pSEC Tag 3BP2 cDNA  Expression of myc-tagged 
3BP2 
pSEC Tag+Cbl-b pSEC Tag Cbl-b cDNA  Expression of myc-tagged 
Cbl-b 
pSEC Tag+CD34_IC pSEC Tag CD34_intracellular 
domain cDNA  
Expression of myc-tagged 
CD34 intracell. domain 
pSEC Tag+C3G pSEC Tag C3G cDNA  Expression of myc-tagged 
C3G 
pSEC Tag+DAB2 pSEC Tag DAB2 cDNA  Expression of myc-tagged 
Dab2 
pSEC Tag+SLP65 pSEC Tag SLP65 cDNA  Expression of myc-tagged 
SLP65 
pSEC Tag+SLP76 pSEC Tag SLP76 cDNA  Expression of myc-tagged 
SLP76 
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pSEC Tag+Gab1 pSEC Tag Gab1 cDNA  Expression of myc-tagged 
Gab1 
pSEC Tag+RN-tre pSEC Tag RN-tre cDNA  Expression of myc-tagged 
RN-tre 
2.6. Methods 
2.6.1.Generation of mice 
The gene-targeted mice described in this study were generated following standard 
protocols. The transgenic SLy2 overexpressing mouse line was generated by Miltenyi 
Biotech, Bergisch Gladbach. 
2.6.1.1. Gene-targeted mice 
The two following paragraphs describe the generation of the targeting constructs by two 
different methods. Both constructs were used to electroporate ES cells to obtain 
homologously recombined gene-targeted cells. 
Conventional cloning strategy 
The first targeting construct was generated by cloning of two arms of homology on either 
side of a neomycine resistance gene (neoR) gene. Both arms, the short and the long arm of 
homology, were obtained by PCR from genomic E14 DNA and cloned into pBluescript by 
standard cloning techniques. Targeted disruption of the locus was achieved by placing a 
neoR-cassette between both regions of homology that would be inserted into the genomic 
SLy2 locus upon homologous recombination. To allow negative selection of not 
homologously recombined clones, a HSV-TK cassette was inserted 3’ of the long arm. 
Fosmid derived cloning strategy 
As the frequency of homologous recombination increases with the length of both arms of 
homology, a new technique was applied to construct the second targeting vector. This 
method makes use of fosmid vectors, which consist of a long stretch of genomic DNA 
(~40-60kb) cloned into a plasmid, allowing for propagation in E.coli in the presence of 
chloramphenicole. To generate a targeting construct, a neoR-cassette was inserted via 
homologous recombination (Red/ET cloning system, Gene Bridges, Dresden) into the 
target site. The first step in an ET cloning reaction was the electroporation of the fosmid 
carrying E.coli with an inducible bacterial expression plasmid (pBAD) for the λ-
recombinases Redα and Redβ that contains a temperature-sensitive origin of replication 
(oriR101), allowing propagation of the plasmid only up to 30°C. This rendered the bacteria 
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chloramphenicole/tetracycline double resistant. These double resistant clones were 
picked, grown and expression of the recombinase was induced by addition of L-arabinose 
(20μl of a 1M solution) and incubation of the cells at 37°C. Subsequently, 200ng of the 
neoR-cassette containing short arms (50bp on either side) homologous to the site of 
insertion, was electroporated into the bacteria. The arms of homology were added to the 
neoR-gene by PCR with the primers shown in chapter 2.4. As the neoR-cassette contains a 
kanamycine resistance gene, it rendered the bacteria harbouring a successful 
recombination event double resistant against chloramphenicole and kanamycine. Double 
resistant clones were picked and recombination was assessed by PCR, restriction digest 
and finally by southern blot. The HSV-TK cassette was inserted 3’ of the homology region 
with the same method, using an expression cassette with an additional ampicilline 
resistance gene. 
Culture of murine embryonic fibroblasts (EF) and stem cells (ES) 
EF served as feeder cells for ES cell culture, supplying the stem cells with the necessary 
growth factors. To prevent overgrowth of the ES cells by the EF cells, the latter were 
mitotically inactivated by treatment with mitomycin C for 2.5 hours at 37°C. Afterwards, 
the cells were washed twice with PBS and the ES cells were plated on top. For the 
generation of EF cells, E14.5 mouse embryos were sacrificed and, after removal of head 
and fetal liver, pushed through a 70 μm cell strainer to obtain single cells. The resulting 
fibroblasts were propagated for 4 days and storage frozen at 5x106/vial.  
The medium for ES cell culture was generally supplemented with LIF, to prevent 
differentiation of the cells. The undifferentiated state of the ES cell colonies was 
determined by their morphology. An undifferentiated colony has an elliptic shape, with 
sharp borders and a shiny appearance. Upon differentiation, the colonies develop 
pseudopodia and become grey, granulated and dimly coloured. 
Electroporation of ES cells 
ES cells were transfected by electroporation with one of the SLy2 targeting constructs.  
On the day of transfection, the cells were trypsinised and 5x107 were resuspended in 7ml 
of ES cell medium. 200μg of the linearised targeting construct were solubilised in 1ml PBS 
and mixed with the cells. 800μl of this mix were transferred to each electroporation 
cuvette and electroporated in a Biorad Gene pulser II at 340V and 250μF. After 10min 
incubation on ice, the cells were resuspended in prewarmed ES medium and the content 
of each cuvette was plated on two EF cell covered 10 cm dishes. 
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Selection of recombinant ES cells 
After electroporation, the ES cells were cultivated for 24h without antibiotics. Thereafter 
the medium was supplemented with 200μg/ml neomycine and from day 4 on additionally 
with 2 μM ganciclovir. This double selection favored cells that had incorporated the 
targeting construct (neomycine-selection), but had done so in a homologously 
recombined fashion, without incorporation of the HSV-TK gene (ganciclovir selection). 
Detection of homologously recombined clones 
On day 10 after electroporation the surviving colonies were washed twice with PBS, 
harvested in 20μl PBS with a sterile pipette and each one was transferred to one well of a 
96-well plate. The colonies were separated to single cells by trypsinisation and each well 
was supplemented with EF cells. After two days, two thirds of each well were transferred to 
an EF covered 48-well plate and the remaining third was further propagated in the 96-well 
plate. Again two days later, the cells on the 48-well plates were trypsinised, mixed 1:1 with 
2x cell-freezing-media and stored at -80°C. The colonies in the 96-well plates split to three 
gelatine coated flat bottom 96-well plates. After cultivation for another week with a daily 
change of media, the genomic DNA was prepared and analysed by southern blot for 
homologously recombined clones. 
Superovulation of donor animals 
To maximize the number of blastocysts to be harvested from the C57BL/6 donor mice, 
these were superovulated. On day -6 before injection, the donor mice were injected IP with 
100μl PMSG (pregnant mare serum gonadotropin) around 4.00h p.m. Two days later 
around 2.00h p.m., the same mice were injected IP with 100μl hCG (human chorion 
gonadotropin) and directly mated to C57BL/6 males. This treatment yielded the E 3.5 
blastocysts needed for ES cell injection.   
Generation of chimeric mice 
The C57BL/6 donor blastocysts were injected each with approximately 20 homologously 
recombined ES cells and 10-20 of such manipulated blastocysts were implanted into CD1 
foster mothers, which had been mated to vasectomised males to confer a state of mock 
pregnancy. 19 days later the offspring was born. The degree of chimerism could be 
deduced from the colour pattern of the coat a week later. Upon six weeks of age, the 
chimeric mice were mated to C57BL/6 animals and the resulting offspring was analysed for 
germ line transmission of the mutation by analysis of coat colour and subsequently by 
southern blot and PCR. 
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Typing of mice with the targeted allele 
DNA prepared from tail biopsies served as typing PCR template. The PCR typing strategy 
applied to identify the gene-targeted animals made use of a three primer multiplex PCR 
system with one forward primer and two reverse primers, one complementary to the 
wildtype and the other to the targeted locus. This system yielded a 1000 bp band for the 
wildtype locus and a 750 bp fragment for the targeted locus.  
2.6.1.2. Transgenic mice 
Generation of a transgenic, SLy2 overexpressing mouse line 
To analyse the effect of a constitutive overexpression of SLy 2 in primary lymphocytes, a 
transgenic mouse line was established. The mice were generated by Miltenyi Biotech, 
through pronucleus injection of a SLy2 expression construct into 129/SvJ Ola zygotes. The 
expression construct contained a SLy2 cDNA cloned behind a chimeric promoter 
combining the proximal lck-promoter and the IgH-enhancer, resulting in a robust 
expression in T and B cells (Iritani et al., 1997). 
Typing of transgenic mice 
Transgenic mice were identified by a PCR, amplifying a 650bp fragment from inside the 
transgenic expression construct. Mice carrying two transgenic alleles were identified by 
real time PCR with the following primers and probe set. A PCR for INFβ served as internal 
control. 
Table 10: Primers and probes used in typing of homozygous transgenic animals 
Gene Forward primer Reverse primer Probe sequence 
SLy2 transgenic allele aatacatcaaagctctttctgagga tgggatcactgttccgatatg ggagagga, Probe #55 
INFβ caggcaacctttaagcatcag cctttgacctttcaaatgcag ctgggact, Probe #95 
 
2.6.2. Generation and maintenance of transgenic cell lines 
2.6.2.1. General maintenance 
Splitting and passaging 
Adherent cells were passaged every second day. The cells were washed once with PBS and 
trypsinised at 37°C until detached from the plate. The trypsin was inhibited by addition of 
medium, the cells were centrifuged and 1/10 was seeded again. Cells growing in 
suspension were split 1 to 5 every second day.  
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Freezing and thawing 
Adherent cells were trypsinised, centrifuged and resuspended in 1x freezing medium. 
Suspension cells were harvested, centrifuged and resuspended in 1x freezing medium. To 
ensure a slow cooling process, the filled freezing vials were first stored at -20°C for 30 min 
and then transferred to -80°C afterwards. For long term storage, the vials were kept in 
liquid nitrogen.  
For thawing, the vials were incubated in a 37°C waterbath and the cells were quickly 
transferred to prewarmed medium. Washing removed the DMSO and the cells were 
seeded. 
Determination of cell numbers 
To determine the concentration of a cell suspension, the cells were mixed with trypane-
blue (0.16% in PBS) to stain dead cells, transferred to a Neubauer counting chamber and 
counted under the microscope.  
2.6.2.2. Lentiviral transduction of cells 
The lentiviral vectors used during this study are unable to replicate and follow the lentiviral 
replication cycle only until the integration into the host genome. The lentiviral system 
applied here was of the second generation, with the genes necessary for virus production 
being divided to three different plasmids. Transient transfection of 293FT cells with these 
plasmids resulted in generation of viral particles (Zufferey et al., 1998).  
The first plasmid, pWPI (Klages et al., 2000) contained the SLy2 cDNA (wildtype or different 
mutated forms) under the control of an EF1-α promoter. The cDNA was followed by an 
IRES (internal ribosome entry site) which preceeded an open reading frame for green 
fluorescing protein (eGFP). This bicistronic expression construct ensured expression of the 
SLy2 and eGFP in every transduced cell, allowing the determination of transduction 
efficiency by flow cytometry. Two sequences important for integration and packaging, the 
long terminal repeats (LTRs) flanked the expression cassette on either side. The construct 
contains deletions in the U3 region of the 3’ LTR, which serves as template for the 5’ LTR 
during reverse transcription, resulting in deletions in the lentiviral promoter upon 
integration of the proviral DNA. This disables the transcription and leads to the 
autoinactivation of the vector. The second plasmid codes for the packaging genes gag, pol 
and rev. The vector pCMV-dR8.74psPAX2 used in this study, is deleted for additional viral 
genes, as vpr, vif, vpu or nef (Zufferey et al., 1998). The third plasmid contains the cDNA for 
the G protein of the vesicular stomatitis virus (VSV-G) serving as viral envelope protein. 
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Production of viral particles 
On the day before transfection, 2-3x106 293FT cells were seeded onto a 10 cm dish. The 
next day the cells were transfected by calcium-phosphate. 20μg of the respective pWPI 
construct were mixed with 15μg of PAX2 and 5μg of VSV-G. The mixture was filled up to 
250μl with 2.5 mM HEPES and mixed with 250μl CaCl2. While continuously vortexing, the 
DNA/CaCl2 mixture was dropwise added to 500μl 2xHEBS and then incubated at RT for 30 
min for complex formation. The medium on the 293FT dishes was changed to FCS free 
DMEM and the DNA mix was added to the cells. After incubation for 5 hours, the FCS free 
medium was discarded and 6ml of normal 293FT medium were added. The viral particles 
were harvested 48 hours later by gathering the supernatant of the transfected cells and 
centrifugation at 1200 rpm for 10 min to remove cell debris. Afterwards, the supernatant 
was divided to 2ml freezing tubes, snap-frozen in liquid nitrogen and stored at -80°C 
Generation of stably transduced cell lines 
For the transduction of adherent cells, 1x104 cells were seeded into each well of a 24-well 
plate the day before transduction. The next day, the medium was removed and 500μl of 
lentiviral supernatant, supplemented with 4μg/ml polybrene, were added to the cells. To 
enhance the transduction efficiency, the plates were centrifuged for 2 hours at 1200 rpm 
and 32°C. After centrifugation, the cells were incubated at 37°C for 3-5 hours, after which 
the supernatant was diluted with 500μl. The cells remained in this diluted supernatant 
overnight. The transduction procedure for suspension cells was essentially the same, with 
the exception, that the 1x104 cells were harvested on the day of transduction and 
resuspended in lentiviral supernatant supplemented with 8μg/ml polybrene. As the 
transduction efficiency of Jurkat cells was somewhat lower than that of HeLa, the former 
were transduced twice on two following days. This treatment routinely yielded 85%-96% 
transduced cells, as determined by flow cytometry. 
2.6.2.3. Additional transfection methods 
Calcium-phosphate transfection 
293T and 293FT cells were routinely transfected with Ca-phosphate as described in chapter 
2.6.2.2., to perform expression and interaction studies with different SLy2 constructs and 
additional proteins. 
FuGENE 6 
To transfect HeLa cells FuGENE 6 (Roche, Mannheim) was used, following the instructions 
of the manufacturer. Briefly, 7x104 cells were seeded into each well of a 6-well plate on the 
day before transfection. For each well, 8μl of FuGene reagent were mixed with 92μl serum-
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free DMEM. After incubation for 5 min at RT, this mixture was added to 4μg of the 
respective plasmid DNA, followed by 15 min incubation at RT. The transfection mix was 
added to the cells, which were analysed 24h-48h later. 
2.6.3. Cell culture experiments 
2.6.3.1. Spreading assay 
Transgenic HeLa cells 
To determine the spreading capacity of HeLa cells expressing different SLy2 mutants, the 
cells were detached from the dish by treatment with 0.05 mM EDTA. No trypsine was 
added, to maintain the integrity of the cellular surface molecules. 2-4x104 cells were 
seeded onto a gelatine coated cover glass. Cells were allowed to adhere for 45 min, 
washed with PBS once and fixed in 4% PFA for 15 min, followed by staining for filamentous 
actin (F-actin) and nuclei with phalloidine and DAPI, respectively. The spreading index of 
each cell was determined as the ratio of cell length and cell width. 
Transgenic primary splenocytes 
Lymphocytes, activated through their antigen receptors, show a distinct choreography of 
spreading and contraction at their contact site to an antigen bearing surface.  
The spleens of SLy2 transgenic mice and wildtype littermates were isolated semi-sterile. 
Pushing the organs through 70 μm cell strainers yielded a single cell suspension, which 
was centrifuged and resuspended in 1ml erythrocyte-lysis buffer per spleen and incubated 
at RT for 5 min. Lysis was stopped by addition of 10ml PBS and cells were recovered by 
centrifugation. The cells were MACS separated into B220+ and CD90+ fractions and were 
stimulated one hour with αCD40 and IL-4 (5μg/ml and 10ng/ml) or αCD3 and CD28 
(10μg/ml), respectively. After stimulation, 1x106 cells were seeded onto cover glasses 
coated with αIgM or αCD3 and allowed to adhere on ice for 30 min. To induce spreading, 
the cells were incubated at 37°C followed by fixing with 4% PFA (37°C/ 8 min) after 
different timepoints, ranging from 1-30 min. Again, F-actin and nuclei were stained and the 
spreading index was determined as the size of the area of adherence. 
2.6.3.2. Proliferation assay 
BrdU pulse-chase 
As opposed to the previously described 3H-thymidine incorporation assay, a BrdU pulse-
chase experiment allowed the determination of the proliferation rate over a much larger 
time. The rate of proliferation is deduced from the decline of the BrdU content of the cells. 
1x105 cells were seeded per well of a 6-well plate. The cells were pulsed by incubation in 
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BrdU-supplemented medium (10μg/ml) for eight hours, after which they were washed and 
normal medium was added. To chase, half of the cells of each well were harvested daily, 
stained for BrdU and analysed by flow cytometry. Staining was performed according to 
manufacturer’s instructions. Briefly, the cells were washed with PBS, resuspended in 70% 
EtOH and fixed at 4°C for at least 30 min. Histones were extracted by resuspending the cells 
in 100 mM HCl/0.5% Triton-X-100 and incubation on ice for 10 min. Cells were centrifuged, 
resuspended in ultrapure H2O and genomic DNA was denatured at 95°C for 10 min. 
Thereafter, cells were washed once with PBS/0.5% Triton-X-100 and stained with αBrdU-PE 
in PBS/1% BSA for 30 min at RT. The percentage of BrdU+ cells was determined by FACS 
analysis.  
2.6.4. Biochemical assays 
2.6.4.1. SDS-polyacrylamide gel electrophoresis and Western blotting 
SDS-polyacrylamide gel electrophoresis was used to separate proteins according to their 
molecular weight. The determination of the analysed proteins was facilitated by a 
simultaneously applied molecular weight standard (GE Healthcare, Braunschweig). After 
the gel content had been transferred to a nitrocellulose membrane, proteins were 
detected by specific antibodies and appropriate secondary reagents. 
Sample preparation from cultured cells 
For lysis, the cells were washed once with PBS, centrifuged and resuspended in lysis buffer, 
supplemented with various proteinase and phosphatase inhibitors. To maximize the lysis 
efficiency, the lysates were incubated rotating 15 min at 4°C and cleared by centrifugation 
at 13000 rpm for 10 min afterwards. Sample loading buffer was added 1:5 to each sample 
and proteins were denatured at 95°C for 5 min. Samples were stored at -20°C. 
Sample preparation from mouse organs and blood 
Organs were taken semi-sterile from mice and homogenised in lysis buffer with an ultra-
turrax (speedlevel 6, 5-10 sec). After incubation on ice for 15 min the lysates were cleared 
by centrifugation and the protein concentration was determined by a BCA-assay. Lysates 
were mixed 1:5 with sample loading buffer and proteins were denatured at 95°C for 5 min.  
Blood samples were depleted of erythrocytes prior to lysis. This was achieved by applying 
lympholyte M solution according to the instructions of the manufacturer. Lysis of the 
recovered cells was performed as previously described. 
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Gel electrophoresis, blotting and detection 
The protein samples were separated on 4%-12% or 10% polyacrylamide gels. Routinely, 
pre-cast minigels from Invitrogen were applied. Only IPs of 35S labelled lysates were 
separated on large, individually cast 10% polyacrylamide gels. For separation, up to 30μg 
of total protein were loaded into each sample loading pocket and the samples were 
separated electrophoretically at 100-200V with constant voltage for 1-2 hours. 
The proteins were transferred to a nitrocellulose membrane in a wet-blotting-device 
(Invitrogen, Karlsruhe), according to the manufacturer’s instructions. Afterwards the 
membrane was blocked with 3% skim milk powder in TBS-T for one hour at RT, to prevent 
unspecific binding of the antibodies. Incubation with the first antibody, specific to the 
respective protein, was perfomed in 3% skim milk/TBS-T at 4°C overnight. Afterwards, the 
membrane was washed three times with TBS-T for 5 min each at RT, followed by 
incubation with the secondary antibody, coupled to peroxidase, again in 3% skim 
milk/TBS-T for one hour at RT. The membrane was again washed three times with TBS-T for 
5 min. Signals were detected with X-ray films, after a one-minute incubation of the 
membranes in a 1:1 mixture of ECL solutions 1 and 2. 
2.6.4.2. Immunoprecipitation (IP) 
Immunoprecipitation allows the analysis of physical interactions between proteins in a 
cell-lysate. The primary protein is bound by a specific antibody and the resulting immuno- 
complex is precipitated by binding to protein A- or protein G-coupled agarose beads. 
Analysis of the precipitates by western blotting reveals coimmunoprecipitated interaction 
partners of the primary protein. In the present study, IPs were mostly performed with αHA 
antibodies to precipitate different HA-tagged SLy2 species. 
The cells were lysed as previously described and the antibody was added to the cleared 
lysate, followed by a rotating incubation at 4°C overnight. Washed agarose beads were 
added and again incubated rotating for 1 hour. The beads were washed four times with 
increasing salt conditions and proteins were eluted in 2.5x sample loading buffer at 95°C 
for 10 min. The composition of lysis and wash buffers is shown in chapter 2.2.1. 
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Table 11: Antibodies and agarose-species used in IPs 
















HA-tag Mouse 1:300  Sigma-
Aldrich, 
Taufkirchen 





2.6.4.3. Separation of G- and F-actin fractions 
Actin occurs in two different states inside a cell, either the monomeric, globular (G-) form 
or the polymeric, filamentous (F-) form. The ratio of the G- to the F-state changes 
constantly, e.g. upon cell migration or lamellipodia formation and can be influenced by a 
plethora of stimuli. Many actin associated proteins localise specifically to one or the other 
fraction inside a cell. To analyse the amount of SLy2 recruited to either the G- or the F-actin 
fraction, one 10 cm dish of HeLa cells was lysed with 2ml actin-stabilisation-lysis-buffer. 
Lysates were recovered with a cell scraper and transferred to polyallomer ultra centrifuge 
tubes (Beckman-Coulter, USA), followed by centrifugation for 20 min at 4°C with 32000 
rpm through a glycerol gradient in a Beckman Ultracentrifuge L60 (SW 55 Ti Rotor, and 
corresponding buckets). This resulted in a pellet fraction (F-actin) and the supernatant, 
representing the cytosolic G-actin fraction. The latter was recovered and the pellet was 
resuspended in lysis buffer containing 5 μM Cytochalasin D, stabilising the F-actin. Both 
fractions were mixed with sample loading buffer and denatured for 10 min at 95°C. The 
pellet samples were additionally ultrasonified to shear the genomic DNA, thereby reducing 
the viscosity. Corresponding amounts of each fraction were analysed by western blotting.  
2.6.4.4. Identification of binding partners by 35S-labelling 
The identification of interaction partners by 35S-labelling essentially relies on 
immunoprecipitation and allows the highly sensitive analysis of the interaction partners of 
a protein, without the need for specific antibodies. To radioactively label the cellular 
proteins, the cells were starved in medium lacking methionine and cysteine for 24 hours 
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and then supplemented with radioactively labelled species of these aminoacids (Redivue 
pro mix, GE Healthcare, Munich) for 10 hours. Afterwards, the cells were treated with 
different stimuli, washed and lysed. HA-tagged SLy2 was precipitated from the lysates and 
the IPs were separated on polyacrylamide gels. The gels were fixed and dried as described 
and exposed to X-ray films. 
2.6.5. Immunofluorescence and confocal imaging 
2.6.5.1. Preparation of samples  
Adherent cells were seeded onto gelatine coated cover glasses (Ø=1.3 cm) in a 24-well 
plate one day before staining, if not otherwise stated. For gelatinisation, the cover glasses 
were incubated with PBS/0.2% gelatine for at least 30 min at 37°C. If stimuli were used, the 
cells were treated on the cover glasses, just prior to staining. 
2.6.5.2. Staining procedure 
The complete staining procedure was performed in the 24-well plate on an orbital shaker 
at RT in the dark. The cells were washed at least once with PBS and fixed in 4% PFA for 15 
min, washed once with PBS and permeabilised in PBS/0.05% saponine for 15 min. To avoid 
unspecific binding, the samples were blocked with 2% goat serum in PBS with 1/10 
permeabilisation solution for 20 min, prior to incubation with the primary antibody in PBS 
with 1/10 blocking buffer for at least one hour. Unbound antibody was removed by three 
consecutive washes with 10% permeabilisation buffer, 5 min each. Subsequently, the 
samples were incubated with the fluorescently labelled secondary antibody and eventually 
phalloidine, both in 10% blocking buffer for 45 min. Unbound secondary antibody was 
removed by two PBS washes and nuclei were stained with DAPI for 3 min, followed by two 
final washing steps. For conservation, the samples were mounted with Fluoromount-G on 
clean object slides, and left to dry for at least one day prior to microscopic analysis. 
Alternative staining protocol 
To stain less abundant proteins (cortactin) a slightly modified protocol was applied. After 
fixation, the cells were permeabilised and blocked in PBS with 5% goat serum and 0.3% 
Triton-X-100 for one hour. The samples were incubated with the primary antibody at 4°C 
over night in PBS with 2% BSA and 0.3% Triton-X-100, followed by repeated washing with 
PBS and incubation with the secondary antibody for 1 hour at RT. Afterwards, the samples 
were treated identical to the previous protocol.     
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2.6.5.3. Confocal imaging and analysis 
All images were taken with a Zeiss LSM 510 and 40x or 63x objectives. 
Table12: Fluorophores used in the study with excitation and emission spectra 
Fluorophore Excitation wave length Emission wave length Colour 
DAPI 350 nm 470 nm Blue 
GFP 488 nm 509 nm Green 
Cy3 554 nm 568 nm Orange  
TRITC 557 nm 576 nm Orange  
mCherry 587 nm 610 nm Red 
Alexa-633 633 nm 647 nm Far-red 
 
Cell sizes were determined with the Zeiss LSM Image Browser. The colocalisation studies 
were performed with ImageJ (NIH) and the plugin “Colocalisation-RGB”, with the threshold 
for each colour set to 50-70 points. Colocalised pixels appear white in the merged images. 
2.6.6. Flow cytometry (FACS Analysis) 
Flow cytometry is a powerful tool to qualitatively and quantitatively analyse different cell 
populations. Cells or other particles, marked with a fluorescently labelled antibody, are 
suspended in PBS and pushed with high pressure through a fine nozzle. This yields a thin 
stream of droplets, each surrounding a single cell that passes a laser, scattering the laser 
light. Additionally the fluorescent label is excited and emits light of a specific wavelength. 
The scattered and the emitted light are detected by so called photo-multipliers. The 
scattered light delivers information about the size and the granularity of the cells, whereas 
the emitted light reveals the existence of bound antibodies. Upon permeabilisation of the 
cell membrane with detergents or alcohol, also intracellular targets can be stained. The 
application of multiple lasers and detectors facilitates the analysis of multiple fluorescently 
labelled markers on one cell at the same time, provided non-overlapping emission spectra. 
All FACS analyses were performed at a FACSCanto flow cytometer (BD, Heidelberg). Data 
were analysed with FlowJo software. 
2.6.6.1. Fluorescent labelling of surface markers 
The cells were suspended in FACS staining buffer. Splenocytes, thymocytes and bone 
marrow cells were incubated with Fc-block for 5 min prior to staining, to prevent 
unspecific binding of antibodies to the cells. Cells were stained with the primary antibody 
for 20 min on ice. Unbound antibody was removed by washing with FACS staining buffer 
and cells were subsequently stained for 20 min on ice with the secondary antibody or 
fluorescently labelled streptavidin (in case of biotin labelled primary antibodies). Repeated 
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washing removed unbound antibodies, and the cells were resuspended in FACS staining 
buffer before analysis. 
2.6.6.2. Staining of intracellular epitopes 
Intracellular FACS staining was only performed in the BrdU pulse-chase experiments. The 
staining protocol is described in chapter 2.6.3.2. 
2.6.7. Molecular biology 
2.6.7.1. Agarose gel electrophoresis 
Analytic gel electrophoresis 
Agarose gel electrophoresis was used to separate DNA fragments according to their size. 
The method makes use of the property of DNA to migrate in an electric field from the 
negative to the positive pole. The size dependent separation is facilitated by the negative 
correlation of fragment size and migratory speed, the latter being inverse proportional to 
the logarithm of the molecular weight of the fragment. Added ethidium bromide (EtBr) 
intercalates into the DNA and thus allows the visualisation of the fragments in UV light. 
Agarose gels used ranged from 0.7% to 3% and were prepared by boiling of the respective 
amount of agarose in TAE buffer until a clear solution was obtained. Upon cooling to ~40°C 
EtBr (4μg/ml) was added and the mixture was cast into a gel tray containing combs to form 
pockets for later loading of DNA samples. After setting of the gel, the combs were removed 
and the gel was transferred to a TAE filled running chamber and an electric current ranging 
from 30-120 mA was applied after the DNA samples had been loaded to the pockets. 
Preparative gel electrophoresis 
To isolate fragments of a specific length from a mixture of DNA molecules, the sample was 
separated on an agarose gel and the respective bands were be excised under UV light with 
longer wave length (325 nm). The DNA was isolated from the piece of gel using the 
QIAquick Gel Extraction Kit (Qiagen, Hilden) according to the instructions of the 
manufacturer. 
2.6.7.2. Isolation of plasmid DNA 
Qiagen Kits were used for the isolation of plasmid DNA to obtain DNA with the highest 
possible purity for cloning, transfection and sequencing reactions. Depending on the 
culture size, Mini or Maxi preparations were carried out. The purification was done 
according to the manufacturer’s instructions. 
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Alcalic lysis 
Alcalic lysis (Birnboim and Doly, 1979; Zufferey et al., 1998) was applied to prepare the 
plasmid DNA from a large number of clones for subsequent restriction analysis. The 
bacteria were lysed at 4°C with SDS and NaOH, leading to the denaturation of RNA, DNA 
and proteins. The subsequent neutralisation step results in the renaturation of the plasmid 
DNA, but not the much larger genomic DNA molecules. The latter are precipitated by SDS 
together with RNA and proteins. After clearance, the plasmid DNA can be precipitated 
from the lysate by addition of ethanol.  
 
Experimental protocol I(conventional plasmid preparation) : 
Clones to be analysed were picked into 2ml LB-medium, containing the appropriate 
selective agent and cultivated shaking over night at 37°C. 1.5ml over-night-culture were 
pelleted at 13000 rpm the next day and resuspended in 250μl solution I. The addition of 
250μl solution II and the subsequent gentle mixing resulted in the lysis of the cells and the 
previously described denaturation. Renaturation/precipitation was achieved by adding 
250μl solution III, mixing and a 5 minute incubation on ice. The lysate was cleared through 
centrifugation at 13000 rpm for 15 min and transferred to a new reaction tube. 
Subsequently, 0.8x volumes of isopropanol were added to precipitate the plasmid DNA, 
which was pelleted by centrifugation (13000 rpm, 30 min). The DNA was washed with 70% 
ethanol to remove residual salt and solubilised in 50μl TE buffer after drying. 
 
Experiment al protocol II (fosmid preparation): 
Due to the large size of the fosmid and BAC vectors, a slightly different purification 
protocol was applied. The cells of a 500ml overnight culture were pelleted and lysed in 
36ml of Buffer I. The addition of equal volumes of buffers II and III lead to the lysis, 
denaturation and subsequent renaturation of the fosmid DNA. Lysates were cleared by 
passing through a whatman filter paper and the DNA was precipitated by the addition of 
an equal amount of isopropanol. Precipitates were collected by centrifuging and 
solubilised in 10ml of equilibration buffer. This DNA solution was added to a 
preequilibrated Maxi-prep column and the fosmid DNA was washed, eluted and purified 
according to the manufacturer’s instructions. Because of the low copy number of fosmid 
vectors, 500ml of bacterial culture yielded only around 100μg of DNA.  
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2.6.7.3. Preparation of genomic DNA 
From ES cells in 96-well plates 
To prepare the genomic DNA of ES cells for the subsequent southern blot analysis, the cells 
were lysed over night at 56°C in a humid chamber with 50μl ES cell lysis buffer/well. After 
cooling to room temperature, 100μl ethanol were added to each well and incubated for 
one hour at RT, until white strands of DNA were visible. Three washes with 70% ethanol 
removed residual salts and the DNA was dried completely before the restriction mix was 
added. 
From ES cells grown in dishes 
ES cells from 5-10 cm dishes were harvested by trypsinisation, washed in PBS once and 
lysed overnight at 56°C in 10ml ES cell lysis buffer/10 cm dish. The lysate was divided to ten 
2ml reaction tubes and vortexed together with 1ml of phenol. After centrifugation, the 
upper phase was recovered and transferred to a new reaction tube. Mixing and vortexing 
with an equal amount of chloroform removed the residual phenol and again the aqueous 
phase was transferred to a new tube. The DNA was precipitated with an equal amount of 
isopropanol. The white DNA strands were recovered with a plastic pipette tip, dipped once 
into 70% ethanol to remove residual salt and solubilised in at least 200μl TE buffer.  
From mouse tail biopsies 
The DNA needed for PCR typing of SLy2 ko and SLy2 transgenic mice was gathered from 
mouse tail biopsies, taken at least 3 weeks after birth. Mouse tails were lysed overnight, 
shaking at 56°C in 500μl TNE buffer each, supplemented with 100μg/ml Proteinase K. The 
lysates were cleared by centrifugation at 13000 rpm for 15 min and the supernatant was 
transferred to a new 1.5 ml reaction tube. The DNA was precipitated by addition of 500μl 
isopropanol and pelleted by centrifugation at 13000 rpm for 30 min. The pellet was 
washed in 70% ethanol and 50-150μl TE buffer were added, depending on the size of the 
pellet. The DNA was solubilised one hour at 56°C and at least 24h at 4°C before used in PCR 
reactions. 
2.6.7.4. Restriction of DNA 
The enzymes used for DNA restriction analyses were generally purchased from New 
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Plasmid DNA 
Plasmid DNA was digested at the appropriate temperature with 1x buffer and BSA where 
necessary. At least 5 units of enzyme were used for each μg and digestion was carried out 2 
hours or more. 
Genomic DNA 
Due to the harder accessibility of genomic DNA or the contamination with residual salts, 
RNAs and proteins, especially in the 96-well DNA preparations, a different digestion 
protocol was applied for genomic DNAs. In addition to 1x buffer, every reaction contained 
1x BSA, 1 mM DTT and RNase A. Samples were digested at least for 4 hours, in case of the 
96-well digests over night in a humid chamber.  
2.6.7.5. Preparation of total cellular RNA 
To avoid RNase contamination, all RNA work was done with a special set of pipettes, tips 
and tubes and only DEPC treated water was used in all reactions. 
RNA from different mouse tissues was isolated with the Fluka RNA isolation kit according 
to the instructions of the manufacturer. Solid organ samples were homogenised in 
solution D prior to RNA isolation, whereas blood was lysed completely in solution D, 
without previous removal of erythrocytes. The concentration of the isolated RNAs was 
determined photometrically and the samples were stored at -80°C to minimize decay. 
2.6.7.6. Polymerase chain reaction (PCR) 
PCR uses the property of DNA polymerases to synthesise a new double stranded DNA 
molecule from a single strand. Repeated denaturation and polymerisation leads to an 
exponential amplification of a specific DNA sequence (Mullis et al., 1986). To start 
amplification, the polymerase needs a small double stranded part of DNA, which is 
generated by a 20-30 bp primer that hybridises complementary to the original strand. This 
short double stranded stretch is then elongated at the 3’ end. As the original (template) 
strand is denatured to single strands by heat in every cycle, a thermostable enzyme has to 
be used, which is derived from the bacterium Thermus aquaticus. The constant repeats (up 
to 35) of denaturation, primer annealing and elongation yield the exponential 
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Table 13: Composition of a standard PCR reaction 
Reagent Volume 
DNA 10ng-200ng 
Forward primer (20-100 μM) 1μl 
Reverse primer (20-100 μM) 1μl 
dNTP 1μl 
10x buffer 5μl 
Taq-Polymerase (5 units/μl) 1μl 
H20bidest ad 50μl 
  
The sequences of all primers used in this study are listed in chapter 2.4. 
PCR reactions were assembled on ice, the reaction mix was quickly vortexed and 
centrifuged. The annealing temperature of each primer was deduced from its length and 
base composition. The elongation time could roughly be estimated as 1 minute per kb. 
Table 14 shows a typical PCR program. 
Table 14: Standard conditions for PCR reactions 
Temperature Time Objective Cycle (replication 30-35 times) 
95°C 3 min Initial denaturation of the DNA  
95°C 20 sec Denaturation   X 
55-68°C 30 sec Annealing of primers X 
68-72°C variable Amplification of the complementary 
strand 
X 
4°C infinite Pause  
 
Real Time PCR 
Real Time PCR represents a special PCR technique, which allows the quantitative 
determination of copies of a given sequence inside a complex pool of DNA molecules (e.g. 
a pool of tissue cDNAs). 
The method utilises of a pair of primers yielding the amplification of a small DNA fragment 
(~70 bp) from the respective sequence. After the heat induced strand separation, an 
initially quenched, fluorescently labelled DNA probe binds sequence specific to the strand, 
thereby emitting a light signal. This signal is detected and the quantity of signals for each 
sample is determined by the light cycler. 
During the present study Real Time PCR was applied to differentiate between mice that 
carried one or two alleles of the SLy2-transgene. The primers and probes are depicted in 
chapter 2.6.1.2. 
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Rapid amplification of cDNA ends PCR (RACE PCR) 
RACE PCR allows the amplification of cDNA molecules without knowing the specific 
sequence on both sides of a given stretch of DNA. Accordingly it is used to determine the 
unknown upstream or downstream sequences of cDNAs. During the present study only 5’ 
RACE was performed, with a special oligonucleotide used as upstream primer in reverse 
transcription that binds unspecifically, but preferentially to 5’ RNA ends. During this study 
RACE was applied to RNAs isolated from wildtype and gene-targeted mice to determine 
the nature of the message found in the first SLy2 gene-targeted mouse.  
All RACE reactions were conducted using the SMART RACE cDNA amplification kit by 
Clontech and were done according to the instructions of the manufacturer. The gene 
specific primers (GSPs) used in reverse transcription and RACE PCR are described in chapter 
2.4. 
2.6.7.7. Southern blot analysis 
Southern blot allows the sequence specific detection of DNA fragments (Southern, 1975), 
generated by a restriction digest and size-separated by agarose gel electrophoresis. The 
fragments are blotted to a positively charged nylon membrane and hybridised sequence 
specific by a radioactively labelled probe. By exposition to an X-ray film the bands can be 
visualised. 
Electrophoresis and blotting 
20μg of genomic DNA per sample were restricted as described and subjected to 
electrophoresis. With respect to the large quantity of different fragments the gels were run 
over night at a very low voltage (≤40V) to ensure optimal separation also of larger 
fragments. Subsequently the gels were incubated shaking for 20 min in 0.25 M HCl to 
partially depurinate the DNA fragments, which resulted in breakage, ameliorating the 
transfer of larger fragments (>8kb). The following incubation in 0.4M NaOH for 20 min 
caused the denaturation and separation of the DNA double strands, to facilitate the later 
hybridisation of the DNA-probe. The DNA transfer from the gel to the membrane occurred 
through capillary blotting. The capillary blot was assembled as follows: 
To begin with, a 10 cm stack of paper towels was placed next to a large tray containing the 
transfer solution (0.4M NaOH). The following layers were placed on top of the stack, from 
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• Three layers of 3 mm Whatman paper, drenched in transfer solution 
• The nylon-membrane, equilibrated in transfer solution 
• The gel 
• Two layers of 3 mm Whatman paper, drenched in transfer solution 
• A bridge of 3 mM Whatman paper, drenched in transfer solution, whose end tipped 
into the transfer solution in the tray 
• A glass cover plate 
 
All layers were assembled absolutely free of air bubbles, which would interfere with 
efficient transfer. On top of the glass plate a weight of approximately 0.5 kg was placed, 
and the blot was incubated over night. The capillary forces of the paper towels draw the 
blot solution through the assembled stack, transferring the DNA fragments from the gel 
onto the membrane, where they are bound due to their negative charges. After 
disassembly of the blot, the membrane was briefly washed in 2xSSC and the membrane 
was crosslinked by UV, thereby covalently attaching the DNA to the nylon membrane. 
Probe labelling 
A DNA fragment can be labelled radioactively during an one-step amplification, using 
random primers for initiation and a nucleotide mix containing radioactively labelled 32P-
dCTP (Feinberg and Vogelstein, 1983).  
For probe labelling the Takara Ladderman labelling kit was used according to the 
instructions of the manufacturer. 50μCi 32P-dCTP were used in each labelling reaction. Not 
incorporated radioactive nucleotides were removed by gelfiltration with Microspin S-200 
HR columns.  
Hybridisation and detection 
The hybridisation leads to the generation of stable double stranded hybrids between the 
labelled probe and the DNA fragments on the membrane, due to sequence 
complementarity. These hybrids can later be detected by exposition of the membrane to 
an X-ray film. 
To prevent unspecific binding of the probe, the membrane was incubated in blocking 
solution (ExpressHyb) for at least one hour prior to addition of the probe. After blocking, 
the labelled probe was denatured at 95°C for 5 min and allowed to hybridise with the 
membrane over night. To remove unbound probe, the membranes were washed 
extensively after hybridisation. Three 10 minute washes at RT of the low stringency wash 
solution I were followed by 1-2 washes at 50°C with the high stringency wash solution II, 
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removing essentially all probe fragments not complementary bound. The specifically 
bound probe was detected by autoradiography.  
2.6.7.8. Northern blot analysis 
As opposed to Southern blot analyses, Northern blotting is used to detect messenger RNA 
(mRNA) molecules sequence specifically with a labelled DNA probe. The total cellular RNA 
is separated under denaturing conditions in an agarose gel, containing formaldehyde and 
capillary blotted to a positively charged membrane, where hybridisation to a labelled DNA 
probe and subsequent detection allows the analysis of abundancy and size of the 
respective mRNA. 
Sample preparation and electrophoresis 
Total cellular RNA was isolated from cells or tissues as previously described and denatured 
for 10 min at 70°C in the presence of formaldehyde. The samples were loaded onto 1% 
agarose gels, containing 10% MOPS and 2% formaldehyde and separated at 80V for 4 
hours. A RNA size standard was separated simultaneously to facilitate the determination of 
RNA sizes. 
Blotting procedure and detection 
The capillary blot assembly essentially followed the protocol mentioned in chapter 2.6.7.7., 
with the only exception that 20xSSC was used as transfer buffer. After blotting the RNA size 
ladder was marked under UV light and the membranes were hybridised with DNA probes 
for SLy2 and actin as loading control. Probes were labelled with DIG-nucleotides. The DIG 
Easy Hyb system (Roche, Mannheim) was used for labelling, hybridisation and detection 
was done according to the instructions of the manufacturer. The hybridised blots were 
incubated with αDIG antibody overnight and unbound antibody was removed by washing 
with maleic acid buffer. CDP-Star was used as substrate to visualise the hybridised probe 
by exposure to X-ray films. 
2.6.7.9. Site directed mutagenesis 
To generate the SLy2 species containing the point mutations serine to alanine at position 
23, the QuickChange site directed mutagenesis kit (Stratagene, USA) was applied 
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2.6.7.10. Cloning of plasmid vectors 
In the generation of all plasmid vectors constructed during the present study, standard 
cloning techniques were applied. 
Restriction of vector and insert 
Both the target vector and the insert to be cloned were digested with restriction enzymes 
as described previously to generate compatible ends, either blunt or with single stranded 
overhangs. 
Dephosphorylation of the vector 
To interfere with a self (re-) ligation of the vector backbone in the ligation reaction, the 
linearised vector fragment was dephosphorylated by treatment with the shrimp alkaline 
phosphatase (SAP) for one hour at 37°C. As the ligase is dependent on these terminal 
phosphates, the SAP treatment inhibited the ligation of the vector without the insert 
fragment, which provided the necessary phosphates. 
Ligation of vector and insert 
The ligation of vector and insert fragments was mediated by the T4 phage ligase, which 
catalyses the reaction between the phospho-diester of the 5’ phosphate group and the 3’ 
hydroxyl group of the linear fragments. The ligase mediates ligations between blunt ends 
as well as overhanging ends.  
Important for an efficient ligation is a molar ratio of the vector to the insert of 
approximately 1:3. The reaction was carried out in 20μl with 1x ligation buffer (freshly 
thawn) and 1-2 units of T4 DNA ligase. Ligation occurred at 16°C for one hour and 
subsequent incubation at 4°C overnight. 
Transformation of E.coli 
Chemically competent DH5α or XL1 blue E.coli were used to propagate the ligated 
constructs. Competent bacteria (Cohen et al., 1972) were thawn on ice, mixed with the 
ligation reaction and transformed by a 42°C heatshock for 45 sec. After incubation at 37°C 
for one hour to allow the expression of the resistance gene, the bacteria were plated onto 
LB-agar supplemented with the appropriate antibiotics for selection. Picking of bacterial 
clones and analysis of plasmid construct was performed as described. 
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3. Results 
3.1. SLy2 belongs to the SLy family of adapter proteins 
SH3 protein expressed in lymphocytes (SLy) was the first protein of the SLy family to be 
cloned. It was initially identified as an SH3 and SAM domain containing protein 
preferentially expressed in lymphocytes (Beer et al., 2001). Subsequently it was shown by 
Doreen Cantrells group from Dundee, Scotland, that SLy is specifically phosphorylated on 
Serine 27 upon T cell receptor crosslinking (Astoul et al., 2003).  
3.1.1. Properties of the novel SLy family protein SLy2 
3.1.1.1. Identical molecular structure as SLy 
Analysis of the SLy2 amino acid sequence with the protein database Expasy 
(www.expasy.org) revealed a domain structure that is identical to SLy (Figure 6). The N-
termini of the proteins are composed of a bipartite NLS (aa 4-86), whose sub-domains are 
divided by a 49 amino acid spacer. Located further downstream is the SH3 domain in the 
middle section of the protein (aa 167-222), which is followed by a C-terminal SAM domain 
(aa 241-305). Interestingly, the regions of high identity correlated with the SH3 and the 
SAM domains, indicating that these features are evolutionary conserved. Along the same 
lines, the N-terminal area of homology contains the first part of the bipartite NLS and the 
serine 27 of SLy (corresponding to serine 23 in SLy2), which was shown to be 










Figure 6: Molecular structure (schematic) of SLy and SLy2 as determined by database analyses. The 
complete amino acid sequences of SLy and SLy2 were examined by Expasy/Swiss Prot, which yielded the 
depicted domain structure. The two blue areas in the N-terminus of the protein represent the bipartite 
nuclear loclisation sequence. The numbers below each protein indicate localisation of each domain with 
respect to the amino acid sequence. 
3.1.1.2. Chromosomal localisation and genomic organisation of the sly2-gene 
The sly2-gene is located on chromosome 21 in the human and on chromosome 16 in the 
murine genome. In the human genome it resides in the chromosomal segment q11.2. The 
gene belongs to a cluster whose deregulation is reported for Down-syndrome patients and 
early-onset forms of inheritable Alzheimer’s disease (Groet et al., 1998; Cheon et al., 2003; 
Kimura et al., 2007). 
The sly2 locus is comprised of eight coding exons, with the start ATG in exon 1 and the 
stop codon positioned in exon 8 (Figure 7). The complete locus spans a genomic region of 
50.5kb. The size of the locus is mainly caused by a huge intron of more than 20kb between 
exons 1 and 2. Different databases report splice variants for SLy2 including additional 
exons, yet various RACE and RT-PCR analyses conducted during this thesis could not 
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Figure 7: Exon-intron organisation of the murine genomic sly2-locus. The start ATG is located in exon 1, 
the stop codon resides in the 5' end of exon 8, resulting in an open reading frame of 1116 bp. The coding 
region is marked in black, 5' and 3' UTRs in grey. The sizes of the complete locus, the two largest introns and 
the central exon cluster are depicted. Organisation of the locus is drawn according to the entry in the 
Ensembl database (www.ensembl.org). 
3.1.1.3. Expression pattern of SLy2 
An anti-serum to the murine SLy2 protein was generated to facilitate the determination of 
SLy2 expression by western blotting. Analysis of lysates from different mouse organs 
indicated robust expression of SLy2 in spleen and thymus, yet almost none in the bone 
marrow (Figure 8). Remarkably high protein levels were detected in muscle, brain, heart 
and colon. No expression was found in liver, kidney and lung (data not shown). The signal 
obtained from the pancreas sample seemed to migrate somewhat higher, suggesting a 
different splice variant or posttranslational modification. The former possibility could not 
be ruled out, but all RT-PCRs conducted during this thesis only yielded a single fragment, 
argueing in favour of posttranslational modifications (data not shown). The observed 
expression pattern positions SLy2 between the strictly lymphoid expression of SLy and the 




Figure 8: Expression levels of SLy2 in different mouse organs. Organs were lysed as described and the 
protein concentration of the lysates was determined. 30μg of protein were analysed for each sample. 
Endogenous levels of protein were detected with a polyclonal SLy2 anti-serum. 
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3.1.1.4. SLy2 expression is regulated in B cells 
To confirm data presented by Zhu et al. on the dependency of the expression levels of SLy2 
upon various stimuli, splenic B cells were purified by MACS and stimulated with IL-4, IL-
4+LPS and IL4+α−CD40 for six and 16 hours (Figure 9 and (Zhu et al., 2004)). A subsequent 
western blot analysis proved that the expression of SLy2 was upregulated after these 
proliferation, maturation, and differentiation inducing stimuli. The upregulation was most 




Figure 9: SLy2 expression is regulated in B lymphocytes. Splenic B cells were isolated by MACS and 
treated with the indicated stimuli. Cells were lysed and SLy2 protein levels were analysed by western blotting 
with the purified SLy2 anti-serum. Actin served as loading control. 
 
3.1.1.5. Intracellular localisation of SLy2 
Due to the predicted bipartite NLS in the N-terminus of the protein, it was intriguing to 
analyse the distribution of SLy2 between the nucleus and the cytosol. In addition, the 
phenotype of the SLyΔ/Δ mouse documented drastically the importance of nuclear 
translocation for SLy function (Beer et al., 2005). The separation of cell lysates into nuclear 
and cytoplasmic fractions proved that the majority of the cellular SLy2 molecules resided 
in the cytoplasm, and only a small fraction in the nucleus (Figure 10). To analyse the 
functionality of the predicted NLS in the N-terminus, a deletion mutant was generated, 
which lacked the C-terminal section of the bipartite NLS (SLy2-ΔNLS). Of note, this deletion 
resulted in a marked decrease of the nuclear SLy2. The ΔNLS mutant migrates as a double 
band, which is probably caused by differential phosphorylation (see figure 21 for details).   
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Figure 10: SLy2 contains a functional NLS. SLy2 wildtype or SLy2-ΔNLS expressing HeLa cells were 
subjected to biochemical separation of the nuclear (N) and the cytoplasmic (C) fraction. The integrity of 
fractionation was assessed by probing the membrane with α-Lamin A/C and α-GAPDH for the nuclear and 
the cytoplasmic fraction, respectively.   
 
3.1.1.6. SLy2 is differentially phosphorylated in primary cells and cell lines 
As SLy was shown to be phosphorylated upon TCR ligation, it was apparent to also analyse 
the phosphorylation status of SLy2. In an initial experiment SLy2-HA overexpressing Jurkat 
(data not shown) or SVEC cells were pulsed with 32P labelled orthophosphate. 
Subsequently, the cells were stimulated for different time points with PDBU and ionomycin 
to mimic activation through membrane bound receptors. As apparent, SLy2 was 
prominently phosphorylated from the beginning and the extent did not change over the 
time period tested (Figure 11 A). In contrast, when primary, transgenic thymocytes (see 3.2. 
for details) were subjected to PDBU/ionomycin stimulation, this resulted in a marked and 
sustained induction of phosphorylation of SLy2 (Figure 11 B). Of note, SLy2 was only 
phosphorylated at a minimal level prior to stimulation of the cells, which stands in marked 
contrast to the results obtained from the cell line experiments. 
 




Figure 11: SLy2 is differential phosphorylated in malignant cell lines or primary cells. (A) SLy2-HA 
expressing SVEC cells were pulsed with 32P-labeled orthophosphate, stimulated with PDBU/ionomycin and 
SLy2 was immunoprecipitated with α-HA. The IPs were separated on a 10% polyacrylamide gel and the gel 
was analysed by autoradiography after fixing and drying. (B) Transgenic SLy2-HA expressing thymocytes 
were stimulated with PDBU/ionomycin for the indicated time points and subsequently SLy2 was 
immunoprecipitated and IPs were electrophoretically separated. The gels were stained with ProQ diamond 
phosphostain (Invitrogen) and evaluated in an Amersham Typhoon 8600 phosphoimager.  
3.2. SLy2 transgenic mice 
3.2.1. Generation and confirmation 
To gain insights into the role of this newly identified protein, a transgenic mouse was 
generated. Transgenic mice are a well established and reliable method to analyse the 
cellular and systemic effects of the overexpression of a protein. The injection of a 
eukaryotic expression construct into the pronucleus of a mouse zygote leads to its 
integration into the genome and the re-implantation of such genetically modified zygotes 
into the oviduct of a mock-pregnant foster mouse yields several individual founder 
animals. Breeding of these founders each establishes a transgenic mouse line. It lies in the 
nature of this technique, that the exact location of the transgene insertion remains 
stochastic. To rule out the possibility that the phenotype shown by a transgenic mouse is 
caused by the deletion of a different locus through the insertion, several different 
transgenic lines have to be analysed in parallel.  
The choice of the promoter in the transgenic construct determines the expression pattern 
of the overexpressed protein. As SLy2 was shown to be highly expressed in hematopoietic 
cells and especially upregulated in B cells upon activation with various stimuli (Figure 9) its 
function in the lymphoid lineage should be further elicited. Therefore, a transgenic 
construct was chosen that contained a chimeric promoter, assembled from the 
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immunoglobulin heavy chain enhancer (Eμ) and the proximal promoter of the tec-family 
kinase Lck (lck-prox), resulting in a robust expression in B and T cells respectively (Figure 12 
and (Iritani et al., 1997)). The complete SLy2 cDNA together with an HA-tag was cloned 
behind the chimeric promoter and the integrity of the construct was confirmed by three 
different restriction digests as shown in Figure 12. The generation of the transgenic mice 




Figure 12: Map of the T and B cell specific expression construct. (A) The complete open reading frame of 
SLy2 was cloned together with an HA-tag into the BamHI site of p1026x, downstream of the chimeric 
promoter lck-Eμ. The arrow in the SLy2 ORF indicates the reading direction of the frame. The promoter is 
assembled from the lck proximal promoter and the IgH enhancer (Eμ). Optimal expression of the SLy2 cDNA 
was ensured by a spliceable, but non-translatable expression cassette of the human growth hormone (hGX), 
located 3' of the SLy2 cDNA. (B) p1026x+SLy2-cDNA was digested with BamHI, XbaI and NotI, and analysed 
on a 1% agarose gel. The signal migrating at 3kb in the NotI digest represents the pUC19 backbone of the 
expression construct, whereas the expression cassette migrates above at 7kb. 
 
Tail biopsies were taken from the 32 founder mice to isolate the genomic DNA. The DNA 
samples were digested with BamHI to yield a 1.1 kb fragment encompassing the complete 
transgenic SLy2 ORF. The SLy2 cDNA was used as a southern blot probe, identifying five 
founder mice carrying the transgene: #845, #853, #861, #869 and #871. Since the DNA 
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concentration of the mouse tail DNA preparations is hardly to determine, the differing 
signal strength does not necessarily correspond with the copy number harboured by the 




Figure 13: Southern blot analysis of founder animals. The DNA was prepared from mouse tail biopsies, 
digested with BamHI and separated on 1% agarose gels. Samples were blotted and hybridised with a DNA 
probe complementary to the complete transgenic expression cassette. Mice carrying the transgene are 
shown in red numbers. 
 
These mice were bred to C57BL/6 animals to establish five transgenic mouse lines (tg-1 to 
tg-5). PCR typing of the resulting offspring revealed that #871 was not able to pass on the 
transgene, so that no line could be established from this founder. To assess the expression 
of the SLy2-transgene without killing the mice, the F1 daughter generation of the founder 
animals was bled and total RNA was isolated from the blood samples. Additionally, protein 
samples were prepared from peripheral blood leukocytes. The RNA was analysed by 
northern blotting (Figure 14 A), while western blotting was performed with an α-HA 
antibody to assess the expression on the protein level (Figure 14 B and C). Both methods 
clearly indicated that transcription as well as translation of the transgene was high and 
comparable for the transgenic lines SLy2_tg-1 to SLy2_tg-4 (Figure 14). The expression 
level in B220- cells appeared to be somewhat higher than in the B220+ fraction. The bone 
marrow samples showed the lowest expression of the transgene, which could be due to 
the low abundancy of transgene expressing cells or a lower per-cell expression level in this 
tissue (Figure 14 C). 
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Figure 14: Robust expression of SLy2-HA in transgenic mice. (A) Northern blot analysis of complete RNA 
from peripheral blood of all four transgenic mouse strains. The SLy2 cDNA was used as a probe. The different 
sizes originate from different splice variants with respect to the hGX minigene in the 3' end of the construct. 
The 18s and 24s rRNAs in the gel pictures are shown as loading control beneath the blot. (B) Expression of tg-
SLy2 in peripheral blood. Nucleated blood cells were purified as described, lysed and analysed by western 
blotting. (C) Expression of tg-SLy2 in splenic B and T cells, thymus, bone marrow and blood. Spleen cells from 
wt and tg animals were separated into B220- and B220+ fractions, lysed and analysed by western blotting. 
Blots were probed for GAPDH as loading control. 
3.2.2. Unaltered development of lymphoid cell populations 
Encouraged by the strong expression of the transgene, its influence on the development 
of the different lymphoid cell populations was assessed. Therefore, spleens, thymi and 
bone marrow of transgenic mice and wildtype littermates were isolated and the 
distribution of the different lymphoid populations was analysed by flow cytometry. The 
spleens and thymi of wildtype and transgenic animals displayed equal cell numbers (data 
not shown). With respect to the different T and B cell subpopulations, the analysis 
comprised double-negative (DN) thymocytes, peripheral T cells, immature and mature 
peripheral B cells, transitional 1, marginal zone (MZB) and follicular B cells and plasma cells. 
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All of the analysed populations appeared to be unaltered in spite of the ectopic expression 




Figure 15: Flow cytometric analysis of lymphoid populations. Thymocytes, splenocytes and bone marrow 
cells were isolated as described. The cells were stained with the indicated fluorescently labelled antibodies 
and analysed on a FACS Canto II. The quantifications in the left panels combine the data of three 
independent experiments (n=10, 5 Tg mice, 5 wt mice). The FACS data were evaluated with FlowJo software. 
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3.2.3. Impaired spreading of transgenic B cells to α-IgM coated surfaces 
As SLy was identified, amongst other findings, by its effect on T cell adhesion, it was 
interesting to determine wether the overexpression of SLy2 would have a similar effect. 
Yet, more interesting than mere adhesion would be to analyse the ability of the B cells to 
spread on α-IgM coated surfaces. It is known that upon contact to a surface bound antigen 
or target cell, B cells undergo a distinct choreography of spreading and contraction, to 
maximize the amount of gathered antigen. This behaviour is dependent on the strict 
spatio-temporal regulation of a complex signalling network and interfering with it (e.g. by 
blocking actin polymerisation) will lead to defective activation of the B cells (Fleire et al., 
2006; Harwood and Batista, 2008). 
Wildtype and transgenic B220+ splenocytes were seeded onto cover glasses coated with α-
IgM and allowed to adhere and spread. After different timepoints the cells were fixed and 
stained for F-actin. Determination of the size of the F-actin ring at the contact area 
between the cells and the substrate revealed that the transgenic B cells had apparent 
difficulties in the initial spreading phase as opposed to wildtype cells (Figure 16). After two 
minutes of stimulation, the transgenic cells still did not show any signs of spreading, as 
opposed to the wildtype cells, which had already reached half of their maximum contact 
area. Beginning after 5 min, the transgenic cells started to recover, yet their spreading was 
still impaired at 15 min after onset of stimulation. Indeed, it remained inferior to the 
wildtype situation over the complete time course and only recovered towards the end of 
the time course. 
 




Figure 16: Actin dynamics in B cells interacting with α-IgM coated surfaces. (A) wt and tg splenocytes 
were purified and MACS sorted for B220 surface expression. Isolated splenic B cells were prestimulated for 
one hour with α-CD40 and IL-4 and subsequently allowed to adhere to α-IgM coated cover glasses. The cells 
were fixed in 4% PFA after the indicated time points and stained for F-actin (red) and nuclei (blue) as 
described (scalebar: 10 μm). (B) Quantitative analysis of (A). The size of the area of interaction was 
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3.3. Effects of SLy2 expression on cellular actin networks 
3.3.1. SLy2 overexpression leads to ectopic ruffle formation 
Due to the marked influence of SLy2 on lymphoid actin dynamics, it was mandatory to 
analyse the underlying mechanisms in more detail. As SLy2 was also shown to be 
expressed in the epithelial cell line HeLa (data not shown), these cells were chosen as 
experimental system, whose larger size compared to lymphocytes greatly facilitated the 
analysis of subcelluar structures. Therefore, HeLa cells were transduced with a lentiviral 
expression construct comprising the complete SLy2 cDNA under the control of the EF2α 
promoter, resulting in robust and ubiquitous expression. The SLy2 protein was expressed 
fused to an HA-tag for detection in immuno-fluorescence, as the SLy2 anti-serum did not 
yield satisfying results in such stainings. From the same construct and promoter GFP was 
expressed under the control of an internal ribosome entry site (IRES), thus enabling the 
identification of transduced cells. Control cells were just transduced with the empty IRES-
GFP vector, resulting in GFP expression alone.  
SLy2-HA expressing and control cells were allowed to grow on gelatine coated cover 
glasses, immuno-fluorescently stained for F-actin and analysed by confocal microscopy. 
The pronounced effect of the enhanced SLy2 expression on the actin cytoskeleton was 
immediately evident (Figure 17 A and B). Compared to control cells (Figure 17 A), SLy2-HA 
expressing cells virtually lost all cortical actin and were almost completely devoid of visible 
stress fibres (Figure 17 B left and middle panels). Instead, all their F-actin seemed to cluster 
to lamellipodial- or ruffle-like structures at the distal poles of the cells. A further finding was 
the changed appearance of the cells. Whereas the majority of the control cells displayed an 
even shape, the SLy2-HA expressing cells were marked by the occurrence of many leading 
edges per cell, often yielding a star or tripod like shape (Figure 17 B). Additionally, many of 
the SLy2 overexpressing cells produced long cytoplasmic protrusions, evoking a stretched, 
tubular-like appearance (Figure 17 B, right panel). Frequently, these protrusions seemed to 
connect two cells, thus rather representing thin cytoplasmic bridges, so called cytonemes.  
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Figure 17: Overexpression of SLy2 in epithelial cells induces membrane ruffling and lamellipodia 
formation. HeLa cells were transduced with pWPI-SLy2 or a control construct. The cells were seeded onto 
gelatine-coated cover glasses and allowed to grow overnight. Subsequently the objects were fixed and 
stained for F-actin. Arrowheads indicate stress fibres (A), distal ruffles and lamellipodia (B, left panel) or 
cytonemes (B, middle and right panel) (scalebar: 10 μm). 
 
3.3.2. SLy2 colocalises with F-actin in peripheral ruffles 
Subsequently, the subcellular localisation of SLy2 was analysed in further detail. Therefore, 
control and SLy2 expressing HeLa cells were stained with α−HA and phalloidine, to analyse 
SLy2 and F-actin structures, respectively. Most of the cellular SLy2 molecules resided in the 
cytoplasm, yet a specific fraction reproducibly located to the remarkable F-actin structures 
described above (Figure 18). Thus, the ectopic expression of SLy2 not only led to the 
induction of lamellipodia and ruffles, but the protein also colocalised with F-actin in these 
structures. Interestingly, SLy2 did not colocalise with the cortical actin in the thin cellular 
bridge, further underlining the specificity of its appearance in the peripheral ruffles. The 
images were analysed with ImageJ (NIH) on a per-pixel level and pixels emitting signals 
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Figure 18: SLy2 colocalises with F-actin in ruffles and lamellipodia. HeLa cells were transduced with a 
SLy2-HA expression construct and seeded on gelatine coated cover glasses. Cells were stained with 
phalloidine (red) and α-HA (green) yielding the stainings shown in the left and middle panels, respectively. 
The right panel shows the merged image. Pixels with colocalising staining are marked white (arrowheads). 
Images were analysed with ImageJ (scalebar: 10 μm). 
 
3.3.3. Assessing the role of the domains of SLy2 in actin dynamics 
Due to the characteristic domain structure of SLy2 it was apparent to ask which domains 
would be important in mediating the effects on F-actin dynamics. Deletion mutants of 
SLy2 were generated, lacking the NLS, the SH3 or the SAM domain. In addition, the 
function of the serine residue 23 was addressed by employing a serine 23 to alanine point 
mutated SLy2 species (Figure 19). As demonstrated by western blotting with an α−HA 
antibody, all mutants were expressed correctly. The ΔSAM displayed reduced expression 
levels, as will be mentioned later. Also remarkable was the strongly differing migration 
behaviour of the ΔSAM mutant. Although only 8 aa smaller than the ΔSH3 mutant it 
migrated at only 30kDa. As the sequence of the expression vector was repeatedly 
sequenced and confirmed, the molecular reason for this size-difference remains to be 
determined.   
 




Figure 19: Construction of the different SLy2 deletion mutants. (A) The deletion mutants used in this 
study were constructed on the basis of the Swiss-Prot database structure prediction. (B) Correct expression of 
all mutants was assessed by western blotting of HeLa lysates with an α-HA antibody. 
 
Of note, the various SLy2 deletion mutants showed greatly differing effects on the F-actin 
cytoskeleton. Whereas the S23A mutant retained and even slightly increased the 
reorganisation of the F-actin network, all other mutants lost this ability to differing extent 
(Figure 20, A). The mildest loss of function was caused by deletion of the NLS. The 
induction of the distal ruffles and the effect on cortical actin structures was partially 
retained, but diminished in quantity as well as quality. Also, these cells never took on the 
already mentioned tripod like shape, although they did display a much more tubular 
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morphology compared to control cells. Surprisingly, though still inducing some F-actin 
reorganisation, the ΔNLS mutant did not colocalise with the phalloidine staining anymore, 
as indicated clearly by the lack of white areas in the merged image (Figure 20, B).  
As already mentioned above, the change of serine 23 to alanine, rather enhanced the 
phenotype of SLy2 overexpressing cells (Figure 20 A and B). The cells displayed even more 
ruffles per cell than the wildtype SLy2 expressing cells, yet the overall shape appeared to 
be more round than the control cells. Unique among all tested SLy2 variants was the 
subcellular localisation of the S23A mutant, which was more skewed towards the 
membrane, sometimes even displaying a ring-like distribution along the cell border 
(Figure 20 A). With respect to the colocalisation with F-actin, the S23A mutant was a 
phenocopy of the wildtype protein (Figure 20 B).  
The loss of the SH3 domain abolished much of the SLy2 effect on actin dynamics (Figure 
20, A). The cells regained the natural, less stretched shape of the control sample and also 
the distal ruffles vanished. This phenotype was accompanied by a reappearance of the 
cortical F-actin structures, along with stress fibres. It is consistent with this loss of function 
that the deletion of the SH3 domain also considerably interfered with F-actin 
colocalisation, although not as much as the deletion of NLS domain (Figure 20 B).  
In addition to abolishing the entire effect of SLy2 on the actin cytoskeleton, the deletion of 
the SAM domain also likely implied a severe impact on the overall stability of the protein 
(Figure 20 A and B). This was marked by the finding that most of the transduced cells did 
not show any detectable staining for SLy2-ΔSAM, while FACS analysis of the same cells 
clearly proved normal expression of the IRES-GFP (data not shown). This notion was 
confirmed by western blot analysis with α−HA, which proved a severely lowered level of 
expression compared to the other mutants or the wildtype protein (Figure 19 B). 
Accordingly, it could not be ruled out, that the overall lowered concentration of the 
protein accounted for the apparent lack of the SLy2 effect. Nevertheless, when analysing 
cells with a fairly strong expression of the mutant, these displayed a phenotype most 
similar to the control cells, without extensive induction of distal ruffles or lamellipodia and 
no loss of cortical actin or stress fibres (Figure 20 A). Also the subcellular distribution of the 
protein changed quite drastically from that of the wildtype protein, completely losing all 
correlation to any F-actin structure. Clearly, this was reflected in the colocalisation study 
too (Figure 20 B). Due to the low expression level of the ΔSAM mutant, this species was not 
included in the following analyses, as the missing domain most likely could never solely 
account for the apparent loss of function. 
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Figure 20: SLy2 colocalises with F-actin structures depending on the NLS or the SH3 domain. 
HeLa cells were transduced with the indicated expression constructs and seeded onto gelatine coated cover 
glasses. After growing for 24h, the cells were fixed and stained with anti-HA for SLy2 (green), with phalloidine 
for F-actin (red) and with DAPI for nuclei (blue). (A) Overview images (scalebar: 20 μm). (B) Detailed images 
with a per-pixel colocalisation analysis, conducted with ImageJ and the plugin colocalization RGB. Pixels with 
a colocalisation of both colours are marked white in the merged images (scalebar: 10 μm). 
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To confirm the findings from the immuno-fluorescence analysis by biochemistry, lysates of 
the various HeLa cell lines were separated by ultracentrifugation in a glycerine gradient 
into the F-actin and the G-actin containing fraction. Western blot analysis of the 
fractionated lysates clearly showed that the distribution of the ΔNLS and the ΔSH3 
mutants was skewed towards the G-actin fraction, whereas the wildtype and the S23A 
species almost exclusively appeared in the F-actin fraction (Figure 21 A), indicating an 
incorporation into F-actin associated complexes. The ΔNLS and, to a lesser extent, also the 
ΔSH3 mutants migrated as double bands, which represent most likely differentially 
phosphorylated species, as treatment of the cells with the protein phosphatase inhibitor 




Figure 21: NLS and SH3 mediate the exclusive localisation to the F-actin fraction. (A) HeLa cells 
expressing the indicated constructs were lysed and lysates were ultracentrifuged in a glycerine gradient to 
separate G- and F-actin fractions. The complete lysate (C), the G-actin fraction (G) and the F-actin fraction (F) 
were analysed for the presence of SLy2 by western blotting with an α-HA antibody. (B) The same fractions are 
shown for the ΔNLS mutant after a 5 min treatment of the cells with the phosphatase inhibitor calyculin prior 
to lysis. 
3.3.4. SLy2 expression enhances the spreading behaviour 
To determine the impact of SLy2 on the actin cytoskeleton in a more functional assay, the 
spreading of the transgenic HeLa cells to gelatine coated surfaces was analysed (Figure 22 
A, B and C). Consistent with previous findings concerning the effects on actin dynamics, 
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the wildtype SLy2 expressing cells had spread to a significantly larger extent than their 
control counterparts after 45 min and also the S23A mutant expressing cells spread more 
readily to the gelatine substrate. Surprisingly, the deletion of the NLS or the SH3 domain 
facilitated spreading to a much larger extent than expected, with a spreading index 
significantly higher than that displayed by the control cells (Figure 22 A and B). The 
seemingly diminished spreading activity induced by the SH3 deletion reflects a weakness 
in the analysis, as the spreading index was determined by the ratio of the length to the 
width of each cell. Since the ΔSH3 expressing HeLa cells spread in a more even and round 
fashion, this ratio does not express the effect of this mutant. Yet, if comparing the size of 
the cell-substrate contact area instead, the ΔSH3 mutants aligned with the other SLy2 
species analysed with respect to their spreading behaviour (Figure 22, C). Since the S23A 
expressing cells showed such a pronounced tripod like shape, also here it was difficult to 
determine the true width and length of each cell. Accordingly, this HeLa species was 





Figure 22: Enhanced spreading capacity of transgenic HeLa cells. (A) HeLa cells were transduced with the 
indicated constructs and seeded onto gelatine coated cover glasses. The cells were allowed to adhere for 45' 
and subsequently fixed and stained for F-actin (scalebar: 20 μm). (B) 10 cells were analysed for every species 
and the spreading index was determined as the ratio of length to width of each cell. (C) The size of the cell-
substrate contact area was determined as the product of the length and the width of each cell (***, p<0.0006; 
**, p<0.007; *, p<0.04).      
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3.3.5. The overexpression of SLy2 leads to defective proliferation 
While analysing the SLy2-HA expressing HeLa and Jurkat cell lines, it became apparent that 
the percentage of GFP+ cells in the transduced populations declined over time. This effect 
emerged only in those cells that overexpressed SLy2 and its mutant derivatives but not in 
the control cells, expressing GFP alone (Figure 23, A). To assess if this was caused by a 
diminished rate of proliferation, BrdU pulse-chase experiments were conducted which 
indeed proved an anti-proliferative effect that correlated with the overexpression of SLy2 
(Figure 23, B). As expected, HeLa populations expressing the different mutants did not 
display an equal decline of GFP+ cells. Consistent with previous data, cells overexpressing 
the wildtype or the S23A protein showed the strongest defect, followed by ΔNLS, which 
inhibited cell growth at an intermediate level. Deletion of the SH3 domain almost led to a 
full restoration of a normal proliferation rate. The obvious parallels in the effect of the 
various deletions on actin dynamics and proliferation favoured the assumption that the 
inhibition of cell growth is connected to the massive alterations in the actin cytoskeleton 
observed in these cells.  
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Figure 23: Overexpression of SLy2 inhibits proliferation. (A) Jurkat cells were transduced with SLy2-IRES 
GFP or GFP-only expression constructs. GFP expression served as marker for SLy2 expression and the amount 
of GFP+ positive cells was determined on day 4 and day 18 after transduction. The percentage of GFP+ (Gate 
M1) cells is depicted in each histogram. (B) Transgenic HeLa cells were pulsed with BrdU and the BrdU 
content of the cells was monitored for 5 days. Results are representative of at least 3 independent 
experiments. 
3.3.6. Overexpression of SLy2 causes the formation of cytonemes 
Interestingly, a strict dependency on actin polymerisation was reported for cytokinesis, the 
last step of cell division, in which the two daughter cells separate their cytoplasms after 
successful karyokinesis (Eggert et al., 2006). Interfering with cytokinesis stops the last step 
of cell division, leaving the two daughter cells connected by a thin cytoplasmic tube, a 
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cytoneme. As mentioned above, the overexpression of wildtype SLy2 and the S23A mutant 
induced the formation of such bridges between the cells. The detailed analysis of cells 
growing on gelatine coated cover glasses and stained for F-actin demonstrated that this 
induction of cytonemes almost exclusively occurred in cells expressing SLy2 wildtype or 
S23A (Figure 24).  
 
 
Figure 24: Overexpression of SLy2 induces the formation of cytoplasmic bridges between dividing 
cells. HeLa cells were transduced with expression constructs for various SLy2 species or control plasmids. 
Cells were seeded onto gelatine coated cover glasses, allowed to grow for 24h and stained for F-actin. 
Arrowheads indicate cytonemes (scalebar: 10 μm). 
 
The notion that SLy2 overexpression interfered with cytokinesis received further support 
by the finding, that in SLy2 wildtype, and even more in S23A expressing cultures huge 
multinucleated cells accumulated, probably caused by aberrant cell division (Figure 25). 
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Figure 25: Overexpression of SLy2 in HeLa cells induces generation of giant cells. HeLa cells were 
transduced with SLy2 expression or control constructs and grown in 6-well dishes. Pictures were taken on 
day 5 after transduction. Arrowheads indicate giant, multinucleated cells. 
 
3.4. SLy2 is involved in the activation of Rho-family GTPases 
3.4.1. Dominant negative Rac1N17 counteracts the effects of SLy2 
The Rho-family GTPases Rho, Rac and Cdc42 were shown to be of crucial importance for 
the regulation of a plethora of actin-cytoskeletal processes. Indeed, different actin-
structures can be associated with the function of different Rho family members. The 
induction of stress fibres is connected to the GTPase activity of Rho, while lamellipodia and 
membrane ruffles are mediated mainly through the function of Rac1 and to a lesser extent 
also of Cdc42. In addition, the latter is responsible for the induction of filopodia (Hall, 
1998). Due to the morphology of HeLa cells overexpressing SLy2, an investigation of the 
role of Rac1 in the generation of the phenotype was performed. To determine if the effect 
of SLy2 overexpression on the induction of ruffles and lamellipodia was mediated by Rac1, 
a dominant negative mutant of Rac1, Rac1N17 or a control construct were transfected into 
these cells. Transfectants expressing SLy2 and the control plasmid (indicated by the 
mCherry expression) showed the intense actin-cytoskeletal rearrangements described 
above (Figure 26, middle panels). Yet upon expression of Rac1N17, this phenotype was 
entirely reverted and the double expressing cells took on a wildtype appearance again 
(Figure 26, right panels). The cells displayed a strong staining of the cortical actin networks 
and also stress fibres were reappearing. The same held true for HeLa cells expressing the 
S23A mutant, whose effect was also annihilated by the simultaneous expression of 
Rac1N17. Expression of this dominant negative mutant in control cells without the 
expression of SLy2 showed a rather mild effect on cellular F-actin structures (Figure 26, left 
panels). 
 




Figure 26: Point mutations in Rac interfere with the effect of SLy2 in HeLa cells (I). HeLa cells expressing 
SLy2-wt, SLy2-S23A or a control construct were transfected with a dominant negative Rac1N17 expression 
construct (lower panels) or the empty mCherry vector (upper panels). Transfectants are marked by the red 
colour. Cells were seeded onto gelatine coated cover glasses and stained for F-actin (green) and nuclei (blue). 
Arrowheads indicate SLy2 induced membrane ruffles (scalebar: 10 μm). 
3.4.2.Constitutively active Rac1V12 and SLy2 act in concert 
The dependency of the effect of SLy2 on Rac1 signalling was further supported by the 
phenotype of HeLa cells expressing the constitutively active Rac1 point mutant Rac1V12. 
The control cells, only expressing Rac1V12 displayed the marked induction of lamellipodia 
along the cell cortex. The overexpression of Rac1V12 and SLy2 or SLy2-S23A led to the 
strong induction of dorsal ruffles and to a more spiky confirmation of the cortical F-actin, 
both of which are not induced by the overexpression of SLy2 or RacV12 alone (compare to 
Figure 20 and Figure 27, left panel). A further finding pointing in the same direction was 
the marked poly-karyogeny displayed by HeLa cells co-expressing both SLy2 and Rac1V12 
(Figure 27). This phenotype was not observed in cells expressing the small GTPase alone 
(left panel and (Ridley et al., 1992)) and, as described above, also in SLy2 expressing HeLa 
populations these giant cells only accumulated over a longer period (Figure 25).  
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Figure 27: Point mutations in Rac interfere with the effect of SLy2 in HeLa cells (II). The same cells as in 
Figure 26 were transfected with an expression construct for constitutively active Rac1V12. Transfectants are 
marked by the red colour. Arrowheads indicate lamellipodia (left panel) or dorsal ruffles (middle and right 
panels). The cells were seeded onto gelatine coated cover glasses and stained for F-actin (green) and nuclei 
(blue). 
  
3.5. A search for SLy2-interacting proteins at the cytoskeleton 
The strong effects of ectopic SLy2 expression onto the cytoskeleton lead to the 
subsequent question, which of the plethora of pathways known to be involved in actin 
reorganisation would be employed by this novel adapter protein. In general, two different 
approaches were chosen to unravel binding partners of SLy2. The first one was of 
biochemical nature and consisted of the co-immunoprecipitation (Co-IP) of possible SLy2 
binding partners from 35S labelled cell lysates. The second approach was based on a 
database mediated similarity search for the interaction partners of proteins with SH3 
domains homologous to that of SLy2. 
3.5.1. Co-immunoprecipitation of SLy2 binding partners 
Co-IP is a powerful method to analyse the entity of interaction partners of a given protein. 
To allow the later visualisation by autoradiography, cells expressing SLy2-HA or a control 
construct were metabolically labelled with 35S. Subsequently, the cells were either treated 
with H2O2 and sodium-pervanadate or left untreated prior to lysis and 
immunoprecipitation with α-HA antibody. Figure 28 shows the autoradiographic analysis 
of Co-IPs from murine endothelial cells. Several proteins migrating at different sizes were 
co-immunoprecipitated with SLy2 and did not occur in the control lane. A background 
signal migrated at the same size as SLy2-HA, yet this was most probably unspecific, as the 
control cells did not express any HA-tagged protein. A second signal, which occurred in all 
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four samples, migrated at approximately 42 kDa and most likely represented actin. Most 
interesting, one protein migrating around 90kDa was only co-precipitated upon activation 
of the cells (Figure 28, uppermost arrowhead). This was of special interest as the previously 




Figure 28: Coimmunoprecipitation of SLy2 interacting proteins from 35S-labelled cell lysates. 
Transduced SVEC cells (murine endothelial cell line) expressing SLy2-HA or a control construct, were 
metabolically labelled over night with 35S marked methionine/cysteine. Subsequently, the cells were 
stimulated, lysed and SLy2 was immunoprecipitated with α-HA. Precipitated proteins were separated on 10% 
polyacrylamide gels and radioactively labelled proteins were detected by autoradiography as described. The 
arrowheads indicate signals precipitated only in the SLy2-HA samples. The primary SLy2 IP signal is marked 
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3.5.2. A homology based screen for interaction partners 
SH3 domains have been known to be involved in protein-protein interactions for a long 
time and fulfil crucial functions in many proteins. They mediate protein-protein 
interactions by binding to evolutionary conserved proline rich domains. Facilitated by the 
great number of SH3 domain containing proteins with well described binding partners, a 
BLAST search was performed with the SH3 domain of SLy2. After all double hits and 
entirely unknown proteins were excluded from the primary list of homologous proteins, 
ten candidate proteins emerged. The left panel of figure 29 A shows these candidates, 
sorted by order of the percentage of identity of their SH3 domain to that of SLy2. A 
comprehensive publication database search identified the reported interaction partners 
that the previously identified proteins would bind through their SH3 domains (Figure 29 A, 
right panel). The cDNA for each of these fourteen candidate proteins was amplified by RT-
PCR from mouse tissues and cloned into an expression construct, adding a C-terminal myc-
tag to each open reading frame. The co-transfection of these expression-constructs 
together with a SLy2-HA expression plasmid into 293T cells and subsequent IP with α−HA 
produced a first set of potentially SLy2 interacting proteins (Figure 29, B). With Cbl-b, SLP-
65 and SLP-76 and Gab-1, four out of these seven proteins represent important players of 
antigen receptor proximal signalling. Also connected to TCR signalling was the interaction 
with the intracellular domain of CD2 (LFA-2), which serves as an adhesion molecule in T 
cell-APC interaction. Finally, RN-tre and cortactin represent proteins that are essentially 
involved in regulation of the actin cytoskeleton. RN-tre has been found to bind actin, but 
being a GAP for the GTPases Rab-5 and Rab-43 it mainly exerts effects on endocytosis and 
membrane trafficking (Lanzetti et al., 2004; Haas et al., 2007). Accordingly, out of the seven 
primary candidates, only cortactin is known for being a master regulator of actin dynamics 
in membrane protrusions (Cosen-Binker and Kapus, 2006). 
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Figure 29: A homology based search for SLy2 interacting proteins. (A) A blast search with the SH3 
domain of SLy2 was conducted in NCBI database. Step 1 was the identification of proteins with homologous 
SH3 domains, which are depicted in box 1 (The values describe the percentage of identity between the SH3 
domain of SLy2 and that of the candidate protein). Subsequently Pubmed database was searched for 
proteins interacting with the former proteins through their SH3 domains (box 2). (B) The candidate binding 
partners identified in (A) were cloned into expression construct, adding a C-terminal myc tag. Constructs 
were cotransfected with a SLy2-HA expression plasmid into 293T cells and IPs with α-HA were performed. 
Shown are only those candidates that could be co-immunoprecipitated with SLy2, as determined by western 
blotting with α-myc. 
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3.5.3. SLy2 colocalises with cortactin in peripheral ruffles 
Considering the pronounced effect on cortical actin dynamics observed in SLy2 
overexpressing cells and the coimmunoprecipitation from 293T cells, cortactin was a 
promising candidate to mediate the observed cytoskeletal changes. This multi-domain 
adapter protein was shown, together with its close homologue HS1, to localise to the cell 
membrane upon stimulation, where it binds F-actin, Arp2/3 and WASP family proteins, 
thus leading to the enhanced formation and increased stability of branched actin 
structures (Cosen-Binker and Kapus, 2006).  
To get a first hint about a possible interaction of SLy2 with cortactin, their respective 
localisation was analysed in SLy2-HA overexpressing HeLa cells, co-stained for both 
proteins. Consistent with the previous data, SLy2 and cortactin showed a specific 
colocalisation in the distal ruffles induced by overexpression of SLy2 (Figure 30, upper 
row). Subsequently, it was essential to determine the domain(s) of SLy2 involved in the 
colocalisation with cortactin. As expected, the S23A mutation did rather have an 
enhancing effect on the colocalisation. Consistent with the homology based screen for 
binding partners, the colocalisation signal was lost upon deletion of the SH3 domain. 
Unpredicted, but consistent with previous data, also the deletion of the NLS abolished the 
colocalisation of SLy2 with endogenous cortactin (Figure 30).  
 




Figure 30: SLy2 colocalizes with cortactin in peripheral ruffles. HeLa cells were transduced with different 
SLy2 expression constructs, seeded onto gelatine coated cover glasses and subsequently stained for SLy2 
and cortactin. The SLy2 staining is shown in the left, the cortactin staining in the middle panels. The merged 
images are shown on the right with SLy2 in red and cortactin in green. Pixels with colocalising stainings are 
marked white in the merged images, as indicated by the arrowheads. Images were analysed with ImageJ and 
the plug-in colocalizationRGB (scalebar: 10 μm). 
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3.5.4. SLy2 interacts with cortactin-family proteins 
To analyse the physical interaction of SLy2 and cortactin, SLy2-HA was 
immunoprecipitated from HeLa lysates and the IPs were analysed by western blotting with 
an α-cortactin antibody. As shown in Figure 31 A, endogenous cortactin could be 
precipitated together with SLy2 from unstimulated HeLa cells, transduced with a SLy2-HA 
expression vector. Consistent with the immunofluorescent data, it turned out that the 
ΔNLS and the ΔSH3 mutants were not capable of binding to cortactin anymore (Figure 31 
B, left western blot). Interestingly, stimulation of the cells with the phorbol ester PDBU 
prior to the IP, reconstituted the binding of SLy2 to cortactin in all SLy2 variants, 
independently of the deletion (Figure 31 B, right western blot). The S23A mutant was not 
included in this analysis since gathering the appropriate cell numbers for the IPs was 




Figure 31: Co-immunoprecipitation of cortactin with SLy2. (A) HeLa cells were transduced with SLy2-HA 
or a control construct. SLy2 was precipitated with α-HA and IPs were analysed by western blotting with an α-
cortactin antibody. (B) HeLa cells were transduced as described with expression vectors for various SLy2 
mutants. The cells were left untreated or stimulated with PDBU for 15 min. Subsequently, SLy2 was 
precipitated with α-HA and coimmunoprecipitation was analysed by western blotting with α-cortactin and 
α-HA (IP-control).  
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The cortactin family comprises only two proteins, cortactin itself and HS1, a close 
homologue, which is exclusively expressed in lymphocytes (Weed and Parsons, 2001). As 
HS1 function was shown to be crucial in the formation of an intact immunological synapse 
(Gomez et al., 2006), it was a promising candidate to cause the aberrant spreading to 
antigen coated surfaces seen in SLy2-transgenic B cells. To analyse a possible interaction 
between SLy2 and HS1 in primary lymphocytes, murine splenocytes of wildtype or 
transgenic background were lysed and the transgenic SLy2-HA was precipitated. The IPs 
were analysed by western blotting with α-HS1 antibody and indeed demonstrated an 
interaction of the two proteins (Figure 32). 
 
 
Figure 32: SLy2 also interacts with the cortactin lymphocyte homologue HS1. Murine splenocytes were 
isolated from wildtype or SLy2 transgenic spleens as described. SLy2 was precipitated from lysates with α-HA 
and IPs were analysed with α-HS1. 
3.6. Generation of a SLy2 deficient mouse strain 
The generation of genetic deficiencies by means of gene targeting is a powerful tool in the 
functional analysis of any given protein. Gene-targeting is based on the phenomenon of 
homologous recombination (Thomas and Capecchi, 1986; Thomas et al., 1986). This 
describes the interaction of two homologous stretches of DNA, one on the genomic side, 
the other on an external DNA fragment. Mediated by crossing-over events between these 
identical regions, genetic information is exchanged and thus introduced into the genomic 
DNA in a site specific, i.e. targeted manner. According to the conventional method, as 
introduced by Capecchi and colleagues (Thomas and Capecchi, 1987), an expression 
cassette for a neomycin resistance gene, which is flanked by DNA stretches identical to the 
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insertion site (so called arms of homology), is introduced into the coding region of the 
target gene by homologous recombination. This blocks transcription through insertion of 
a number of ectopic stop codons and simultaneously allows the positive selection of cells 
carrying the mutation. To maximise the inhibitory effect of the cassette, the latter is 
inserted in inverted orientation into the target gene, so that its own transcription interferes 
with that of the genomic locus. As homologous recombination is such an unlikely event, 
the vast majority of cells contain random integrations of the construct. Accordingly, a 
negative selection cassette, the thymidine kinase of Herpes Simplex Virus (HSV-tk), is also 
inserted into the targeting construct. This gene is positioned outside of the homology 
arms, and is thus only inserted upon random integration and not in the case of 
homologous recombination. Supplementation of the ES cell medium with the HSV-tk 
substrate ganciclovir leads to the generation and integration of the nucleotide analogon 
and thus to the counter selection of those ES cell clones with random integrations. After a 
ten day period of double selection, the surviving ES cell colonies are picked, propagated 
and checked for homologous integration of the targeting construct. ES cells carrying the 
desired mutation are subsequently injected into 3.5 day mouse blastocysts and implanted 
into mock-pregnant foster mothers, resulting in the chimeric animals founding a gene-
targeted mouse strain.  
3.6.1. First targeting strategy 
To achieve the targeted deletion of the sly2-locus, the neoR-cassette was planned to be 
inserted into the first coding exon of SLy2 (exon1) only a few base pairs downstream of the 
start ATG. A targeting construct was cloned with one arm of homology on either side of 
the neoR, representing the regions flanking the insertion site. To minimise the alteration of 
the genomic locus, the selection cassette was inserted without the deletion of 
endogenous sequence, maintaining the original pattern of splice donors and acceptors. 
The homology arms were generated by PCR from E14 ES cell genomic DNA, to guarantee 
complete sequence identity. The short arm of homology located 5’ of the neoR comprised 
2.5kb of genomic sequence, whereas the long arm of homology consisted of the 
downstream adjacent 5.1kb of the SLy2 locus. Both arms of homology were cloned into 
pBluescript, 5’ and 3’ of the previously inserted neoR-cassette and followed by the HSV-tk 
gene. Integrity of the construct was determined by analysis of various restriction digests 
(data not shown).  
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The southern blot strategy to detect homologously recombined ES cell clones employed a 
5’ flanking probe, hybridisation of which would yield an 11.4kb and an 8.9kb fragment for 
the wildtype or the targeted locus, respectively (Figure 33).  
 
 
Figure 33: First strategy to genetically inactivate the sly2-locus. To achieve an inactivation of the sly2-
locus, a neomycin resistance gene expression cassette (neoR) was inserted in inverted orientation with 
respect to the transcriptional start of the endogenous reading frame, directly downstream of the first ATG. To 
detect homologously recombined ES cell clones a southern blot strategy was designed, which employs a 
probe flanking the targeting construct on the 5' side. Hybridisation of this probe to BamHI digested genomic 
DNA would yield a signal migrating at 11.4 kb in the wildtype locus and one migrating at 8.9 kb in the 
targeted situation. UTRs are marked in grey, coding exons in black (not drawn to scale) (red arrows indicate 
the direction of transcription). 
 
E14.1 ES cells were electroporated with the linearised targeting construct and double 
selected for 10 days with G418 (geneticin) and ganciclovir. 500 clones were analysed by 
southern blot, four of which were identified as homologously recombined (Figure 34 A). 
Two of these clones, C12 and G5, were injected into blastocysts and gave rise to two 
independently generated SLy2 gene-targeted mouse lines. Figure 34 B shows the southern 
blot analysis of mouse tail DNA from strain C12. 
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Figure 34: Targeted ES cell clones and mice. (A) The ES cell DNA was isolated and analysed by southern 
blot as described. The 5' flanking probe was hybridised to BamHI digested DNA. Shown are the four 
homologously recombined clones and a wildtype control. The clones C12 and G5 were injected into 
blastocysts to generate gene-targeted mouse strains. (B) Genomic DNA from mouse tail biopsies (strain C12) 
was isolated as described. The DNA was digested with BamHI and wildtype and targeted fragments were 
detected by hybridisation with the 5' flanking probe. 
 
3.6.1.1. SLy2 gene-targeted mice express functional SLy2 protein 
To confirm the inactivation of the sly2-locus in the gene-targeted mice, splenocytes of 
wildtype and gene-targeted mice were isolated and analysed by northern and western 
blotting for SLy2 expression. Northern blot analysis with a complete SLy2 cDNA probe 
clearly proves that there was still a substantial amount of SLy2 mRNA, although at 
diminished levels compared to wildtype (Figure 35 A). Western blot analysis with a 
polyclonal α-SLy2 serum indicated that, in contrast to the mRNA, the protein levels of SLy2 
were equal in wildtype and gene-targeted mice (Figure 35 B). A further striking finding was 
the apparently unchanged size of the message and the corresponding protein in the 
wildtype and the targeted situation (Figure 35 A and B). 
 




Figure 35: Expression of SLy2 in wildtype as well as in gene-targeted mice. (A) RNA was isolated from 
thymi of wildtype and gene-targeted mice as described. 20μg of total RNA from each sample were separated 
on a formaldehyde containing 1% agarose gel (left panel), blotted and hybridised with full length cDNA 
probes of SLy2 and GAPDH (right panel), the latter serving as loading control. (B) Splenocytes (Sp) and 
thymocytes (Th) from wildtype and gene-targeted mice were isolated and lysed as described. Lysates were 
separated on 10% polyacrylamide gels and immunoblotted with a peptide-purified α-SLy2 polyclonal serum. 
 
3.6.1.2.  Ectopic splicing and an alternative ATG lead to SLy2 expression in 
gene-targeted mice 
To unravel the nature of the unexpected SLy2 expression in the gene-targeted mice, RACE 
PCR was employed. As the region of interest was located in the 5’ part of the mRNA, the 
RACE PCR was performed with a gene specific reverse primer in exon 5. This led to the 
amplification of different fragments, depending on the genotype. The wildtype cDNA 
yielded the expected fragment of approximately 600bp, sequencing of which proved the 
annotated sequence and exon-intron structure (Figure 36 A left gel lane and B upper 
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drawing). Gel electrophoresis indicated that the RACE product from the gene-targeted 
cDNA migrated slightly higher than the wildtype fragment. Additionally, there was a 
second amplicon in the gene-targeted situation, migrating just below 2.0kb (arrowhead in 
A). Cloning and sequencing of both gene-targeted fragments showed the difference to the 
wildtype situation. The large amplificate comprised exons 1-5 and the complete neoR 
selection cassette inserted into exon 1. The smaller, more abundant fragment also 





Figure 36: RACE PCR on wildtype and gene-targeted SLy2 cDNA yields different fragments. (A) RACE 
PCR was performed on cDNA from wildtype and gene-targeted splenocytes with a reverse primer in exon 5. 
The fragments are roughly 30 bp bigger than expected from the locus, due to additional nucleotides in the 5' 
RACE primer. The arrowhead indicates the large fragment amplified only from gene-targeted cDNA. (B) 
Schematic drawing of the wildtype and the gene-targeted cDNA species. The arrow indicates the gene 
specific reverse primer used for the 5' RACE reaction. Below the sequence, the length of the fragments 
yielded in the RACE PCR is depicted as confirmed by sequencing. 
 
The analysis of the hybrid mRNA sequence (SLy2 + neoR) with a detection program for 
cryptic splice sites (splicefinder, H. Schaal, personal communication) suggested the 
existence of two fairly strong splice acceptors in the vicinity of the start codon of the neoR-
gene. Subsequent sequence analysis of the now known hybrid fragment proved the 
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existence of more than one alternative start ATG, usage of which would yield an ORF* in 
frame with the original one (Figure 37). This new ORF would lead to a similarily sized 
protein only lacking the first nine amino acids, which would also include the first 6 residues 
of the N-terminal fraction of the bipartite NLS. 
 
 
Figure 37: A theory to explain expression of a wildtype sized SLy2 from the targeted locus. Splicing of 
an hypothetical upstream exon onto one of two strong splice acceptors (red asterisks) in the neoR expression 
cassette and subsequent usage of an alternative ATG* in the 3' end of the cassette leads to the transcription 
of a new mRNA, ORF*, with the same reading frame as the wildtype message. The hypothetical upstream 
exon is indicated by a question mark. 
 
3.6.2. Second targeting strategy 
Sensitized by the outcome of the first attempt to generate SLy2 deficient mice, the second 
targeting strategy was designed to rule out the possibility of such ectopic expression. As 
the nature of the hypothetical upstream exon remained obscure, only deletion of the 
larger part of the genomic locus could insure its complete inactivation. Therefore, the neoR 
cassette was inserted such, that it replaced all of the genomic sequence between exons 2 
through exon 6, thereby deleting approximately 15kb of genomic sequence (Figure 38).  
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Figure 38: Second strategy to genetically inactivate the sly2-locus. To ensure the inactivation of the sly2-
locus, the genomic region between exons 2-6 was replaced by the neomycin resistance cassette. The 
insertion left the 5' region of exon 2 and the 3' region of exon 6 intact, to facilitate correct splicing from exon 
1 and to exon 7, respectively. The southern blot strategy to detect homologously recombined ES cell clones 
is comprised of an external 5' and a 3' probe. Hybridisation of the former to SapI digested genomic DNA 
would yield a signal migrating at 27.1 kb in the wildtype locus and 23.1kb in the targeted situation. The 3' 
probe, together with a BglI digest would detect a fragment of 23.1kb in the wildtype and 12.4kb in the 
targeted locus (not drawn to scale) (red arrows indicate the direction of transcription). 
 
Because the targeting efficiency negatively correlates with the size of the deletion, but 
positively with the length of the arms of homology, these had to be of adequate size. As a 
conventional cloning strategy limits this size to roughly 5kb, Red/ET cloning was applied as 
a new technique. This method makes use of fosmid or BAC vectors which contain 40kb up 
to 200kb of genomic sequence cloned into a vector, allowing propagation in E.coli. The 
neoR-cassette was not conventionally cloned, but rather recombined into these vectors. 
This intra-bacterial genetic modification was mediated by a recombinase from the λ-
phage, expressed inducibly from an external plasmid. This enzyme mediates with high 
efficiency the recombination between homologous sequences as short as 50bp. Thus, both 
the neoR and the HSV-tk cassette were flanked by such miniature arms homologous to the 
target site and inserted into the fosmid, resulting in the final targeting construct. The 
integrity of the resulting fosmid was determined by restriction digests (Figure 39).  
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Figure 39: Generation of the second targeting construct. (A) The genomic locus of sly2 and the 
corresponding fosmid-clone. (B) The second targeting construct was generated by Red/ET cloning in two 
consecutive steps. First the HSV-tk cassette was inserted at the border between the genomic sequence and 
the fosmid backbone. Subsequently, the neoR cassette was integrated, deleting approximately 15kb of 
genomic sequence from exon2 to 6. Shown above are the fosmid map and both cassettes with their 
respective arms of homology as generated by PCR prior to recombination. (C) Restriction digests showing the 
correct integration of both selection markers. Blue arrowheads indicate the fragments, which increases in 
size between the wildtype and the first recombination step due to the incorporation of the HSV-tk cassette. 
Green arrowheads mark the bands which disappear due to the replacement of the genomic sequence by the 
neoR cassette. The fosmid WI1-1784F7 was purchased through www.bacpac.chori.com. 
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E14.1 ES cells were electroporated with this construct and the southern blot analysis of 500 
clones identified four homologously recombined clones according to the 3’ flanking 
probe. Two clones, C5 and B6, also showed the recombination event on the 5’ end of the 
locus (Figure 40). A sly2 gene-targeted mouse strain has been generated by injection of ES 





Figure 40: Targeted ES cell clones. (A+B) ES cell DNA was isolated and analysed by Southern blot as 
described. The 5' and the 3' flanking probe were hybridised to SapI or BglI digested DNA, respectively. (C) 
Single integration of the targeting construct was shown with a probe detecting the neomycin resistance 
cassette. Hybridisation to a SapI digested DNA yielded a single band migrating at 23.1kb. The additional 
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4. Discussion 
4.1. The SLy family of putative adapter proteins 
By definition, adapter proteins comprise various interaction domains, mediating either 
protein-protein binding or the interaction between proteins and other cellular 
components (e.g. membranes or lipids). In addition, they are marked by the absence of 
enzymatically active domains. Due to their modular structure they facilitate specific 
binding of different interaction partners at the same time and thus hold crucial functions in 
the spatial-temporal regulation of cellular signalling circuits and pathways.  
When SLy was initially discovered, the structural analysis of its amino acid sequence 
instantly showed that both of these hallmark criteria of adapter proteins were met. The 
existence of an SH3 and a SAM domain in addition to the absence of any enzymatic 
domains led to the classification of this novel lymphocyte protein as an adapter molecule 
(Beer et al., 2001). The NLS in the N-terminus of all SLy proteins urges the question, if these 
molecules carry out regulatory functions by transporting or sequestering binding partners 
from or to the nucleus.  
The novel family member SLy2 has been identified by two other groups independently, 
resulting in the names HACS1 and NASH1 (Claudio et al., 2001; Uchida et al., 2001). 
Aligning the amino acid sequences of SLy and SLy2 reveals that the overall identity 
between the two proteins is only 43.3%. Yet, there are several clusters of very high identity 
found along the complete sequence (Figure 1). In addition, analysis of the SLy2 amino-acid 
sequence by the proteomics database Expasy.org reveals, that both proteins show an 
identical molecular organisation with respect to the NLS, the SH3 and the SAM domain. 
Interestingly, the clusters of high identity correlate with the identified domains, indicating 
a high selection pressure onto these structures.  
SASH1 was identified as the third protein of the SLy family. It differs greatly from SLy and 
SLy2 with respect to its size (110kDa (SASH1) vs. 55kDa (SLy) vs. 48kDa (SLy2)) and also 
shows a somewhat different molecular structure. Most identical to the two smaller proteins 
is the middle domain of SASH1, which is flanked by an additional coiled-coil motif in the N-
terminus and a second SAM domain in the C-terminus. In spite of the different structure, 
the functional domains show up to 80% sequence identity between these proteins. 
Surprisingly, the BLAST analysis of the SH3 domains of SLy and SLy2 indicates a very low 
level of sequence identity to the SH3 domains of other signalling molecules, the most 
identical being the SH3 of CD2-associated protein, CD2-AP with 42%. This positions the SLy 
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proteins in distance to other SH3 containing molecules and, supported by the striking 
similarity of the modular structure, suggests a close relationship of these three proteins 
and thus leads to the definition of the novel SLy-family of proteins.  
4.1.1. Different expression patterns for SLy, SLy2 and SASH1 
In evolutionary terms, SASH1 is the most ancient member of this family, as it occurs already 
in arthropods such as D. melanogaster, whereas SLy and SLy2 are restricted to bony fish 
and land borne vertebrate species. It is in agreement with this finding that the expression 
of SASH1 is ubiquitous, in contrast to the highly specific and thus further refined 
expression patterns of SLy and SLy2. Given the high degree of sequence and structural 
identity between both proteins, their expression pattern is surprisingly different. While SLy 
is exclusively expressed in the lymphoid cell lineage (Beer et al., 2001), SLy2 occurs in a 
broader range of tissues. The strong expression in the lymphoid organs (with the 
exception of the bone marrow) has been reported elsewhere (Claudio et al., 2001; Uchida 
et al., 2001). Also the expression of SLy2 in the brain was described (Claudio et al., 2001), 
albeit not at such high levels as encountered in hematopoietic tissues. Completely novel, 
and in marked contrast to published findings is the presence of remarkable SLy2 levels in 
skeletal and heart muscle (Figure 9). This is of special interest with respect to the newly 
identified role of SLy2 in actin dynamics as these play a pivotal role in muscle cell function. 
The analysis of SLy2 deficient mice will help to elucidate the function of this novel adapter 
also in the non-hematopoietic tissues.  
The immunoblot analysis of different murine tissues gives rise to speculations on different 
splice variants of SLy2, as the signal is of clearly different size in different organs. This 
would be consistent with data found on www.ensembl.org and accordingly this matter 
was addressed extensively during this study. Yet, RT-PCR analysis with forward and reverse 
primers in different exons could not identify differentially spliced SLy2 species including 
exons 1-8. To verify the additional splice variants proposed in the ensembl database, also 
RT-PCR with primers in the suggested novel upstream exons was conducted, which did not 
yield any fragments at all (data not shown). Secondly, during the expression analysis of the 
first SLy2-gene-targeted mouse, intensive RACE PCR analysis of the 5’ part of the SLy2 
mRNA was conducted. This never yielded any differentially sized PCR products, arguing 
against the alternative upstream exons suggested by www.ensembl.org. The only 
argument in favor of an additional upstream exon is the outcome of the first targeting 
strategy, where splicing from a hypothetical 5’ exon into the neoR cassette resulted in the 
rescued expression of SLy2 in the gene-targeted mice. Yet, the existence of this exon 
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remains speculative, as it could not be identified in the RACE PCR (Figures 35-37). 
Accordingly, the true nature of the differentially sized immunoblot signals remains elusive, 
as they might also be accounted for by posttranslational modifications. A first hint in that 
direction is the protein size of approximately 50kDa observed in the western blot analysis, 
which differs by 8kDa from the 42kDa, predicted according to the amino acid sequence 
(Figure 9).  Worth mentioning in this respect is the markedly different migration behaviour 
of the ΔSAM deletion mutant (Figure 19), which only displays a size of 30kDa in western 
blot analyses. In contrast to this, the ΔSH3 mutant migrates at approximately 42kDa, 
although both mutants differ only by 8 aa in length. To completely rule out the possibility 
that this size-shift is due to proteolytic activity, it would be necessary to analyse the 
sequence of the expressed protein. Another interesting hypothesis would be that the 
deletion of the SAM domain interferes with a posttranslational modification of SLy2, which 
might be responsible for the size shift. Along these lines, SAM domains have repeatedly 
been shown to mediate interaction with small ubiquitin related modifier (SUMO)-
conjugating enzymes (Chakrabarti et al., 1999; Chakrabarti et al., 2000; Zhang et al., 2004).  
As SUMO has a molecular weight of approximately 10kDa, this would nicely correspond to 
the size-shift occurring upon deletion of the SAM domain. This interesting possibility 
awaits further investigation.  
4.1.2. Molecular properties of SLy2 
In the two different first publications describing SLy2, there is great controversy with 
respect to the subcellular localisation of the protein. While Uchida et al. report an 
exclusively nuclear localisation of SLy2 (and thus termed it NASH), Claudio et al. detect only 
a minor fraction of SLy2 in the nucleus, while the bulk amount resides in the cytoplasm 
(Claudio et al., 2001; Uchida et al., 2001). This latter finding is also supported by the results 
obtained during this thesis (Figure 11). As both groups performed their analyses in 
overexpression systems using very similar cells, the only obvious difference between the 
experiments is the N-terminal GFP-tag used by Uchida et al. As this bulky tag is located 
close to the NLS it potentially interferes with the correct subcellular localisation of the 
protein. The HA-tag used by Claudio et al. and in this thesis probably infers less sterical 
inhibition. In support of that theory, C-terminally GFP-tagged SLy2 that was initially used in 
immunofluorescent studies during this work, showed no nuclear localisation at all (data 
not shown). Consistent with the predicted function of the NLS, the amount of SLy2 located 
in the nucleus is diminished upon deletion of the NLS domain, although it has to be noted 
that the nuclear localisation is not abolished. As only the second part of the bipartite NLS 
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was deleted in the mutant, the 5’ part of the domain potentially accounts for this residual 
amount of nuclear SLy2 (Figure 10). Alternatively, one could argue that SLy2 translocates 
to the nucleus as a homodimer, which would raise the possibility that wildtype/ΔNLS 
heterodimers make up for the HA staining in the nuclear compartement. This question will 
be addressed in future studies by reexpressing the ΔNLS SLy2 deletion mutant in a SLy2-/- 
background.      
Given the identification of SLy2 as a potentially tumour associated molecule it is worth 
mentioning that SLy2 is constitutively and prominently phosphorylated in different 
malignant cell lines (Figure 11 and data not shown). As this stands in marked contrast to 
the situation occurring in primary cells, it is tempting to speculate that the 
phosphorylation renders SLy2 more active. This is also suggested by the finding, that the 
phosphorylation status of this adapter protein is drastically increased upon activation of 
the cells. Further investigation about the responsible kinase(s) and the downstream effects 
of SLy2 phosphorylation will help to elucidate this matter. Since serine is the most 
abundant amino acid in SLy2, it will be difficult to determine exact sites of 
phosphorylation. Furthermore, a database analysis has identified several tyrosine residues 
as possible kinase targets. The NLS deficient SLy2 species further suggests a connection 
between impaired SLy2 phosphorylation and diminished functionality, since it displays the 
co-migration of an apparently less phosphorylated second band. It would be interesting to 
analyse if the reduced activity of SLy2-ΔNLS is caused by the reduced amount of fully 
phosphorylated SLy2. Of note, the deletion of the first section of the NLS together with the 
serine residue 27 completely abrogates SLy function, as shown by phenotypical 
comparison of SLyΔ/Δ and SLy-/- mice (B. Reis personal communication and (Beer et al., 
2005)). Accordingly, subsequent analyses will have to show if this is also the case for SLy2.   
4.1.3. A notorious locus in different pathogenic conditions 
In the human genome, the sly2 gene is located on chromosome 21 in the region 21q11.2, 
which is frequently targeted by translocation events in hematopoietic malignancies 
(Mitelman et al., 1997). Along the same lines, SLy2 was reported to be upregulated in 
different leukemic cell lines and primary human tumours (Claudio et al., 2001; Williams et 
al., 2003). This notion receives further support by studies conducted in the laboratory of 
Prof. Bernhard Holzmann at the Technical University of Munich, which also showed an 
upregulation of the SLy2 mRNA in different human tumour tissues, including colon, 
pancreas and liver (Dr. Klaus-Peter Janssen, personal communication). However, it has to 
be noted that a recent publication reports the region 21q11.2 to be often affected by loss-
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of-heterozygosity events in human lung cancer. Consistently, Yamada and colleagues find 
SLy2 to be downregulated in different cell lines derived from human lung cancer, thus 
rather suggesting a tumour suppressor activity, which was also reported for SASH1 (Zeller 
et al., 2003; Yamada et al., 2008). This controversy is further intensified by the finding 
presented in this study, that the overexpression of SLy2 induces aberrant cytokinesis and 
accordingly causes a proliferation defect in different human cancer cell lines (Figure 23).  
The most obvious disease genetically related to chromosome 21 is Down syndrome, 
caused by a trisomy due to defective meiosis. As the aetiology of this disorder is commonly 
attributed to gene dosage effects, the expression of various genes located on chromosome 
21 has been analysed in wildtype and trisomic situations. Cheon and co-workers compared 
the levels of six different proteins and could show that the expression of SLy2 was 
significantly downregulated in the cerebral cortex of Down syndrome fetuses. This stands 
in marked contrast to what was expected from the multiplicity of the locus (Cheon et al., 
2003). However, the completely descriptional character of this study does not allow any 
speculations about the connection between the decreased SLy2 protein levels and the 
disease phenotype. Another interesting finding is that region 21q11.2 has been connected 
to the abnormal myelopoiesis and frequent occurrence of leukaemia in Down syndrome 
patients, representing one of the main reasons for the limited life span especially in Down 
syndrome children (Izraeli et al., 2007). 
A neuro-pathologic condition connected to this chromosomal region is Alzheimer’s 
disease (Groet et al., 1998), whose incidence is also significantly increased in Down 
syndrome patients (Zigman and Lott, 2007). Amongst other genes in this region, also SLy2 
has been identified as a marker correlating with a predisposition to Alzheimer’s (Kimura et 
al., 2007). Remarkable in this respect is the finding that SLy2 is highly and specifically 
expressed in the hippocampus (Lein et al., 2007). This region of the brain has been 
implicated with long term memory and is amongst the first structures to be affected by the 
β-amyloid-plaques. The importance of F-Actin reorganisation in hippocampal neuron 
synapse formation, which is important in the formation of long-term memory, implies a 
possible role for SLy2 in these processes (Wegner et al., 2008). 
Taken together, these findings suggest that the chromosomal region around SLy2 
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4.2. SLy2 transgenic mice 
SLy2 expression is upregulated in B cells upon stimulation with various maturation and 
proliferation inducing stimuli (Figure 9). Zhu et al. expanded this finding to a functional 
level by transducing primary splenic B cells with a SLy2 expression construct. In agreement 
with the upregulated expression after stimulation with CD40L and IgM, the SLy2 
overexpression induced the differentiation of B cells towards a plasma cell fate (Zhu et al., 
2004). To determine this maturation inducing effect in a physiological setting in vivo, we 
generated transgenic mice with a constitutively elevated expression level of SLy2 in B and 
T cells (Figure 14). To our surprise, the different T and B cell populations did not show any 
alterations, as defined by FACS analysis. Also, we could not confirm the elevated levels of 
CD138 or the decrease in CD23 expression reported in the work of Zhu and coworkers 
(Figure 15). Although the plasma cell levels (B220+, CD138+) appear slightly elevated in the 
transgenic mice, this phenomenon is not significant (p>0.2) (Figure 15, lowest panels). 
Consistent with this, also the serum antibody levels were unaltered compared to wildtype 
mice (K. Buchholz, personal communication). The differing results might be explained by a 
more drastic overexpression in the transduction system compared to the transgenic cells. 
Also, the in vitro nature of the transduction experiments might lead to an artificial situation 
that is not comparable to the in vivo studies, especially since the B cells had to be 
stimulated prior to retroviral transduction (Zhu et al., 2004). It remains to be determined 
how B and T cells of transgenic mice behave in an infectious setting or after immunisation 
of the mice with T-dependent or T-independent antigens. 
4.3. Form follows function – the F-actin cytoskeleton 
Actin is the hallmark protein of one of the three pillars of cytoskeletal structures, which also 
comprise the microtubular network and the intermediate filament system. By polymerising 
of actin monomers (globular, G-actin) into multimers of a helical, filamentous structure (F-
actin), the foundation for a plethora of different functions is laid. In general, two different 
forms of F-actin are known, stretched linear filaments and branched networks. Depending 
on the required morphology either of them is employed specifically, e.g. in the formation 
of protrusive structures. The former accounts for long, finger-like protrusions such as 
filopodia, used to probe the surrounding area. The latter is found in broad, sheet like 
lamellipodia and ruffles, involved in the organisation of the leading edge in a migrating 
cell. Additionally, both structures are assembled to higher ordered complexes (Chhabra 
and Higgs, 2007). With its high degree of flexibility and the plethora of possible structures 
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it is not surprising that the F-actin cytoskeleton is involved in almost each aspect of cellular 
biology. 
4.3.1. A new player in the field? 
It has emerged in the recent years how important the reorganisation of the F-actin 
cytoskeleton is during the intial events of lymphocyte activation (Vicente-Manzanares and 
Sanchez-Madrid, 2004; Billadeau and Burkhardt, 2006; Harwood and Batista, 2008). During 
the first minutes after the encounter of an antigen presenting cell or antigen coated 
surface, T and B cells undergo drastic rearrangements of their actin cytoskeleton (Fleire et 
al., 2006; Barral et al., 2008). Quickly after the engagement of the antigen receptors, the 
whole actin network focuses towards the cell-antigen contact area and serves as scaffold 
for an IS. In addition to this structural function, the actin polymers also actively transport 
integrin-molecules into the p-SMAC (peripheral supra molecular activation cluster), which 
are attached to actin via the protein talin (Vicente-Manzanares and Sanchez-Madrid, 2004; 
Harwood and Batista, 2008). Besides these intracellular reorganisation events, especially B 
cells have been shown to literally perform a choreography of spreading and contraction, 
thereby gathering the maximum of possible antigen binding to their B cell receptors 
(Fleire et al., 2006). It is of great interest in this respect that transgenic B cells 
overexpressing SLy2 show marked difficulties in the initial spreading on an α-IgM coated 
surface (Figure 16). In wildtype B cells the F-actin structures at the contact plane between 
cell and surface show a clear spreading during the first 15 minutes. The same structures in 
the transgenic cells remain largely unchanged during the first two minutes and also then 
only partially increase their size. Approximately 5 minutes after cell-substrate contact, the 
transgenic cells reach their peak with respect to the relative size of the contact area, 
identically to the wildtype cells, although still at decreased levels. The wildtype cells 
maintain a stable size of the contact area for approximately 10 minutes, after which they 
begin to contract again, reaching the initial size in the following 15 minutes. In contrast, 
the size of the F-actin structures at the synapse of transgenic B cells immediately starts to 
decline after having reached the peak size, indicating that these cells are unable to 
maintain a stable contact with the antigen coated surface. This effect was not due to 
decreased surface expression of IgM on these cells, as shown in Figure 15, third row of 
panels. Accordingly, the aberrant spreading must be accounted for by an inability to 
correctly reorganise the F-actin network beneath the cell membrane at the contact site 
between the cell and the substrate (Figure 16). Further experiments will have to show at 
which point and in which pathway SLy2 exerts its effects on F-actin reorganisation. It will 
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be revealing to analyse the intracellular Ca2+-signals upon activation in the transgenic cells, 
as those have been shown to be impaired by interfering with actin polymerisation (Varma 
et al., 2006). It is a remarkable finding that the transgenic B cells are not only impaired in 
their spreading, but potentially also in the maintenance of a mature synapse. This hints 
towards an additional defect in the microtubule system, which was shown to be 
responsible for the stabilisation of the IS (Bunnell et al., 2001). Yet, given the intensive 
crosstalk between the actin and the tubulin network, it can not be ruled out at this point, 
that the stabilisation defect is also due to defective F-actin assembly at the contact zone 
between the cell and the antigen coated surface.  
4.3.2. Aberrant induction of branched F-actin networks 
As the actin structure underlying the IS is homologous to a lamellipodium (Billadeau and 
Burkhardt, 2006) and SLy2 was shown to be expressed in HeLa cells (data not shown), we 
used this well characterised cell line to further define the role of this novel adapter in the 
regulation of the actin cytoskeleton. The expression of SLy2 under the control of the EF2α-
promoter in these cells induced a drastic reorganisation of F-actin structures. The most 
prominent feature was the extreme skewing of most of the cellular F-actin towards the 
distal poles of the cells, where it formed sheet like lamellipodia and peripheral ruffles 
(Figure 17, right panels). Concurrently, the previously highly abundant stress fibres 
dissolved, as did the cortical F-actin, located underneath the membrane in wildtype cells 
(Figure 17, left panel). The simultaneously occurring induction of one F-actin structure with 
the disassembly of another is a highly interesting finding, as different F-actin structures are 
based on the action of different signalling networks (Chhabra and Higgs, 2007). Small 
GTPases of the Rho-family proved to be of pivotal importance in this respect (Hall, 1998). 
The activity of RhoA enhances cell contractility through the formation of stress fibres, 
intracellular “cables” assembled from anti-parallel bundles of linear F-actin. At each end 
they are attached to focal adhesions (FA), integrin-rich complexes that mediate a firm 
interaction between a cell and its substratum, the formation of which is also induced by 
the activity of RhoA (Ridley and Hall, 1992). On the other hand, the activity of two other 
prominent members of the Rho-family, Rac and Cdc42 lead to the extension and migration 
of the cell, primarily by the formation of lamellipodia and filopodia at the leading edge, 
assembled from a network of branched actin filaments. Secondly, Rac and Cdc42 activate 
the effector PAK, which induces the disassembly of stress fibres and FA, thereby enabling 
the cell to migrate by decreasing the contractility and loosening the adhesion, respectively 
(Manser et al., 1997; Hall, 1998). It is in agreement with the disassembly of intracellular 
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stress fibres that the SLy2 overexpressing cells take on a markedly spread morphology, 
often displaying several long and thin protrusions (Figure 17, middle panels) 
(Schoenwaelder and Burridge, 1999). In line with the previous findings, SLy2 was never 
found to colocalise with FA in HeLa cells (data not shown). 
4.3.2.1.  Different domains of SLy2 account for its localisation to F-actin 
structures and their induction 
Double stainings clearly show the colocalisation of SLy2 with the F-actin structures 
induced by its overexpression (Figure 18). It was a surprising finding, when analysing the 
HeLa cells expressing the different SLy2 mutant proteins, that the localisation to and the 
induction of the peripheral ruffles can be uncoupled (Figure 20 B). The deletion of the 
second part of the NLS clearly impairs the ability of SLy2 to induce peripheral ruffles, 
although not abolishing it. Equally unexpected was the missing enrichment in F-actin 
structures. With respect to the decreased nuclear localisation of SLy2 upon deletion of the 
NLS it is mandatory to analyse what causes the impaired induction of membrane ruffles. 
Given the less pronounced colocalisation of this deletion mutant with F-actin structures, it 
will be interesting to define the molecular functions of this domain apart from nuclear 
transport. The deletion of the SH3 domain yields quite the contrary result: now the 
induction of ruffled membranes is lost, but the protein still colocalises, at least to some 
extent, with the F-actin. This suggests that SLy2 interacts with a cytosolic protein via its 
SH3 domain and that this interaction does not have to occur in the immediate proximity to 
the place where the ruffles are subsequently induced. On the other hand, the localised 
accumulation alone obviously does not suffice to induce membrane ruffling (Figure 20 B). 
This finding received further support from biochemical separations of HeLa cell lysates into 
G-actin and F-actin rich fractions. Whereas wildtype SLy2 and the S23A point mutant 
exclusively co-purified to the F-actin fraction, ΔNLS and ΔSH3 displayed a different 
distribution. After the deletion of the NLS, at least half of the SLy2 molecules occur in the 
G-actin fraction, while this fraction was markedly decreased upon deletion of the SH3 
domain (Figure 21). Also, the phenotype of the NLS deletion mutant elicits speculations 
about the specific function of this domain, as it is apparently not only mediating the 
nuclear localisation of SLy2 (compare to Figure 10). Considering the compromised 
functionality of the NLS or the SH3 deleted SLy2 mutants it is interesting that both migrate 
as a double band. Furthermore, the treatment of the cells with the phosphatase inhibitor 
calyculin shifts the distribution of SLy2-ΔNLS towards the upper band, suggesting that the 
size difference is due to differential phosphorylation (Figure 21, right panel). Given the 
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constitutive phosphorylation of the wildtype SLy2 protein in different cell lines (Figure 11 
and data not shown) it is tempting to speculate that phosphorylation of SLy2 is needed to 
exert its full effect on F-actin dynamics. However, the amino acid residues that are 
modified by phosphorylation have to be identified before this hypothesis can be verified in 
an experimental setting. 
Concerning the phenotype of the deletion of the SAM domain, future experiments 
analysing the overall stability of the protein have to show if the complete loss of function 
effect is protein intrinsic. Yet, this is suggested by the immunofluorescent analysis of the 
few cells expressing it at levels comparable to the other SLy2 species (Figure 20 A and B). It 
would be interesting to treat the ΔSAM expressing cells with proteasome inhibitors and 
investigate if the cells take on a similar morphology as the SLy2 wildtype expressing cells. 
However, the pleiotropic effects of such inhibitors have to be taken into account. 
Subsequently, assessing the impact of the SAM domain alone by expressing it ectopically 
in HeLa cells would yield further information about its function. Of note, ongoing 
experiments suggest that the deletion of the SAM domain leads to a loss of function 
phenotype in SLy without interfering with the cellular levels of the protein (D. Finkenstädt, 
personal communication). 
4.3.2.2. A potentially regulatory function of serine residue 23 in SLy2 
Overexpression of a serine to alanine point mutant in aa position 23 of SLy2 induces even 
more ruffles in the HeLa cells and also leads to an increasingly condensed morphology of 
the cells, compared to overexpression of the wildtype protein or the NLS deletion. 
Consistently, the intracellular localisation of the mutant protein seems to be skewed 
towards the membrane (Figure 20 A and B). It is worth mentioning that the amino acids 
up- and downstream of Ser23 are highly conserved between SLy and SLy2 (Figure 1). 
Database analysis indicates that this sequence represents the consensus motif of protein 
kinase D (PKD) target substrates (Doppler et al., 2005), and it was shown for SLy that the 
corresponding Ser27 is phosphorylated in vitro by this kinase (B. Reis, personal 
communication). Of note, the phosphorylation of Ser27 in SLy leads to the generation of a 
14-3-3 binding site and mutation of this residue to alanine abolishes the binding of 
different 14-3-3 proteins to SLy (S. Brandt and B. Reis, personal communication). Since also 
SLy2 is interacting with various 14-3-3 family proteins (S. Brandt, personal communication), 
it is tempting to speculate that the mutation of serine to alanine in position 23 also yields 
defective binding of SLy2 to 14-3-3 proteins and that this results in the enhanced activity 
of this mutant to induce peripheral ruffles. 
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4.3.3. Enhanced spreading of SLy2 overexpressing HeLa cells 
The molecular machineries that are involved in lamellipodia formation also control cell 
spreading and migration (Pollard et al., 2000; Ridley et al., 2003; Chhabra and Higgs, 2007). 
Thus, it is consistent with the strong induction of peripheral membrane ruffles and 
lamellipodia by SLy2, that the transgenic HeLa cells also exhibited increased spreading on 
gelatine coated surfaces. In agreement with previous findings, HeLa cells overexpressing 
SLy2 displayed pronounced membrane protrusions and multiple lamellipodia, as opposed 
to the rather round and evenly shaped control cells (Figure 22). A surprise was the strong 
spreading of the ΔSH3 expressing cells, although these cells did not display multiple 
lamellipodia but rather produced one big ring-like structure of F-actin surrounding the cell. 
Potentially, this is caused by a less locally restricted induction of F-actin. 
The outcome of the spreading analysis appears to stand in contradiction to the results 
from the transgenic B cells, which clearly exhibited impaired spreading on antigen coated 
surfaces (Figure 16). A possible explanation for this diverging behaviour could be that the 
overexpression of SLy2 leads to the induction of lamellipodia without a defined spatio-
temporal regulation. This probably does not impose an obstacle to HeLa spreading on 
gelatine as it seems somewhat erratic in its direction. Yet, such a locally restricted 
regulation of the F-actin network is mandatory for the antigen induced spreading 
preceeding the establishment of a mature IS at the contact plane between the cell and the 
surface (Bunnell et al., 2001; Vicente-Manzanares and Sanchez-Madrid, 2004; Harwood and 
Batista, 2008). This suggests that the high abundance of SLy2 molecules in the transgenic B 
cells apparently rather disturbs than promotes spreading.  
4.3.4. Defective cytokinesis through ectopic SLy2 expression 
Cytokinesis represents the last step in mitosis and describes the final separation of one 
mother into two daughter cells, after successful karyokinesis. Again, the F-actin 
cytoskeleton is involved in this process at multiple levels (reviewed in (Eggert et al., 2006)). 
Accordingly, it is of interest that the overexpression of SLy2 causes a proliferational defect 
in all cell lines analysed (Jurkat, HeLa, SVEC) (Figure 23 and data not shown). Especially 
HeLa cells expressing SLy2 wildtype or the S23A mutant exhibited extensive difficulties in 
the last steps of cell division as indicated by the accumulation of cytoplasmic bridges 
between the daughter cells (Figure 24). Probably as a result of the impaired cytokinesis, 
giant and multinucleated cells accumulated in long time cultures especially of SLy2-S23A 
overexpressing HeLa cells (Figure 25). Considering the deleterious effects of SLy2 
overexpression on other RhoA mediated structures such as stress fibres, it is worth 
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mentioning that Bement and colleagues could show the specific enrichment of active 
RhoA at the cleavage plain between dividing cells shortly before cell division is 
accomplished (Bement et al., 2005). Also, different regulators of RhoA activity accumulate 
at the cleavage plain (Kimura et al., 2000; Hirose et al., 2001) and the deepening of the 
cleavage furrow is mediated by actin and myosin II, the activity of which is also controlled 
by RhoA (Uyeda et al., 2004). Cytokinesis ends with the abscission of the two daughter 
cells, preceeded by the ingression of the cleavage furrow, which leads to the formation of a 
thin cytoplasmic bridge of 1-1.5 μm strength. The diameter of this bridge reduces to 
approximately 0.2 μm during maturation (Mullins and Biesele, 1977; Piel et al., 2001). 
Concurrently, the maintenance of the bridge becomes insensitive to actin depolymerising 
agents like Latrunculin B, indicating that it is no longer dependent on F-actin 
reorganisation (Echard et al., 2004). This suggests an involvement of SLy2 into this process 
at an earlier time point. Consistently, many of the cytonemes found between SLy2 
expressing cells are considerably thicker than the described 0.2–1.5 μm (Figure 24). In 
addition, given the pivotal role of RhoA in cytokinesis, this small GTPase seems to be a 
potential target of SLy2 activity worthwhile of further investigation. An additional 
phenotypical hint towards an implication of SLy2 in cytokinesis is the finding that U2OS 
cells depleted for the protein Bruce display the same cytonemes as seen in SLy2 
overexpressing cells (Pohl and Jentsch, 2008). Interestingly, this knock down of Bruce leads 
to a defect in the last stages of cytokinesis. Another theory to explain the cytokinesis defect 
of SLy2 overexpressing cells could be a possible impairment of the spatio-temporal 
induction of F-actin, thus leading to a defect in the localised actin reorganisation at the 
cleavage plain, elicited by an excess of SLy2 throughout the cell. 
4.3.5. Rac1 is involved in the effect of SLy2 on the actin cytoskeleton 
As mentioned above, the role of different Rho-family members in the formation of diverse 
F-actin structures is well established (Ridley, 2001; Ladwein and Rottner, 2008). As SLy2 
overexpression clearly induces the generation of lamellipodia and membrane ruffles, Rac 
proteins were the first candidates to be tested as the potential mediators of the effects of 
SLy2 on the actin cytoskeleton. To analyse the Rac-dependency of the phenotype of SLy2 
overexpression, cells were transfected with expression vectors for a dominant-negative 
point mutant of Rac1, Rac1N17 (Ridley et al., 1992). Indeed, the formation of membrane 
ruffles in SLy2 overexpressing cells was strongly Rac1 dependent, as the expression of 
Rac1N17 completely abolished the phenotype elicited by SLy2 (Figure 26). An additional 
hint was the phenotype displayed by HeLa cells stably expressing SLy2, which were 
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transfected with an expression vector for constitutively active Rac1V12 (Figure 27). In 
contrast to the smooth lamellipodia induced by Rac1 activity alone (left panel), the double 
expressors took on a spiky appearance due to the characteristic topology of the cortical F-
actin. Further suggesting a combined activity of SLy2 and Rac1 was the massive 
occurrence of dorsal ruffles (middle and right panels), which was not accounted for by 
Rac1V12 activity alone (left panel). Furthermore, most of the double transfected cells 
contained several nuclei, a phenotype that was not seen in cells overexpressing only 
Rac1V12 (Figure 27 and (Ridley et al., 1992)). This obvious defect in cell-division was 
apparently caused by the synergistic action of SLy2 and Rac1V12. In addition, Ridley and 
colleagues also report that the microinjection of Rac1V12 into Swiss 3T3 mouse fibroblasts 
induces the accumulation of vesicles in these cells, which originate from pinocytosis (see 
Figure 27 middle panel, ring-like F-actin structures and (Ridley et al., 1992)). Of note, these 
vesicles are also sometimes witnessed in HeLa cell overexpressing SLy2 wildtype or SLy2 
S23A (data not shown). In conclusion, it is clear that the generation of the peripheral ruffles 
and other ectopic F-actin structures induced by SLy2 is dependent on Rac. Albeit it remains 
elusive until now, which nucleation promoting factor (NPF) is involved here, as either NPFs 
I (N-WASP, WAVE1, WAVE2) or NPFs II (cortactin/HS1) are reported to mediate lamellipodia 
and ruffle formation and both classes of proteins depend on the activation through Rac 
proteins (Cosen-Binker and Kapus, 2006; Takenawa and Suetsugu, 2007; Ladwein and 
Rottner, 2008). 
4.3.6. SLy2 interacts with proteins of the cortactin family 
Actin polymerisation starts with the formation of actin-oligomers, which further assemble 
into filaments. Since the generation of these actin di- and trimers is energetically 
unfavored, the equilibrium in these first steps is clearly skewed towards the monomeric 
molecule (Chhabra and Higgs, 2007). The two groups of NPFs are involved in the 
nucleation of monomeric actin into F-actin, in a separate as well as a synergistic fashion. 
Both cortactin/HS1 and WAVE1-3 are involved in the generation of lamellipodial structures 
and membrane ruffles (Cosen-Binker and Kapus, 2006; Takenawa and Suetsugu, 2007). 
Even more, both HS1 and WAVE were shown to be essential for the formation of IS and the 
subsequent activation of T cells (Gomez et al., 2006; Nolz et al., 2006). 
To identify the downstream effectors of SLy2 that mediate the formation of lamellipodia, 
two different approaches were chosen. IPs of SLy2 from metabolically labelled cell lysates 
yielded a first hint at the “interactome” of SLy2. A protein band migrating at 85-90kDa 
especially raised our interest, as it only seemed to co-precipitate with SLy2 after 
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stimulation of the cells with sodium ortho-vanadate and hydrogen peroxide (Figure 28) 
and because a member of the second class of NPFs, cortactin, migrates at that size. The 
treatment of cells with both oxidising agents leads to the persistent inactivation of cellular 
phosphatases, as important residues in their active centre are irreversibly oxidised. This 
results in the accumulation of phosphorylated signalling proteins and thus an enhanced 
activation status of the cell (Wienands et al., 1996). Remarkably, stimulation of cells with 
PDGF, LPA or bradykinine, which are well known activators of Rac1, RhoA or Cdc42 and 
their respective F-actin structures, induces intracellular peroxide production (Rhee et al., 
2000; Reth, 2002).  
The second approach to find SLy2 interacting proteins was a database search for proteins 
interacting with molecules containing SH3 domains homologous to that of SLy2. This led 
to the identification of 14 candidate proteins, which potentially interact with SLy2 (Figure 
29). Interestingly, many of the hits yielded by this functionally unbiased approach are well-
known regulators of the actin-cytoskeleton, such as the Rho-family GTPases and cortactin. 
However, only the interaction with cortactin was confirmed in the subsequent 
immunoprecipitation studies. As cortactin is a well known regulator of branched actin 
networks, it is a likely candidate to mediate the effects of SLy2 on the actin cytoskeleton. 
This hypothesis received further support by the finding that the inability of different SLy2 
deletion mutants to colocalise with the F-actin rich ruffles correlates with their inability to 
colocalise and to coimmunoprecipitate with cortactin (Figure 30 and 31). Although the 
latter finding underlines the specificity of the SLy2-cortactin interaction, future 
experiments in a completely endogenous situation will have to be performed for final 
confirmation.  
As mentioned above, cortactin is involved in the generation of lamellipodia through the 
concomitant binding of Arp2/3 complex, F-actin and WASP proteins. To facilitate cellular 
migration, the induction of lamellipodia has to coincide with the establishment of new 
focal contacts to the substratum, in order to generate the needed traction. Their absence 
results in the uplifting and back folding of the induced lamellipodia, resulting in extensive 
membrane ruffling (Weaver et al., 2001; Ammer and Weed, 2008). This is supported by 
findings from SLy2 overexpressing cells that show remarkable ruffling, but fail to exhibit 
enhanced migratory capacities (data not shown). It remains elusive, if the interaction of 
SLy2 and cortactin leads to the activation or the inhibition of the latter. This matter is 
further complicated due to conflicting data on the effect of cortactin downregulation on 
the spreading and migratory capacity of the cell. Illes and colleagues show on the one 
hand that RNAi mediated cortactin knock down leads to impaired spreading of COS-7 cells 
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on fibronectin (Illes et al., 2006). On the other hand, Kempiak et al. show that cortactin 
knock down in rat adeno-carcinoma cells leads to enhanced formation of lamellipodia and 
van Rossum et al. suggest that downregulated expression of cortactin leads to enhanced 
spreading and adhesion, but diminishes the migratory behaviour of breast epithelial cells 
(Kempiak et al., 2005; van Rossum et al., 2006). It remains to be elucidated how the 
interaction of SLy2 and cortactin can account for the marked changes in F-actin 
organisation in SLy2 overexpressing cells.  
With respect to the high basal expression of SLy2 in brain and the specific expression in the 
hippocampus it is of great interest that the hippocampal expression of cortactin is highly 
regulated and appears to affect the plasticity of hippocampal neurons during REM sleep 
phases (Davis et al., 2006).  
As mentioned above, the F-actin structure underlying the IS is homologous to a 
lamellipodium. In agreement with this, HS1, a protein from the cortactin family, is of 
pivotal importance in the generation and maintenance of this specific structure and the 
subsequent activation of T and NK cells. In addition, HS1 deficient mice display defective B 
cell proliferation after IgM stimulation and decreased T-independent immunoglobulin 
production (Taniuchi et al., 1995; Gomez et al., 2006; Butler et al., 2008). Considering the 
defect in antigen induced spreading in SLy2 overexpressing B cells, it is thus remarkable 
that SLy2 also interacts with HS1 in primary splenocytes (Figure 32). This makes HS1 a likely 
candidate to mediate the effects of SLy2 on the intact formation of the F-actin 
cytoskeleton at the IS, especially as the protein was shown to affect NK cell spreading in 
response to ICAM-1 coated surfaces (Butler et al., 2008). 
4.4. Targeting SLy2 
With the aim to abrogate expression from the sly2 locus but to reduce the impact on 
adjacent loci to a minimum, the first targeting strategy only encompassed the insertion of 
a neoR cassette into the first coding exon in the reverse direction with respect to the 
reading frame of the endogenous locus (Figure 33). The strong transcriptional activity of 
the PGK-promoter in the inserted sequence should thus mediate an additional inhibiting 
effect on the SLy2 expression. Unexpectedly, unaltered SLy2 mRNA and protein levels were 
detected in the gene-targeted mice (Figure 35). As the RACE analysis clearly proved a 
correct insertion of the neoR cassette at the intended location, an aberrant targeting event 
could be excluded as the reason (Figure 36). Given the existence of splice acceptors in the 
3’ end of the neoR cassette, these results suggest an ectopic splicing event. Since the 
cassette is located in the first coding exon, this unexpected splicing accounts for the 
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transcripts of identical size in the wildtype and the gene-targeted situation. This 
hypothesis received additional support by the identically sized SLy2 mRNAs in the 
wildtype and the gene-targeted situation, in spite of the inserted neoR cassette in the first 
exon. The markedly reduced amount of the hybrid mRNA species containing the complete 
resistance cassette compared to the spliced variant is further stressing the efficiency of this 
splice event. Yet it has to be noted that the postulated existence of an unknown upstream 
exon, needed to provide the splice donors, could not be proven. These findings elicit 
further discussion concerning the additional upstream exons and splice variants resulting 
thereof. An alternative explanation would be the formation of a new promoter inside the 
neoR cassette. Since the cassette is positioned within the SLy2 locus in an inverted 
orientation its strong promoter is located in the 3’ part. Potentially, this would yield an as 
yet hypothetical promoter that could mediate the recruitment of the transcriptional 
machinery and subsequent production of the alternative mRNA. However, such an ectopic 
promoter function would most probably have been already described elsewhere, given 
the frequent usage of the PGK-neoR cassette in various gene-targeted mouse strains. 
It can only be speculated wether the alternative gene product expressed from the targeted 
locus could exert full function, yet this seems very likely, given the lack of only six residues 
of the N-terminal part of the NLS and the presence of all other functional domains 
including the serine residue 23. 
4.5.Conclusion and outlook 
The thesis presented here provides essential evidence that SLy2 is a new factor in actin 
dynamics and represents the first molecular characterisation of this novel adapter protein. 
So far, published knowledge about SLy2 rather concentrated on the expression levels in 
different diseases and especially malignancies and the control of SLy2 expression in 
primary B cells. Biochemical and immunohistological analyses strongly suggest that SLy2 
exerts its effects on the actin cytoskeleton by interaction with the NPF II cortactin. In 
addition, the Rac1 dependency of the SLy2 effect was demonstrated by the coexpression 
of SLy2 and dominant negative Rac1 protein. Albeit, given the involvement of Rac1 in actin 
reorganisation up- and downstream of cortactin, no conclusion can be drawn towards the 
operating level of SLy2. Consistent with the interaction with the cortactin homologue HS1, 
SLy2 was shown to be involved in the complex spreading and contraction choreography 
displayed by B cells encountering membrane bound antigen. How this inhibitory effect of 
SLy2 overexpression influences the activation-specific and proliferative capacities of 
primary B cells still has to be determined. Also, in spite of the novel data presented here, 
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the complete working mechanism of this newly identified adapter still remains elusive. In 
addition, the effects of abrogated SLy2 expression on the activation of hematopoietic cells 
will have to be unravelled. With the sly2-gene-targeted mouse strain generated during this 
thesis the foundation for such analyses is laid. 
Until now, when analysing the role of SLy2, the main focus was always on its function in 
hematopoietic cells. This is mainly due to the reported upregulation of the expression of 
this protein in malignant cells of hematopoietic origin. Thus, it is necessary to determine its 
role in other tissues such as smooth and skeletal muscle or brain, in all of which SLy2 is 
highly expressed. Notably, actin reorganisation is of pivotal importance in the central 
functions of all of the tissues mentioned. Given the involvement of SLy2 in such profound 
cellular functions as cell spreading and proliferation, it will be highly interesting to analyse 
the phenotype of the gene-targeted SLy2 deficient mice.  
126  5. Summary 
5. Summary 
This thesis represents the first molecular characterisation of SLy2, a novel member of the 
recently described SLy family of adapter proteins. SLy2 was previously identified as HACS1 
on the basis of its deregulated expression in different hematopoietic cancer cell lines 
(Claudio et al., 2001). Database analysis defined an identical modular organisation of SLy 
and SLy2, with an N-terminal NLS-, a central SH3- and a C-terminal SAM domain.  
Western blot analysis using a polyclonal anti-serum demonstrated SLy2 expression 
throughout the hematopoietic tissues, but also in muscle, heart, brain and colon. In vivo 
overexpression in B cells of a transgenic mouse line established a role for SLy2 in the initial 
spreading and contraction of B cells in response to contact with antigen containing 
membranes. In vitro overexpression of wildtype SLy2 protein in HeLa cells resulted in the 
prominent and robust induction of branched F-actin structures like lamellipodia and 
peripheral ruffles, to which SLy2 also specifically localised. This primary effect was 
accompanied by markedly enhanced spreading and correlated with diminished 
proliferation, most probably due to defective cytokinesis in SLy2 overexpressing cells. Of 
note, it could be shown that the deletion of the various functional domains affected this 
impact on F-actin reorganisation to different degrees: The removal of the NLS domain 
impaired ruffle formation only mildly, although the specific colocalisation with F-actin was 
abrogated. In contrast to this, the SH3 domain proved to be of pivotal importance for the 
F-actin reorganising effect of SLy2, with the mutant protein retaining some ability to 
recruit to peripheral branched F-actin structures. This functional dichotomy awaits further 
elucidation. Finally, the loss of the SAM domain led to a complete loss of function, yet the 
diminished protein levels of this mutant might potentially lead to an overinterpretation of 
this effect. Furthermore, the molecular cause for the characteristic size-shift of the ΔSAM 
mutant remains to be defined. The mutation of a conserved serine residue in the N-
terminus (serine 23) resulted in an even enhanced phenotype of the overexpressing cells, 
thus proposing a regulatory function for this amino acid. Interestingly, SLy was shown to 
be phosphorylated at this residue upon T cell receptor ligation (Astoul et al., 2003).  
Overexpression studies with different point mutants of Rac1 suggested a direct role for this 
small GTPase in the SLy2 induced F-actin structures. Dominant negative Rac1N17 
abrogated the F-actin inducing effects of SLy2, while constitutively active Rac1V12 even 
enhanced this phenotype.   
Ultimately, two complementary approaches towards the identification of downstream 
SLy2 effectors proved the interaction with the members of the cortactin family of 
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nucleation promoting factors, cortactin and its lymphocyte homologue HS1. As their role 
in the induction of lamellipodia and immunological synapses has been clearly established 
before, they are highly likely to be the mediators of the actin regulatory effects of SLy2.  
 
With the generation of gene targeted SLy2 deficient mice, an in depth analysis of this novel 
regulator of branched F-actin structures in vivo is now possible. 
 
5.1. Zusammenfassung 
Die vorliegende Dissertation beinhaltet die erste molekulare Charakterisierung des 
Proteins SLy2. Auf Grund des hohen Expressionslevels in Zellen des hämatopoietischen 
Systems  und seiner markanten Domänenstruktur ist SLy2 ursprünglich als hematopoietic 
adapter protein containing SH3 and SAM domains 1 (HACS1) beschrieben worden (Claudio 
et al., 2001). Eine Analyse der molekularen Struktur auf Grund von Datenbankvergleichen 
ergab einen zu SLy hochidentischen Aufbau, bestimmt durch eine N-terminale Kern-
Lokalisationssequenz (NLS), eine zentrale SH3 und eine C-terminale SAM Domäne. 
Es konnte gezeigt werden, dass SLy2 sowohl in allen hämatopoietischen Geweben, als 
auch in Muskel, Herz, Gehirn, Dünndarm und Pankreas exprimiert wird. In vivo führte eine 
verstärkte Expression von SLy2 in transgenen murinen B Lymphozyten zu einer Störung 
der Zellausdehnung und –kontraktion während der frühen Antwort auf oberflächen-
fixierte Antigene. In vitro bedingte eine Überexpression von SLy2 in HeLa Zellen die 
Bildung von Membrankrausen und Lamellipodien, beides von verzweigtem F-Aktin 
geprägte zelluläre Strukturen. Es wurde außerdem eine spezifische Lokalisation von SLy2 
in diesen Strukturen beschrieben. Als sekundärer Effekt wurde eine deutlich beschleunigte 
Ausbreitung dieser Zellen auf mit Gelatine beschichteten Oberflächen gezeigt. Auffällig 
war außerdem die verminderte Zellteilungsaktivität der transgenen Zellen, die 
wahrscheinlich auf einer gestörten Zytokinese beruht, was durch das verstärkte Auftreten 
von Zytoplasma-Brücken, sog. Zytonemen zwischen den SLy2-transgenen HeLa Zellen 
nahegelegt wurde.  
Interessanterweise tragen die verschiedenen Domänen von SLy2 zu unterschiedlichem 
Ausmaß zu diesem Phänotyp bei. Während eine SLy2-Mutante ohne die NLS nur mehr 
einen eingeschränkten Einfluss auf die genannten zellulären Strukturen nahm, bedeutete 
die Beseitigung der SH3 Domäne beinahe einen kompletten Verlust der Lamellipodien-
induzierenden Aktivität. Der Effekt der SAM Domäne konnte nicht abschließend evaluiert 
werden, da eine Mutante ohne diese Domäne nur zu einem deutlich verminderten 
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Ausmaß exprimiert wurde. Allerdings zeigen auch Zellen mit hoher Expression dieser 
Mutante einen weitgehend wildtypischen Phänotyp. Die Punktmutation eines 
konservierten Serin-Restes im N-Terminus (Serin 23) zu Alanin resultierte in einer 
Verstärkung des beschriebenen Effekts auf Membrankrausen und Lamellipodien. 
Stimmigerweise zeigten Zellen mit dieser Mutante auch die stärksten Zellteilungsdefekte. 
Dies ist vor allem vor dem Hintergrund interessant, dass das analoge Serin 27 in SLy als Ziel 
der PKD ausgemacht wurde. Beide Ergebnisse legen eine regulatorische Funktion dieser 
Aminosäure nahe (Astoul et al., 2003).  
Durch die Überexpression von verschiedenen Rac1 Punktmutanten konnte eine 
Einflussnahme dieser kleinen GTPase auf die von SLy2 bedingten F-Aktin Strukturen 
gezeigt werden. Die dominant negative Mutante Rac1N17 verhinderte bei gleichzeitiger 
Expression mit SLy2 die Bildung der auffälligen Membranstrukturen. Dem gegenüber 
bedingte die Expression der allzeit aktivierten Variante Rac1V12 noch eine zusätzliche 
Verstärkung des SLy2 Effektes. 
Schlussendlich konnten die beiden Proteine der Cortactin Familie, Cortactin und das 
lymphozyten-spezifische HS1 als Interaktionspartner identifiziert werden. Da die Rolle 
dieser beiden Adaptoren in der Bildung von verzweigten F-Aktin Strukturen bereits klar 
definiert wurde, stellen sie vielversprechende Effektoren für die von SLy2 ausgelösten F-
Aktin Zytoskelett Veränderungen dar. 
 
Die in dieser Arbeit generierte SLy2-defiziente Mauslinie wird in Zukunft eine tiefgreifende 
in vivo Analyse der Effekte dieses Proteins auf das Aktin Zytoskelett ermöglichen.  
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